Characterisation of limbal stem cells by Shaharuddin, Bakiah Binti
  
 
 
Characterisation of Limbal Stem Cells 
 
 
A thesis submitted to Newcastle University 
for the Degree of Doctor of Philosophy 
 
by 
 
BAKIAH BINTI SHAHARUDDIN 
 
 
Institute of Genetic Medicine 
School Of Medical Sciences 
Newcastle University 
July 2015 
 
 
CONFIDENTIAL 
 
 
i 
 
Abstract 
Abstract 
The cornea is the anterior most structure at the front of the eye and its most important 
function is to transmit light to the retina for a clear vision. The external surface of the 
cornea is composed of an epithelium which is continuous with the surrounding 
conjunctiva. The corneal limbus forms the narrow transition zone between the corneal 
and conjunctival epithelia and is believed to harbour the cornea stem cells. Limbal stem 
cell (LSC) deficiency (LSCD) is a painful and blinding condition of the eye. The recent 
technique of ex vivo expansion of healthy autologous limbal epithelia for transplantation 
is the mainstay of cellular therapy for this condition. Successful outcome of ex vivo 
expanded LSC transplantation is dependent on the quality of the transplanted tissues. 
The main aims of this thesis are;  i) to characterise human LSC from both primary LEC 
(LEC) and from a human telomerase-immortalised corneal epithelial cell (HTCEC) line, 
ii) to enrich for LSC by utilising the side population (SP) discrimination assay. Further, 
adult stem cells are promising candidates for promoting donor-specific tolerance and 
adult stem cells have immunosuppressive mechanisms to protect them from 
immunological reactions which are damaging to the survival of the transplanted tissues. 
Therefore, another aim of the study was iii) to investigate the immunobiological aspects 
of LSC including HLA expression and cellular migration which can promote the 
success of cellular transplantation. LSC markers were characterised in both LEC and 
HTCEC. Using an optimised protocol, SP were identified in LEC and HTCEC. Isolated 
limbal mesenchymal stem cells (MSC) fulfil the minimum requirement of a human 
MSC. These limbal MSC (LMSC) exhibited plasticity, could maintain the expression of 
limbal markers and demonstrated viable growth on a biological substrate, qualities 
making them a suitable alternative to cultured limbal explants for clinical 
transplantation. SP cells in HTCEC and LMSC expressed known common limbal 
markers, stem cell antigens and the chemokine CXCR4.  The presence of CXCR4 and 
CXCL12-mediated cellular migration were demonstrated in HTCEC. Further, HTCEC 
constitutively expressed HLA Class I antigens, while HLA Class II expressions were 
induced by Interferon-γ stimulation. In this study, HTCEC HLA-typing was presented 
and that HTCEC were in many ways comparable to LEC, therefore suitable as a LSC 
replacement or as a robust model for further understanding of LSC biology.  
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Chapter 1 LITERATURE REVIEW 
1.1 Corneal Blindness 
1.1.1 Definition, epidemiology and patho-physiology 
According to the World Health Organisation (WHO) fact sheets on visual impairment 
and blindness, there are 285 million people who are visually impaired worldwide 
(WHO, 2014). Out of this, 39 million are blind, while 246 million have low vision. In 
the United Kingdom (UK), currently there are 2 million people living with sight loss. It 
was estimated that this will rise to 2.3 million by the year 2020 (Fight-for-Sight, 2014). 
There are 335,000 adults and 25,000 children in the UK who are registered as blind or 
partially blind according to “Fight for Sight” key facts (Figure 1.1).  
 
Diseases affecting the cornea are the second most important causes of blindness after 
cataracts. The epidemiology of “corneal blindness” is complicated and covers a wide 
variety of patho-physiologies which mostly arise from infectious and inflammatory 
conditions and differ from one country to another. Corneal blindness carries a morbidity 
which affects quality of life and is often associated with an increased economic burden 
(Whitcher et al., 2001).  
1.1.2 Anatomy of the cornea and limbus 
The cornea is the anterior most structure at the front of the eye (Figure 1.2). Its most 
important function is to transmit light onto the retina. Hence, the cornea has a smooth 
and transparent avascular surface. It also contributes as part of the physical, 
physiological and immunological defence mechanisms of the ocular surface. The cornea 
is tough with high tensile strength and flexibility to resist mechanical damage. It has 
inherent mechanisms to maintain the eye shape and eye pressure. The cornea has an 
overlying tear film which plays a major role in ocular surface immunology. 
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Figure 1.1 Key facts on sight loss and eye conditions.  [http://fightforsight.org.uk/sight-
loss-facts] 
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Figure 1.2 Anatomy of the eye and the limbus. 
 
The cornea is a highly specialized structure with five distinct layers (Figure 1.3). The 
outermost layer of the cornea is the thin epithelial cell layer, which is composed of 5-6 
layers of squamous, stratified, and non-keratinised cells (Sevel and Isaacs, 1988). The 
epithelium continues into the edge of the cornea towards the conjunctiva. The 
Bowman’s layer is the basement membrane of the epithelium which is an acellular 
membrane, at the outer part of the corneal stroma.  
 
The majority (80%) of corneal thickness is contributed by the stromal layer; the cornea 
enjoys beneficial physical properties which constantly keep it in a dehydrated state due 
to the organisation of tightly packed collagen lamellae and the presence of compact 
keratocyte networks within the stroma. The next layer is the thick Descemet’s 
membrane, which is the basement membrane of the corneal endothelium - the most 
posterior part of the cornea. The endothelium faces the aqueous humour, and supplies 
the stroma with nutrients. It is equipped with physiological tight junctions with integral 
transport systems to maintain corneal functions. The corneal stroma continues up to the 
sclera and the endothelium is connected to the trabecular meshwork through a transition 
zone. The corneal limbus is a narrow strip of pigmented transitional zone between 
cornea and conjunctiva, located circumferentially peripheral to the cornea.  
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Figure 1.3 Diagrammatic representation of human cornea.  The three main layers; 
epithelium, stroma and endothelium. The Bowman’s membrane is an acellular layer 
which lies in the anterior stroma, just beneath the basement membrane of the 
epithelium. The Descemet’s membrane is the basement membrane of the endothelia 
(Shaharuddin et al., 2013b). 
 
1.1.3 Development of the human cornea 
The fetal cornea can be identified at the 6
th
 week of gestation; it is formed from the 
surface ectoderm overlying the lens (Figure 1.4). In the beginning, the cornea consists 
of two layers; the epithelium and endothelium with an acellular space in between, the 
primary stroma (Sevel and Isaacs, 1988). Studies in quails and chicks demonstrated a 
huge contribution of neural crest cells in periocular structures, refractive media, and the 
cornea (Creuzet et al., 2005). 
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Figure 1.4 Fetal cornea development. (A) Forebrain and developing optic vesicles as 
seen in a 4-mm embryo. (B) Double-layered optic cup and invaginating lens vesicle as 
seen in a 7.5-mm embryo. The optic stalk connects the developing eye to the brain. (C) 
Ocular structures as seen in a 15-week fetus when all the layers of the eye 
are established. The hyaloid artery traverses the vitreous body from the optic disc to 
the posterior surface of the lens. (Modified from Mann IC, The Development of 
the Human Eye. New York, Grune and Stratton, 1974)  
 
1.1.4 LSC niche 
Adult stem cells are now believed to reside in most tissue populations for regenerative 
purposes and tissue repair. The defining characteristics of stem cells are self-renewal, 
which is the ability of the cells to replicate themselves and produce progenitor cells with 
high fidelity, and the capacity to differentiate into multiple different cell lineages. To 
ensure stem cells maintenance, stem cells are protected from hostile external factors in a 
specialized microenvironment i.e. stem cell niche. Within this protective niche, stem 
cells maintain cell-cell interactions with their neighbouring cells. They are able to 
secrete extracellular matrix and other factors that allow the resident stem cells to 
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maintain their stemness in an undifferentiated state. This potentially makes stem cells 
last as long as the life span of the organism.  
 
There is mounting evidence that corneal LSC may reside in the basal layer of the limbus 
(Davanger and Evensen, 1971), (Schermer et al., 1986), (Schlotzer-Schrehardt and 
Kruse, 2005),(Yeung et al., 2008), (Sun et al., 2010). When comparing the proliferative 
potential of limbal versus corneal cells, limbal cells showed greater growth rates than 
corneal cells when they were serially transplanted (Graziella Pellegrini et al., 1999) 
(Wei et al., 1993).  
The limbus consists of multi-layers of cells, which are dispersed in the stroma, rich in 
blood vessels, contains melanocytes and have an abundant nerve supply (Figure 1.5). 
There are associated changes at the limbus; whereby the epithelium thickens from 5-6 
layers at the corneal centre, to 10-12 layers in thickness.  The Bowman’s layer is also 
absent at this region, which results in the undulated corneal epithelium  lying directly on 
the corneal stroma, in which the stromal collagen is also less organised and there is 
abundant fibroblast-like cells. These configurations are now referred as the “Palisades 
of Vogt” (Shanmuganathan et al., 2007; Yeung et al., 2008; Nubile et al., 2012). The 
Descemet’s membrane is also absent, and the endothelial cells appear bigger and flatter 
here.  
 
There are others cells lying in close proximity to LSC, namely the transient amplifying 
cells (TAC), melanocytes and Langerhan’s cell (LC) (Figure 1.5). It remains to be 
determined whether these cell types act as niche cells. It is believed that early TAC will 
differentiate into late TACs located at the corneal basal layer, then into suprabasal post-
mitotic cells (PMC), and finally into superficial terminally differentiated cells (TDC). 
Structurally, the basement membrane separates the epithelium from the underlying 
stroma. The limbal stroma contains mesenchymal cells, which may also serve as niche 
cells (Schlotzer-Schrehardt and Kruse, 2005). 
 
Supporting evidence also come from the fact there is absence of the major corneal 
epithelial differentiation markers, CK3 and CK12 keratins in limbal basal cells. The 
exclusive location of slow-cycling and label retaining cells in the limbal basal layer was 
also observed (Cotsarelis et al., 1989). The presence of 64K keratin in all layers of 
rabbit corneal epithelium but localized to the suprabasal area of the limbus showed that 
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the limbal epithelium is less differentiated (Schermer et al., 1986).  A seminal work by 
Pellegrini et al, also points to ocular surface epithelium  consisting of  holoclones with 
the properties of stem cells (Graziella Pellegrini et al., 1999).  
 
Figure 1.5 The corneal limbus and the LSC niche. (Shaharuddin et al., 2013b). 
 
The hypothesis that limbal stem cells are only confined to the limbus has been 
challenged by Majo et al, who suggested that the limbus is an equilibrium zone where 
the conjunctiva and corneal epithelia are confronted, similar to the tectonic plates (Majo 
et al., 2008; Sun et al., 2010). Factors like the dome-shaped of the cornea, lid blinking, 
ocular pressure and corneal stromal elasticity, hold the conjunctiva and corneal epithelia 
in two opposite directions, by way of confronting the limbus. In brief, disturbance to the 
equilibrium i.e limbal stem cell deficiency causes migration of limbal stem cells onto 
the cornea.  
 
To support this, recent findings have demonstrated that self-renewal capacity of corneal 
epithelium is also shared by central corneal cells as a response to central corneal 
wounding (Ki-Sook Park et al., 2006; Chang et al., 2008). More interestingly, 
peripheral limbal and central corneal regenerative capacity remains the same with 
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limbal ablation for at least 24 hours after corneal wounding (Chang et al., 2008). This 
clearly shows  that oligopotent corneal stem cells are spread throughout corneal basal 
epithelium (Majo et al., 2008) and not exclusive to the limbus.  Despite this 
controversy, decades of scientific evidence and reports have localised the limbus as the 
location of corneal epithelial stem cells. 
 
In response to corneal injury, limbal cells are induced to migrate and differentiate 
centripetally (Wei et al., 1993). Removal of the limbus also diminishes the capacity of 
cornea to regenerate  itself (Huang and Tseng, 1991). More recent advances using the 
lineage tracing technique in K14+ve Confetti mice supported the evidence that mouse 
limbus significantly contributed to self renewal and regeneration of the mouse cornea 
(Amitai-Lange et al., 2015; Di Girolamo et al., 2015). Limbal cells also responded 
rapidly to major wounding compared to the wound healing potential of the long-term 
corneal clones which mainly responded to minor injury (Amitai-Lange et al., 2015). 
 
It has been estimated that up to six limbal epithelial crypts may be present in the human 
cornea. The unique structure of the column and the undulating junctions between limbal 
epithelium and stroma also protect the cells from shear forces.  These are papilla-like 
columns, richly vascularised and highly innervated. They extend radially into the 
conjunctiva or circumferentially at the periphery of the cornea (Dua et al., 2005).  
 
Melanin pigments which causes dark discolouration in these cells, offer a protection 
against possible insults of ultraviolet light and the generation of reactive oxygen 
species. The presence of limbal blood vessels close to the underlying stroma also 
provides nourishment to the cells. The limbal stroma is also highly innervated. These 
characteristics make the limbal region an ideal protective micro-environment and fulfil 
the requirements of a stem cell niche.  
 
1.1.5 Molecular Characterisation of LSC  
p63 is a homolog of transcription factors belonging to a family of tumour suppressor 
proteins which include p53 and p73 (Benard et al., 2003). It is involved in Notch 
signalling and plays a role in the regulation of epithelial morphogenesis. All isoforms of 
the p63 protein consist of a DNA-binding domain and a carboxyl-terminal 
oligomerisation domain. There are 2 forms of p63; isoforms with an added amino-
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terminal transactivation domain are termed TAp63 and those without are ∆Np63. In 
addition, there are three forms of the carboxyl-terminal oligomerisation domain – α, β, 
and γ. This results in a total of six p63 isoforms (Figure 1.6). p63 is expressed at the 
limbal basal epithelium, and co-expression of p63 with Connexin43 was evident in the 
central corneal epithelium (Du et al., 2003). Although not specific to limbal cells, p63 
may be a marker of undifferentiated precursor cells, either stem cells or TAC.   
 
Mutations in the p63 gene have been associated with ectrodactyly, ectodermal 
dysplasia, and facial clefts syndrome (Celli et al., 1999). The inheritance is by 
autosomal dominant and is characterised in part by the lack of normal stratified 
epithelium (Celli et al., 1999; Mills et al., 1999).  p63 knockout mice show severe 
abnormalities of ectodermal differentiation (Mills et al., 1999) where the skin in these 
mice is composed of a single layer, lacking any normal stratification.  
 
Studies have localised p63, and in particular the ∆Np63α isoform, to the nuclei of 
progenitor cells in various epithelial structures (Yang et al., 1998). Specifically in the 
case of corneal epithelial progenitors, immunohistochemistry and cell culture studies 
have localised this particular isoform of p63 to the LSC (G. Pellegrini et al., 2001). 
There has however been growing evidence that ∆Np63α is also expressed by early TAC 
(Espana et al., 2004; Harkin et al., 2004a; Dua et al., 2005; Anshu et al., 2011), 
although these findings may be as a result of poor p63 isoform specificity of the 
antibody (Enzo Di Iorio et al., 2005; Kawasaki et al., 2005). In addition, Pellegrini and 
co-workers have recently shown using molecular biology techniques (rather than 
immunohistochemistry alone) that the ∆Np63α  isoform is specific to LSC (Enzo Di 
Iorio et al., 2005; E. Di Iorio et al., 2006).  
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Figure 1.6 Six isoforms of the transcription factor p63. All isoforms consist of a DNA-
binding domain. Some of these p63 isoforms have an added transactivation (TA) 
domain, the so-called TAp63 isoforms. Those without the TA domain are termed 
∆Np63. All isoforms have an oligomerisation domain of which there are three different 
forms (α, β, and γ). These variations result in a total of six p63 isoforms – TAp63α, 
TAp63β, TAp63γ, ∆Np63α, ∆Np63β, and ∆Np63γ. (Murray-Zmijewski et al., 2006)   
 
Integrins are integral cell membrane glycoproteins which aid cell-cell and cell-matrix 
interactions (Belkin and Stepp, 2000). Although previous studies have proposed α9β1 
integrin as a putative marker for LSC (Stepp et al., 1995), recent studies suggest that 
the α6β4 and α3β1 integrins are associated with BrdU label retaining basal cells of the 
limbal epithelium (Ahdeah Pajoohesh-Ganji et al., 2006). This suggests α6β4 and α3β1 
integrins as putative LSC markers, and the α9β1 integrin as a marker for early transient 
amplifying cells.  
 
Adenosine tri-phosphate binding cassette G2 (ABCG2) is a cell surface transport 
protein, which is preferentially expressed in a variety of adult stem cells (Zhou et al., 
2001; Naylor et al., 2004). This protein is a member of the White subfamily, and is 
alternatively referred to as a breast cancer resistance protein (BRCP). It functions as a 
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xenobiotic transporter which may play a major role in multi-drug resistance. It has 
recently been shown that ABCG2 expression can be localised to basal cells of the 
limbal epithelium and that approximately 3% of LEC express ABCG2 (Satoko Hori et 
al., 2004; Budak et al., 2005; Cintia S. de Paiva et al., 2005a).  
 
The protein encoded by cytokeratin 3 (CK3) gene is a type II cytokeratin; consisting of 
basic or neutral proteins which are arranged in pairs of heterotypic keratin chains. It is 
co-expressed during differentiation of simple and stratified epithelial tissues. This type 
II cytokeratin is specifically expressed in the corneal epithelium with family member 
CK12. CK3  and 12 are intermediate filament, which together with microfilaments and 
microtubules, form the cytoskeleton of all vertebrate cells (Strelkov et al., 2003). CK3 
associates with CK12 to form the CK3/12 dimer. Using ICC, it has been shown that 
CK3/12 identifies the more differentiated cells in the corneal epithelium (Schermer et 
al., 1986; Kurpakus et al., 1990). This CK dimer is therefore absent in the LSC and 
early TACs of the limbal epithelium, and is therefore an important negative marker for 
LSC.  
 
Connexin43 is an integral membrane protein of the connexin family, alpha-type (group 
II) subfamily. Functionally, Connexin43 is involved in gap junction formation, while 
the absence of functional gap junctions has been reported to be an important property 
possessed by stem cells in order to maintain a distinct intracellular environment (Matic 
et al., 1997; Trosko et al., 2000). It has been localized to the basal cells of the corneal 
epithelium (Matic et al., 1997; Wolosin et al., 2002), but shown to be absent from the 
basal cells of the limbal epithelium where both the LSC and the early TACs reside (Du 
et al., 2003). It is therefore an important negative marker for LSC.  
 
CCAAT/enhancer binding protein-delta (C/EBPδ) is an important transcriptional 
activator in the regulation of genes involved in cellular proliferation, differentiation, 
metabolism and inflammatory responses (Ramji and Foka, 2002). Recently, it has been 
shown that it plays an important role in the cell cycle and cell renewal of LSC. Co-
expression of C/EBPδ, Bmi-1, and ΔNp63alpha was used to identify mitotically 
quiescent LSC (Barbaro et al., 2007).  
 
Bmi-1 (B lymphoma Mo-MLV insertion-region 1) is a component of a Polycomb 
group, a complex class required to maintain the transcriptional repressive state of many 
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genes, including Hox genes, throughout development and is believed to prevent 
unnecessary proliferation and differentiation of leukaemic stem cells (Lessard and 
Sauvageau, 2003) and thought to play a role in cell renewal (Molofsky et al., 2003; In-
kyung Park et al., 2003).  
 
Importin 13 is a recently investigated marker of  LSC markers (Wang et al., 2009). It is 
involved in the bidirectional transfer of substrates through the nuclear pore complexes 
between the nuclear and cytoplasmic compartments (Mingot et al., 2001; Liang et al., 
2008; Bono et al., 2010). Expression of Importin 13 in human limbal basal cells has 
been shown to be related to maintaining the properties of corneal progenitor cells.  
 
Keratin 10 (K10) has been detected in the suprabasal limbal region in the late 
embryonic rat cornea at 20.5 days post conception and also in neonatal rats but was 
absent in adult rats (Waters et al., 2009). K10 is hypothesized to be important in the 
development, but not the maintenance of the LSC niche. However, the role of K10 in 
the LSC niche remains unclear. 
 
Identification and verification of LSC specific markers is still an ongoing challenging 
process. Isolation of LSC currently uses some non-specific markers. Often this would 
require a panel of positive and negative markers, a technique similarly observed in the 
haematopoietic and renal systems. Unfortunately, there are minimal cell surface markers 
that are associated with LSC. The use of specific cell surface markers would allow 
techniques such as fluorescence activated and magnetic cell sorting to be used for better 
isolation  of  LSC (Antonelli et al., 2004). Enriched cell populations could then be 
further characterised by gene expression, immunofluorescence or protein expression 
studies.  
 
1.1.6 Maintenance of corneal epithelium 
Stem cells divide asymmetrically to maintain cellular homeostasis by the processes of 
self renewal and differentiation. In contrast to symmetric cell division, stem cells divide 
asymmetrically to produce two daughter cells with different cellular fates (Figure 1.7). 
One daughter cell has the same stem cell characteristics with the original stem cell 
including its proliferative capacity and maintenance of the dedifferentiation state, and 
the other daughter undergoes differentiation. The daughter stem cell’s fate is normally 
to replenish the stem cell depot.  
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Figure 1.7 Asymmetric division of a corneal epithelial stem cell. The stem cell produced 
will replenish the pool, while the transient amplifying cell further divides and 
subsequently differentiate to terminally differentiated cells.  
 
The XYZ hypothesis by (Thoft and Friend, 1983) has revolutionised the understanding 
on the LSC maintenance. It clarifies the corneal epithelial homeostasis in normal 
conditions and in response to injury, and aging. The hypothesis states that aged or 
damaged central corneal epithelial cells (through exfoliation, trauma or disease) are 
continuously replenished through centripetal migration of LSC.  
 
The balance between cell proliferation and cell loss is directed by the equation 
X + Y = Z where; X represents basal corneal epithelial cell movement towards the 
surface, Y represents movement of peripheral epithelial cells towards the central cornea 
and Z represents desquamation of the surface epithelium (Figure 1.8). 
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Figure 1.8 XYZ hypothesis on LSC maintenance explained by centripetal migration of 
LSC. The balance between cell proliferation and cell loss is directed by the equation 
X + Y = Z where; X represents basal corneal epithelial cell movement towards the 
surface, Y represents movement of peripheral epithelial cells towards the central cornea 
and Z represents desquamation of the surface epithelium (Fernández et al., 2008).  
 
1.1.7 Enrichment method for LSC – Side population assay 
The side population (SP) discrimination assay is based on the differential potential of 
cells to efflux vital dyes; the most widely used of these is Hoechst 33342 dye. This 
efflux potential is due to expression of members of the ATP-binding cassette (ABC) 
family of transporter proteins expressed within the cell membrane (Zhou et al., 2001).  
 
When bone marrow cell populations were incubated with Hoechst dye and subjected to 
flow cytometry, active efflux of the dye caused a population of cells to appear as a 
segregated cohort known as SP. The SP phenotype of these cells was confirmed by the 
addition of a transporter inhibitor to cells from the same cell preparation that prevents 
dye efflux, FTC.  
 
All ABC transporters contain two transmembrane-spanning domains (TMD) and ATP-
binding domains (ABC). Typically, the transmembrane regions provide a translocation 
pathway for a specific substrate which allows transport of variety of substrates (Figure 
1.9). The release of energy occurs intracytoplasmic which is a molecular compartment 
provided by the nucleotide binding domains. As the ABC cassettes bind and hydrolyze 
ATP, conformational changes occur and transmitted to the membrane-spanning 
domains, where they induce rearrangements that translocate the substrate from one side 
of the membrane to the other. The SP phenotype is lost upon inhibition of ABC 
transporter activity. 
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Figure 1.9 Membrane topology models for ABC transporters. The green bars represent 
predicted transmembrane helices, the purple circles represent the ABC domains, the 
gold trees are glycosylation sites at the extracellular surface. (Szakács et al., 2008).  
 
1.1.8 Alternative sources of stem cells at the limbus: MSC 
The limbal epithelium also possesses stromal cells which are adherent to plastic, have 
fibroblastic morphology and are able to differentiate into multiple lineages suggestive of 
MSC (Branch et al., 2012; Garfias et al., 2012; Gui-Gang Li et al., 2012). These cells 
can be isolated using protocols as described by previous investigators (Polisetty et al., 
2008). Human corneal mesenchymal stromal stem cells, unlike bone marrow-derived 
MSC, develop from neural crest cells (Hoar, 1982)  and are believed to support the 
growth of limbal epithelial cells (Pinnamaneni and Funderburgh, 2012; Bray et al., 
2014).  
 
1.1.9 Limbal stem cell deficiency 
LSCD refers to a condition caused by abnormal maintenance of the LSC, as a result of a 
reduction in the frequency of LSC resulting in abnormal maintenance (Ahmad, 2012). 
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It can be broadly categorised into unilateral or bilateral involvement, acute or chronic 
conditions (Table 1.1). Among the causes are hereditary genetic disorders called 
aniridia, where there is developmental dysgenesis of the anterior chamber of the eye due 
to PAX6 gene mutation (He et al., 2012; Smith et al., 2012). Acquired causes of LSCD 
include chemical and thermal injury, inflammatory conditions i.e Steven-Johnson 
syndrome, ocular cicatricial phemphigoid and chronic limbitis. Cryotherapy to the 
limbus, radiation and topical instillation or subconjunctival injection of toxic drugs are 
some iatrogenic causes. Persistent traumatic friction to the limbus due to contact lens 
wear and chemical irritation due to contact lens solution can also contribute to this.  
Excessive surgery to the limbal region e.g. removal of pterygium is also a known cause 
for loss of LSC.  
 
Table 1.1 Classification of causes of LSCD 
PRIMARY (inherited) SECONDARY (acquired) 
Aniridia Injury 
Ectodermal dysplasias Mechanical trauma 
 Chemical or thermal burns 
 Iatrogenic 
 Extensive limbal surgery  
 Cryotherapy  
 
Topical or subconjunctival application of 
cytotoxic agents 
 Contact lens associated LSCD 
 Inflammatory eye disease 
 Stevens-Johnson syndrome 
 Ocular cicatricial pemphigoid 
 Chronic limbitis  
  
 
 
Pathologically, the causes of LSCD may be the result of any one or a combination of 
these mechanisms; true loss of LSC, dysfunctional LSC, an alteration in the LSC niche 
micro-environment, or in the case of corneal inflammation or infection, a transient 
‘distress’ or a disruption in the growth or proliferation of LSC. 
 
Signs of LSCD include intense vascularisation, chronic inflammation, recurrent 
epithelial defects, and stromal scarring (Figure 1.10). Intense inflammation will 
inadvertently cause secondary problems like increased eye pressure, which can result in 
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the development of glaucoma and death of the optic nerve ganglion cells. Most patients 
will lose their vision due to the primary or secondary causes during the course of the 
disease. LSCD is usually clinically diagnosed although the use of confocal microscopy 
and impression cytology is substantially supported (Nubile et al., 2012). 
 
 
Figure 1.10 Clinical signs of LSCD. (A) Acute ocular changes showing  limbal 
ischaemia, vascularisation, stromal opacity and epithelial erosion (B) and (C) chronic 
changes with conjunctivalisation of the cornea and corneal opacity. (D) Clearing of 
visual axis after treatment with cultivated corneal epithelium-AM scaffold.  [Photos 
courtesy of (A) Sajjad Ahmad, (B) Scheffer Tseng [Downloaded from 
http://www.revoptom.com/content/c/21674/ on 15 February 2013, (C) and (D) courtesy 
of Dr Tsutomo Inotomi]  
 
1.1.10 Diagnosis of LSCD 
Patients with this condition present with redness in the eye, eye discomfort, excessive 
tearing, and reduced vision or blindness. Clinical signs of LSCD involve conjunctival 
epithelial outgrowth on the cornea or “conjunctivalisation” which gives rise to most of 
the symptoms. Other signs include recurrent epithelial erosion, corneal haziness or 
opacity and late fluorescence staining. Definitive diagnosis would require impression 
cytology to look for conjunctiva cells or goblet cells in the corneal surface. 
Immunofluorescence studies for CK3 and 19 would also support the diagnosis of 
LSCD.  
 
1.1.11 Management of LSCD 
Historically, LSCD was treated with whole cornea transplantation to replace the stem 
cell loss or dysfunction. However, whole cornea transplantation will only invoke failure 
in the absence of healthy limbal cells because of the absence of host stem cells and 
inadequate stem cells in the graft. Thus, re-epithelisation will only take place when 
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there are residual healthy limbal cells in the diseased eye, or a sufficient number of 
limbal cells are replaced. 
 
Management of LSCD includes transplantation of healthy limbal tissue or cells to the 
damaged limbal areas. This is conventionally done by transplanting whole pieces of 
healthy limbal tissue (Kenyon and Tseng., 1989). However, this surgical method will 
usually involve a large area of graft taken from a donor site, thus rendering it 
susceptible to secondary LSCD. 
 
In cases where cadaveric tissues or tissues taken from another healthy living donor are 
transplanted, measures to control graft allorejection have to be taken. Patients receiving 
allogeneic grafts have to be prescribed oral cyclosporine and prednisolone and put on 
topical steroids and antibiotic for extended period of time post-operatively. Limbal 
autografts also carry several adverse complications which are related to the grafts i.e. 
graft dislodging and misalignment. Inappropriate graft size leads to chronic ocular 
surface exposure, which potentially results in epithelial breakdown and 
conjunctivalisation of the cornea (Baradaran-Rafii et al., 2012). The algorithm for the 
management for LSCD is described in Figure 1.11. 
 
19 
 
Chapter 1: Literature Review 
9
 
 
Figure 1.11 Management options of LSCD. This includes conservative (non-surgical) 
and surgical management. Surgical management strategies for mild partial LSCD and 
severe partial or total LSCD are highlighted. 
 
1.1.12 New techniques in the treatment of LSCD (ex vivo expanded limbal 
epithelium) 
A landmark report in 1997 by Pellegrini revealed a successful transplantation of ex vivo 
expanded limbal epithelium from a contralateral healthy limbal tissue grown on a fibrin 
carrier (Graziella Pellegrini et al., 1997). The advantage of using autologous ex vivo 
expansion of limbal epithelium is the small sized-biopsy taken from the healthy eye 
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which will prevent secondary LSCD in the donor eye. The need for immune-
suppression is also eliminated.  
 
Since then, numerous reports have used the method of cultivating a corneal epithelial 
sheet on a substrate before transferring this tissue construct to the eye. In addition, there 
have also been reports on the use of cultivated oral mucosa epithelial transplantation for 
severe bilateral conditions (Nakamura et al., 2004; Inatomi et al., 2006). In the explant 
method, a small biopsy taken from the contralateral eye is placed on AM, which 
provides a surrogate environment for a stem cell niche. 
1.1.13 Alternative sources for LSC transplantation 
The lack of donor corneas in sufficient quantity and of sufficient quality to generate 
LEC for transplantation has motivated many clinicians and scientists to search for 
alternative sources of cells for cellular therapy. The option for replacement of adult 
limbal epithelial stem cells sourced from outside the cornea includes human embryonic 
stem cells (hESC) which can be directed to the corneal epithelial lineage (Kobayashi et 
al., 2013).   
 
The use of appropriate extra cellular matrix i.e. collagen IV, laminin or fibronectin in a 
differential protocol successfully directs hESC into corneal epithelia (Ahmad et al., 
2007).  In a mouse derived ESC, the use of collagen IV as a culture substrate has 
resulted in corneal progenitors which expressed PAX6 and CK12 genes. PAX6 is 
important for ocular development while CK12 has been regarded as a specific marker of 
corneal epithelial differentiation. Indeed, transplantation of these corneal progenitors on 
denuded cornea produced epithelial surface re-epithelisation after 24 hours. However, 
restrictions surrounding ESC, namely ethical issues, technique of differentiation, 
accessibility and the costs, have limited the use of ESC for larger scale translational 
approach.  
 
In the meantime, the advent of human induced pluripotent stem cells (iPSC) has partly 
resolved the ethical issues surrounding ESC.  The use of transcription factors;  Oct3/4, 
Sox2, c-Myc and Klf4 (Kazutoshi Takahashi and Yamanaka, 2006), on somatic cells 
can induce pluripotency in these cells, a process called “reprogramming”. Hayashi et al 
successfully induced cornea epithelial cells from human adult dermal fibroblast-derived 
iPSC and human adult corneal LEC-derived iPSC (Hayashi et al., 2012) by using the 
21 
 
Chapter 1: Literature Review 
stromal cell-derived inducing activity method. In an animal model, mouse iPSC had 
been demonstrated to differentiate into corneal epithelial-like cells when co-cultured 
with a corneal stromal cells in the presence of additional factors such as β-FGF, EGF 
and NGF (Yu et al., 2013). 
 
Derivation of whole cornea from a parthenogenetically activated oocyst (hpSC) 
(Revazova et al., 2007; Ostrowska et al., 2011; Turovets et al., 2011) is also an option. 
Parthenogenesis is asexual reproduction of eggs without contribution of the 
spermatozoa. hpSC lines have similar morphology to hESC, express pluripotent stem 
cell markers, have high alkaline phosphatase level and telomerase activity, and have the 
ability to differentiate in vitro and in vivo into derivatives of the three embryonic germ 
layers. Production of HLA-homozygous hpSC lines is also advantageous as being 
compatible with segments of human population, other than the 1 
donor. This makes these cell lines a more favourable option as a transplantation therapy 
than ESC (Revazova et al., 2007; Turovets et al., 2011). 
 
Likewise, transcriptionally induced pluripotent cells could also be a source of tumour 
formation (Hentze et al., 2009; Cunningham et al., 2012) and poses the problem of 
immunogenicity when used in transplantation (Boyd et al., 2012). By re-programming 
stage-specific embryonic antigen-4 (SSEA4), SSEA4+ve limbal fibroblasts isolated 
from corneal stroma keratocytes and bone-marrow derived MSC could be differentiated 
into corneal epithelium (Katikireddy et al., 2014). This was grown in under specific 3D 
culture system in embryonic stem cell media. 
 
From the cord lining stem cells obtained from the waste birth products of fetal umbilical 
cord, investigators have isolated MSC and epithelial stem cells sourced from the 
external lining which comprises of umbilical cord AM. The bilayered lining of the 
membrane is advantageous for many epidermal and dermal keratinocytes derivatives. 
They also have potential to derive the epithelia for skin, liver and cornea(Matsuura et 
al., 2014).   
 
In the case of total and bilateral LSCD, cultivated oral mucosa epithelial transplantation 
on AM has also been clinically applied with promising results (Koizumi et al., 2000; 
Nakamura et al., 2004). This approach when reviewed for 15 treated eyes showed a 
success rate of 67% total re-epithelisation, without any major complications for a period 
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of at least 34 months. Similar method, but in the absence of 3T3 feeders and animal 
serum has also been trialled in two patients with successful regeneration of corneal 
epithelium (Kolli et al., 2014). 
 
1.1.14 Biological substrates for limbal stem cell transplantation 
Historically, the strategy for LSC transplantation utilized fibrin sheet to treat LSCD 
(Graziella Pellegrini et al., 1997). A mixture of fibrinogen and thrombin was placed on 
a plastic ring to allow a coagulation cascade. Primary limbal keratinocytes were grown 
on feeder layers on this fibrin sheet and the cell to matrix construct were then 
transplanted to patients’ eyes (Rama et al., 2001). A clinical trial involving larger 
number of patients showed a success rate of 76.6% up to 10 years (Rama et al., 2010). 
 
Amniotic membrane (AM) as part of the carrier system to transfer limbal epithelial 
sheets has been the substrate of choice to restore ocular surface disorders (Saw et al., 
2007). AM facilitates re-epithelisation and has been shown to have anti-inflammatory 
(Shimmura et al., 2001), anti-angiogenic (Jae Chan Kim and Tseng, 1995; S. C. G. 
Tseng, 2001),  and anti-scarring properties (Scheffer C. G. Tseng et al., 1999).   
 
To date, AM has been the most widely used substrate to deliver LSC to the ocular 
surface. Several modifications have been tried to provide different forms of AM to 
improve its quality as a carrier, including the use of denuded AM over an intact 
membrane (Koizumi et al., 2000). However, the drawbacks are the difficulty to sustain 
the donor supply, ineffective and costly screening of the tissues, and clinical variations 
in the tissues which might affect the growth conditions. Hence, researchers have 
explored the potentials of other materials and used new strategies to develop tissue-
engineered constructs to improve the outcome of limbal transplantation for ocular 
surface regeneration.  
 
1.1.15 The outcome of ex vivo expanded limbal epithelial transplantation 
Short term review of 28 clinical studies on cultivated corneal epithelial transplantation 
since 1997 to 2010 shows a  success rate of 67% (Baylis et al., 2011). This would 
probably be due to the majority of tissues used in these studies being autologous in 
nature (84%). Another long term study on the outcome of cultured limbal epithelial 
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transplantation using fibrin as a carrier gave 66% of full success, 19% for partial 
success and 15% of failure rate respectively (Graziella Pellegrini et al., 2013).  
 
In a review of clinical outcomes (Shortt et al., 2007b), despite the heterogeneity of the  
type of grafts, the biological carrier to transplant LSC, culture methods, and the clinical 
cause of the disease, the overall outcome of 17 studies was 67% success rate.   
It could not be emphasized enough that long term success of LSC transplantation 
depends on the quality of the grafts or the frequency of LSC on the grafts. This can be 
overcome by more effective identification or isolation of LSC, or the use of enrichment 
methods for LSC. It would also be expected that a major issue with allogeneic limbal 
tissue or cell transplants remains their immunogenicity. 
 
1.1.16 Current prospective on tissue engineering for LSC transplantation 
Tissue engineering was first introduced as an interdisciplinary approach to restore or 
enhance the biological functions of tissues and organs using substrates (Langer and 
Vacanti, 1993). The issue of cell sourcing was initially addressed by the use of adult 
stem cells or ESC. Although ESC have better differentiation and expansion potential 
than adult stem cells their use is hampered by ethical issues, regulatory problems and 
associated funding limitations. On the other hand, adult stem cells have limited 
differentiation capability. The advent of the Nobel Prize-winning development of 
human induced-pluripotent stem cells (IPSC) by Yamanaka group (Kazutoshi 
Takahashi and Yamanaka, 2006) seemed to offer a solution to the problems concerning 
the use of adult stem cells and ESC. However, the use of IPSC has been under scrutiny 
for possible genetic and epigenetic aberrations and tumorigenesis after transplantation. 
 
The second major component in tissue engineering is the biomaterials used as the 
substrate or scaffolds for cell delivery. The initial focus was to replicate the physical 
and mechanical properties of the target tissues. Prospectively, more emphasis is being 
given to the integration of the substrates with the biological environment resembling 
closely the supportive extra cellular matrix (ECM).  
 
The use of hydrogels which are biocompatible, inert and biodegradable is more 
attractive to replace or to complement AM. Hydrogels are more structurally uniformed 
and the physical and mechanical properties can be modified to suit cellular proliferation 
24 
 
Chapter 1: Literature Review 
(Wright et al., 2013b). Hydrogels are made up of a 3D network of polymers and water, 
comprised of macro-molecules connected by electrostatic forces, hydrogen bond, or 
covalent links. As a scaffold, hydrogels can encapsulate cells and biomolecules as a 
cellular niche. Cross-linking of plastically compressed collagen hydrogels (Levis et al., 
2010; Mi et al., 2011; Levis et al., 2012) and alginate hydrogels are some of the 
examples useful for clinical epithelial transplantation (Wright et al., 2013a; Wright et 
al., 2013b; Wright et al., 2014). 
 
An artificial niche environment for LSC is an innovative mechanism to refine the LSCD 
treatment.  Bioartificial alginate hydrogel systems provide a LSC microenvironment 
which allows slow release of therapeutic factors by the LSC to promote epithelisation 
and wound healing. In this model, growth factors such as epidermal growth factor, 
keratinocyte growth factor and hepatocyte growth factor migrate through the gel micro 
structure to facilitate the repair of the damaged corneal surface (Fritchley et al., 2000).  
 
Collagen forms the majority of constituents in the human cornea. Scaffolds of 
compressed collagen gel when compared to denuded AM have been demonstrated to be 
a better support for the growth of LEC (Groves and Jiang, 1995). This proved to be 
mechanically strong, thin and transparent. However, further investigations to study its 
immunogenicity based on its purity are needed. The use of recombinant collagen type I 
and IV has raised the issue of replacement of naturally occurring collagens, however 
this might come with increased costs (Feng et al., 2014). 
 
Other strategies like decellularisation of tissues and organs have emerged, where 
complete removal of cells and cellular materials is done to reduce immunogenicity 
(Lynch and Ahearne, 2013). This is performed by using chemical and enzymatic 
methods for decellularistion, followed by re-seeding with new cells, a process called 
“scaffold recellularisation”. However, maintaining a close balance of preserving 
structural, mechanical and physiological properties of the scaffold and reducing cellular 
immunogenicity still remain the challenges in this area. 
 
Fabricated nanofibers are a new substrate which is biocompatible with LEC and use of 
these with cells resulted in  good cellular adhesion and cell proliferation (Sharma et al., 
2011). Fibrous nanoscaffolds from poly-ε-caprolactone (PCL) are highly porous, have 
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high surface: volume ratio and as a 3D biocompatible structure, this can mimic the 
physiological extra cellular matrix, used for synthetic ocular surface regeneration. 
 
There is an increasing need to develop a synthetic, biocompatible and slowly 
biodegradable material which could be used as substitute for the AM. The use of a 
synthetic material would avoid the risk of infection. A biodegradable material has the 
advantage of variable degradation rate for the viable cells to be released at the site of 
injury. A contact lens which is resilient, biocompatible, and able to adapt to the surface 
of the eye is also an ideal carrier system for delivering of cultured corneal epithelium 
(Fiorica et al., 2011).  This is an interesting finding which needs further investigations 
to materialize as a cellular-based therapy. 
 
A technique developed to escape from any use of carrier system is a new temperature-
responsive polymer e.g.  poly N-isopropylacrylamide (PIPAAm) as a cell sheet 
engineering system. This method allows transfer of cells and the extra cellular matrix to 
the ocular surface (Nagase et al., 2009) at different temperature conditions in the 
absence of a scaffold (Kobayashi et al., 2013). PIPAAm polymer and its co-polymer 
show a hydrophobic state at 37 °C and at this temperature cells would adhere and 
proliferate. At 32 °C and below, the cells are detached because of polymer hydration, 
which allows harvesting of the cells in a mono layer cell sheet while maintaining  cell-
to-cell  and cell to-extra cellular matrix contact (Matsuura et al., 2014).  
 
Bioprinting is a new technology where scaffolding materials, living cells and extra 
cellular matrix can be delivered for regenerative purposes into a chosen material in an 
organized manner by a previously determined bio-printer (Pati et al., 2014). As an 
example, human cardiomyocyte progenitor cells were successfully bio-printed on 
alginate scaffolds suitable as a cardiac construct (Gaetani et al., 2012). This technique is 
still obscure in the field of LSC.   
 
1.2 Immunological Aspects of Corneal Transplantation  
1.2.1 Corneal transplantation 
The cornea is the most transplanted organ in UK (with 3061 transplantations or 49.6 
performed per million populations in 2009-2010 (Johnson, 2010)). This is the highest 
recorded rate of transplantation surpassing solid organ transplantation such as adult 
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kidney transplantation which was 892, pancreas – 200, cardiothoracic organ transplants 
- 272 and liver – 679 cases during the same period.  
 
Corneal transplantation is the definitive therapy for most causes of corneal blindness. 
Importantly, transplantation is also performed to replace rejected or failed previous 
grafts in 20% of cases (K A Williams et al., 2008). Approaches to corneal 
transplantation surgeries have evolved from whole cornea or partial thickness 
transplantation, to single layer keratoplasty, with very promising outcomes (Lee et al., 
2009; Borderie et al., 2012).   
 
However, corneal transplantation is contraindicated in the treatment of LSCD, which is 
an important cause of corneal blindness. Failure of grafts in this condition is due to loss 
of host stem cells and inadequate self renewing cells to replenish the surface of graft 
from the donor. In the case of LSCD, cellular therapy such as ex vivo limbal epithelial  
transplantation has shown impressive advances as future treatment in the past decade or 
so (Graziella Pellegrini et al., 1997; S. C. G. Tseng, 2001; Shortt et al., 2007b; Shortt et 
al., 2008; Rama et al., 2010).  
 
The cornea is devoid of blood vessels and assumed to be protective of immune rejection 
of transplanted grafts, a condition termed “corneal immune privilege” (Azar, 2006). Its 
avascularity implies a lack of angiogenic factors or the possibility of it secreting anti-
angiogenic factors. Vascularisation evokes an immune response and has implications 
for graft allorejection. In addition, absence of corneal lymphatics prevents the 
channelling of antigen presenting cells to the regional lymph nodes thus not allowing 
alloantigen-specific T cells to be activated. Activated T cells travel to the graft bed and 
initiate the crucial process of graft rejection. However, the relative ease of topical 
steroid application on the cornea and the immune tolerance in the anterior chamber also 
add to its relative success rate.  
 
Despite being the most frequent organ transplanted, the immunology of corneal 
transplantation and rejection is not fully studied. For the most part, outcomes for whole 
cornea transplantation (penetrating keratoplasty) are dependent on the indications for 
surgery. The mechanism of rejection in cornea transplantation is a delayed type; T cell- 
mediated immune response which is accelerated by inflammatory process. 
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1.2.2  Mechanisms of immune privileges in the cornea  
Cornea transplantation has been regarded differently from other organ transplants due to 
the immune privileged nature of the anterior chamber of the eye and the lack of direct 
allorecognition. Medawar revolutionised the concept of immune privilege in the cornea 
in 1940s (Medawar, 1948). He observed how skin grafts transplanted in the brain and 
the anterior chamber of the eyes could remain intact for extended periods of time in the 
absence of any vascularisation (Medawar, 1948). Medawar suggested that the immune 
reaction is mediated by blood plasma or by cells transported in it. During corneal 
transplantation, vascularisation caused the breakdown of the immunologically 
privileged status of the cornea, resulting in graft rejection. It was also suggested that the 
epithelium rather than the stroma played a role in the immune reaction (Billingham and 
Boswell, 1953).   
 
The immune privilege of the cornea depends on multiple mechanisms to prevent 
immune destruction of grafts by allogeneic responses. At present, three major lines of 
thought prevail regarding the molecular mechanisms of immune privilege in the eye: (1) 
anatomical, cellular, and molecular barriers in the eye; (2) anterior chamber associated 
immune deviation (ACAID); and (3) immune suppressive microenvironment in the eye.  
 
Firstly, there is a direct absence of anatomical lymphatic drainage and a physiological 
blood-ocular barrier in the cornea which defines the immunological tolerance. Without 
lymphatic drainage, the antigens are unable to leave the grafts to the draining lymph 
nodes.  The blood-ocular barrier effectively presents a physiological block for the 
immune cells to enter the tissues. These factors collectively act as physical barriers to 
stimulate immune response to grafts. 
 
ACAID was first described as an aberrant immune response of the eye (Kaplan and 
Streilein, 1977). This refers to the phenomenon where antigen-specific systemic 
immunological tolerance is induced to an antigen that has been introduced to the 
anterior chamber (Figure 1.12). In this situation, antibody responses are preserved while 
cellular responses such as delayed type hypersensitivity (DTH) and cytotoxic T cells 
(CTL) are suppressed. These include alloantigens involved in transplantation, soluble 
protein antigens, viral antigens, and tumour antigens (J. Y. Niederkorn and Mellon, 
1996).  
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Vascularisation causes an allograft to be deemed high risk and robs its immune 
privilege status. Immunological rejections in high risk vascularised allografts occurs due 
to increased level of chemokines and inflammations at the site of the grafts, attracting 
allospesific activated T cells to the site (Y. Sano et al., 1995; Azar, 2006; Amescua et 
al., 2008). Chemokines are heparin-binding pro-inflammatory proteins that are 
responsible for directing leucocytes migration. Chemokines are categorised into CXC, 
CC, C and CX3C based on the cysteine residue at the protein terminal. CXC 
chemokines i.e. CXCL1, play a major role in recruiting activated allospecific T cells, 
macrophages and other potent inflammatory mediators to the graft site, causing 
immunogenic rejection (Amescua et al., 2008). 
 
Figure 1.12 Components of ocular surface immunity. They include physiological barrier 
of the precorneal tear film, induction of ACAID and immunosuppressive environment 
in the eye.  Immunomodulatory molecules in the cornea consist of neuropeptides, 
cytokines, growth factors and soluble immune peptides which have anti-inflammatory, 
anti-angiogenic, and pro-apoptotic activities that lead to death of allospecific T cells. 
[Abbreviations: GDNF= glial derived neurotrophic factor, APC=antigen presenting 
cells, TGF-β=tumour growth factor-beta, VIP=vasointestinal peptide, TSP-1= 
thrombospondin-1,  PD-1-B7-H1= programmed death-1 Ligand-B7-H1 binding, T reg= 
regulatory T cells, MIP-2= macrophage inflammatory protein-2, CXCL2= C-X-C 
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ligand-2, NKT= natural killer T cells, IL-10=interleukin-10, CCL5=C-C ligand-5). 
(Shaharuddin et al., 2013b)] 
 
The anterior chamber contains tumour growth factor (TGF)-β and thrombospondin- 
(TSP)-1, and antigen presenting cells which capture the antigens and secrete these into 
the blood stream through the trabecular meshwork and reach the marginal zone in the 
spleen. TGF-β stops proliferation of cells, induces differentiation, or promotes apoptosis 
while TSP-1 has an inhibitory effect on angiogenesis. Furthermore, there is production 
of TGF-β, macrophage inflammatory protein- (MIP) 2 and CXC-ligand 2 (CXCL2) in 
the spleen. These in turn attract and binds to NKT cells and stimulate the production of 
TGF-β, IL-10, TSP-1 and CC-ligand 5 (CCL5). In the spleen there is formation of 
clusters of T cells and subsequent induction of regulatory T cells, or ACAID-inducing-T 
regulatory cells (ACAID-T Reg). CD8+ T regulatory cells down regulate Th1 and Th2 
effector functions in the eye, while CD4+ T regulatory cells inhibit differentiation of 
Th1 cells in the lymph node. 
1.2.3 Rejection in corneal transplantation 
Common indications for penetrating keratoplasty are keratoconus, corneal dystrophies, 
corneal opacities and post cataract surgeries.  Comparisons on the outcome of corneal 
transplantation are difficult because of the non-uniformity of data on surgical 
indications, patient demography, type of grafts, survival analysis and range of follow-
up. In general, uncomplicated low risk grafts give the highest survival rate with topical 
steroidal immune-suppression. Based on surgical indications, the Australian Corneal 
Graft Registry reported keratoconus has the highest 10-year survival rate (89%), 
compared to Fuch’s corneal dystrophy (73%), non-herpetic corneal opacity (70%), 
herpetic corneal opacity (60%), pseudophakic and aphakic corneal oedema (40%), and 
regrafting (30%) (K A Williams et al., 2008).  
 
A breakdown of survival analysis shows the fate of allogeneic penetrating keratoplasty  
for correcting visual acuity  was highest in the first year follow-up i.e. 87% and reduced 
to 52% after 10 years among Asians (Tan et al., 2008). Generally, failed grafts are due 
to irreversible immunological rejection (34%), while corneal endothelial cell failure due 
to glaucoma (24%) and infection (14%) are common causes of failed grafts (K A 
Williams et al., 2008). A similar trend is observed in a study of second grafts; in the 
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majority of cases immune rejection is the main cause of graft failure, although 
recurrence of disease and endothelial decompensation are also important causes 
(Kirkness et al., 1990). 
 
Clinically, other associated factors which are implicated include degree of pre-
vascularisation of the recipient bed, size of donor corneal button, position of the donor 
corneal button in the recipient bed, preservation methods for the donor corneal button, 
choice of immunosuppression and immune status of the recipient.  
 
Generally, the immune response to alloantigens is polarised in two directions; A) 
Activation of T helper type 1 (Th l) effector cells which results in production of 
interferon (IFN)-γ, introduction of CD4+ as a surface determinant and mediation of 
delayed immune response. B) Activation of the T helper type 2 (Th2) pathways, may 
produce cytokines which cross regulate Th1 factors and inhibit their mediator functions. 
IFN-γ is an important pro-inflammatory cytokine in the rejection of MHC-matched 
corneal allografts. It has been shown that manipulating the alloantigenic response from 
Th1 to Th2 pathways by blocking IFN-γ production in MHC-matched allografts 
significantly reduces graft rejection rate (Hargrave et al., 2004).  
 
The mechanism of rejection in cornea transplantation is a delayed type T cell- mediated 
immune response which is accelerated by inflammatory process. In a rat corneal 
transplantation, CD4+ cells had an important role in the mechanism of rejection, while 
the role of CD8+ T cells was not clearly shown. Interleukin (IL)-2, IL-4 and IFN-γ are 
regarded as important inflammatory markers for corneal rejection(Torres et al., 1996).  
 
This finding is in agreement  with an experimental sheep corneal transplantation model, 
where acute rejection is associated with graft neovascularisation, infiltration of CD4+ 
and CD8+ T cells, and production of IFN-γ and IL-2 in the graft (Ka Williams et al., 
1999). But production of tumour necrosis factor (TNF)-α, IL-4 and IL-10 was not 
evident, which the investigators hypothesised might be due to rapid T cell death due to 
Fas-FasL interactions (Yamagami et al., 1997). The expected result of this interaction 
would be induction of apoptosis in Fas bearing infiltrating leucocytes such as CD4+ T 
cells, CD8+ T cells, neutrophils, and macrophages (K A Williams et al., 2005). The role 
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of TNF-α in initiating, maintaining and resolving inflammatory processes, has been 
observed to show dynamic changes in allograft transplantation (Chan et al., 1999). 
 
Corneal epithelium and stroma both peripherally and centrally, contain  dendritic cells 
(DC) which undergo maturation by expressing MHC Class II and B7 co-stimulatory 
molecules during inflammation (Hamrah et al., 2003).  B7 co-stimulatory molecules 
provide potent stimulation for MHC/peptide-T cell receptor interaction to result in 
activation of T cells. B7 molecules are present as dimers on the surface of DC or other 
forms of APC.  
 
A novel negative regulatory molecule has been described recently, which is a new 
member of the B7-CD28 super family, and it is referred to as programmed death-1 (PD-
1) (Junko Hori et al., 2006). B7-H1is a potential ligand for PD-1 (Freeman et al., 2000). 
B7-H1 has been found in corneal epithelium and endothelium and is believed to have 
pro-apoptotic actions on T cells, thus prolonging the survival of corneal grafts (Junko 
Hori et al., 2006). 
 
1.2.4 Major Histocompatibility Complex (MHC) expression in cornea 
transplantation 
The MHC gene complex present antigen to T cells and determines the compatibility of 
donors for organ transplants. The Human Leucocyte Antigen system (HLA) represents 
MHC which encodes for genes related to immune system and cell surface antigen 
presenting proteins. MHC class II antigen presentation pathways are expressed by 
professional antigen presenting cells (APC) e.g. dendritic cells, macrophages, B-cells, 
or epithelial LC.  
A critical factor influencing corneal graft rejection is the presence and the high density 
of such dendritic cells in the graft (donor APCs). Avoiding placement of a graft near the 
limbal area where the APCs are abundant is a logical surgical strategy in this instance.  
An approach towards a donor specific-immnosuppression by regulatory T cells to 
achieve graft tolerance may be taken to eliminate the risk of a violent rejection when 
donor’s and recipient dendritic cells coexist.  
 
The most important antigen presenting cells in the cornea is bone marrow-derived MHC 
Class II+ LC which are responsible for the sensitisation of the host to alloantigens. 
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Under normal conditions LC reside in the limbal area but may migrate to the cornea in 
response to inflammatory conditions (Jerry Y Niederkorn, 1995). Activation of 
alloreactive T cells is dependent on the antigen presenting cells for the host to recognise 
foreign antigens on the grafts. 
 
There is uneven distribution of LC which express HLA class II molecules in the cornea; 
this could possibly be the answer for prolonged survival of these grafts (Hamrah et al., 
2002).  LC were originally thought to be exclusively abundant in the limbal and 
conjunctival region, but not at the central cornea (JY Niederkorn et al., 1992; D. L. 
Williams, 2005). HLA class II expression in normal corneal stroma and endothelia is 
also lacking, and mostly confined to the limbal region of the epithelium (Foets et al., 
1991).  
 
Expression of Class II is also absent without stimulation by inflammatory mediators 
(Nicholls et al., 2006). However, more recent findings demonstrated that a 
heterogeneous population of immature and precursor dendritic cells also reside in the 
central corneal region (Hamrah et al., 2002). These cells labelled as “MHC Class II-
negative” are believed to be progenitor or immature LC. Although these immature cells 
are capable of antigen uptake and processing them, they are incapable to furnish naïve T 
cells with requisite B7 co-stimulatory molecules, thus unable to activate T cells 
(Thomson et al., 1995). This mechanism of active suppression of LC maturation could 
be an important mechanism of corneal immune privilege. 
 
Not surprisingly, there is low incidence of corneal graft rejection although HLA antigen 
matching of donor and recipient is not normally performed, especially in low risk grafts. 
In a study performed by The Collaborative Corneal Transplantation Studies Group in 
high risk corneal transplantation patients,  HLA-A, B and HLA-DR matching did not 
reduce the rate of graft failure in this high risk group (1992). Additionally, a recent 
finding showed that although matching of HLA-A and -B did not significantly affect the 
rejection rate in low risk group, it certainly benefitted the high risk group. (Khaireddin 
et al., 2003). HLA-DR matching was also demonstrated to significantly reduce allograft 
rejection by 40%, 3 years after surgery in the high risk group(Khaireddin et al., 2003). 
The disadvantages of HLA matching include the costs and extended waiting time for 
suitable grafts. However, these need to be seriously weighed against the risk of failed 
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grafts and further therapeutic complications, regrafting and the overall impact on the 
pool of available donated corneas. 
 
Despite encouraging results from MHC matching, grafts can still be rejected due to 
incompatibility in the minor MHC antigens. Th1 pathway and IFN-γ production was 
shown to be the mechanism involved in rejection of MHC-matched corneal allografts 
where minor MHC antigens are presented to the host (Hargrave et al., 2004). Minor 
MHC antigens are naturally occurring polypeptides processed and presented by MHC 
molecules, shown to increase risk of grafts failure in grafts-versus-host disease. Minor 
MHC antigens induce activation of T cells and also play an important role in allograft 
rejection of solid organs following transplantations (Yoichiro Sano et al., 2000; Kwun 
et al., 2011; Pabón et al., 2011). Minor H antigens are loaded to MHC molecules in 
corneal grafts allowing for indirect T cell allorecognition (Sonoda et al., 1995). 
Alloreactive T cells recognise allogeneic peptides “indirectly” when they are introduced 
to self-MHC class I and II molecules. On the other hand, “direct” allorecognition occurs 
when T cells recognise donor alloantigens directly, irrespective of the peptides 
associated with the MHC molecules. 
 
Experimental stimulation of human corneal epithelial cells with recombinant human 
IFN-γ demonstrated increased expression of MHC Class II antigens (Iwata et al., 
1992)
,
(Iwata et al., 1994)
 
and significant  ability to stimulate allogeneic lymphocytes 
(Iwata et al., 1994).  Another study revealed corneal epithelium and  endothelium 
express MHC class II antigens when stimulated by  IFN-γ, whereas it had no effect on 
the expression of MHC class I antigens (el-Asrar et al., 1989).   
 
1.2.4 Methods to prevent rejection 
Strategies to reduce rejection rate must take into consideration immunosuppressive 
reagents and gene therapy. The use of anti-inflammatory mediators is an additional 
strategy to prolong survival of grafts. Soluble TNF-α receptor type I in a topical 
instillation form has shown favourable results in reducing murine allogeneic reactions 
(Qian et al., 2000). TNF-α is a potent pro-inflammatory cytokine in alloimmune 
response. It is a macrophage derived cytokine responsible for expression of adhesion 
and co-stimulatory molecules, neutrophils activation, chemokine stimulation and 
inducing the nuclear factor-ΚB signalling pathway.  
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More recently, administration of IL-1 receptor antagonist (IL-1Ra) was shown to be a 
promising as an effective modality for suppressing IL-1-mediated processes to counter 
rejection in corneal transplantation (Dana et al., 1997; Stapleton et al., 2008) to 
corticosteroid immune suppression in mice allogeneic grafts. IL-1 is involved in 
mediation of acute phase reactions, chemotaxis, stimulation of new vessels and most 
importantly, the migration and recruitment of LC. IL-1Ra is produced in abundance at 
the apical epithelial region in fresh cornea (Heur et al., 2009). This potent inflammatory 
cytokine is derived from monocytes, macrophages and resident corneal cells and is 
expressed at high levels during corneal transplantation immune response. IL-1 receptor 
antagonist (IL-1Ra) has the effect of neutralising IL-1 by suppressing LC migration, 
thus prolonging survival of allografts. Interestingly, the success of experimental ex-vivo 
transduction of IL-1Ra in rat cornea will be a new landmark in corneal gene therapy to 
treat corneal inflammatory conditions and corneal transplantation (Yuan et al., 2012).  
 
NGF gene therapy in combination with a cytotoxic T lymphocyte antigen 4 
immunoglobulin G (CTLA4Ig) has shown to prolong rodent corneal allografts survival 
by mediating its anti-inflammatory and anti-apoptotic pathways (Gong et al., 2007). 
This is not surprising since NGF and its receptors are abundantly present in a densely 
innervated organ like the cornea and are responsible for the wound healing process 
(Kinoshita and Ueta, 2010). 
 
In other pharmacological developments, suppression of inflammation by interleukin-10 
(IL-10)(Boorstein et al., 1994) and inhibition of intercellular adhesion molecule-1 or its 
ligand (Whitcup et al., 1993) are prospective potential therapies. 
 
1.3 Conclusion 
A challenging aspect of LSC is the absence of specific markers to uniquely identify 
these stem cells and to distinguish them from other adult stem cells, or LSC derived 
from TAC. This necessitates the characterization process involving several modalities 
i.e. RT-PCR, immunochemistry or cell cycling methods. A consistent isolation method 
for LSC should also be instigated, to include protocols to enrich for LSC such as 
functional phenotypic assays like the SP assay. 
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Ex vivo expanded limbal epithelial transplantation has proven to be able to reconstruct 
the ocular surface in LSCD eyes. However, this method needs to be further refined to 
include protocols to assess tissue viability, the quality of   tissue constructs and safety 
assessment. In order for LSC to be successfully translated into favourable clinical 
outcomes, a good manufacturing practice (GMP)-compliant protocol would be a 
positive step towards achieving high quality tissues to fulfil the requirements for clinical 
transplantation(DiIorio et al., 2010).  
 
As the most transplanted organ, the importance of understanding corneal immunology is 
of considerable interest. A major issue with whole cornea transplantation, allogeneic 
limbal tissues or ex vivo LSC transplants remains their immunogenicity. Questions arise 
whether the ocular immune system is similar in all regions of the eye, and does the 
immune privilege status of the anterior chamber apply to other ocular tissues? It would 
be interesting to explore immunogenicity of grafts placed on the cornea in an ocular 
reconstruction surgery where no breach of the anterior chamber happens at all. 
 
Further investigation on the immunological factors in the cornea that allow tolerogenic 
potential of the organ to respond to ocular antigens is necessary to exploit corneal 
immune privilege to its full advantage. Identification of inflammatory molecules and 
apoptotic markers, their signalling pathways, and role of HLA matching, are some of 
the strategies to promote the survival of whole corneal and LSC transplantation. 
Furthermore, differential expressions of HLA antigens during inflammation and 
rejection process may elucidate the role of antibodies alone, or in combination with 
other soluble factors in donor antigen-specific immune suppression. This approach of 
immune suppression by regulatory T cells may potentially achieve graft tolerance to 
eliminate the risk of a violent rejection.  
 
1.4 Objectives 
This project will aim to address a deficit in our knowledge of LSC biology, namely the 
characterization of LEC from both primary LEC and a human telomerase-immortalized 
corneal epithelial cell (HTCEC) line, limbal SP cells (as an enriched adult stem cell 
population) and studying the biological and immunological properties of corneal 
epithelial cells with implications on LSC transplantation. A novel therapeutic approach 
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to culture an alternative stem cell population sourced from the corneal limbus on 
cryopreserved AM, thawed from frozen will be tested as a preferred biodegradable 
scaffold. 
1.4.1 Experimental Approaches and Techniques 
Aim 1 
To achieve these objectives, specific aims will involve these techniques;  
1) Isolation of human LEC from primary donor corneas. 
2) Characterisation methods for both human LEC and HTCEC. 
3) Optimisation of LSP protocol for both human LEC and HTCEC. 
4) Characterisation of human limbal SP (LSP) cells. 
 
Aim 2  
To study the biological and immunological properties of corneal epithelial cells with 
implications on LSC transplantation, these techniques will be employed;  
1) Examine the expression of HLA class I & II molecules in corneal epithelial cells. 
2) Determine the HLA expression under stimulation of pro-inflammatory cytokines.  
3) Study cellular migration in corneal epithelial cells. 
 
Aim 3:  From the results defined in Aim 1, research grade cryopreserved AM obtained 
from NHS Blood and Transplant will be used as a substrate to promote cellular 
proliferation and differentiation of LMSC.  .  
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Chapter 2 GENERAL MATERIAL AND METHODS 
2.1 Ethics and Research Approval 
This project was conducted according to the ethical principles of the Declaration of 
Helsinki for human experiments. Project and ethical approvals received for this project 
were as listed: 
2.2 Project Approval 
This project had received project and ethical approval from the Ethics Committee, 
Faculty of Medical School, Newcastle University on 18 January 2013 (No. 00617/2012) 
and amended on 24 April 2013 (N0. 00617_1/2013) (Appendix 1). 
The corneal tissues were harvested by the The Eye Bank and stored in Optisol media 
contaning dextran. All requests for human cells, tissues and organs from the bank were 
peer-reviewed for merit and procurement feasibility and in order to apply for tissues we 
provided proof that we had ethical approval from Newcastle University for this research. 
We did not require any identifiers to the donors, other than age, gender, time of death to 
preservation in the media mentioned above and death to delivery interval. Therefore 
there was no issue with storage of personal data.  
 
Data generated from our study were kept on computers housed within Newcastle 
University.  Results of our studies were available to other researchers and the public via 
publication in peer reviewed journals, the university website and by presentation at 
conferences.  
 
As a general rule, we received donor corneas which had satisfied the General Organ 
Donor Criteria, with the exception of age and blood type. All tissues had undergone 
screening for infective diseases e.g. HIV, Hepatitis B or C, syphilis, cytomegalovirus 
and Epstein Barr Virus. In addition, the donors did not have known corneal trauma or 
diseases or intra-ocular eye surgery. Additional exclusion criteria were as at the 
discretion of the Eye Banks. Alternatively, donor cornea which was not suitable for 
transplantation was assigned for research and training.  
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2.3 Human Tissue Authority License 
For use of human tissues in research, the Institute of Genetic Medicine has been 
approved for handling, storage and research on human disorders and functions in the 
body (Appendix 2).  
2.4 Material Transfer Agreement (MTA) 
The approval for use of human corneascleral rings was obtained through a material 
transfer agreement with the Central Manchester and Manchester Children’s University 
Hospitals (NHS Trust) (Appendix 3). Donor corneas were either unused whole cornea 
from clinical transplantation, or whole cornea/corneoscleral rims suitable for research 
and training. 
2.5 Ethics/Project approval  
The ethical approval for the use of human AM was obtained through Newcastle 
Uteroplacental Bank Ethics Committee, application reference number 13.04 (Appendix 
4).  
2.6 Ethics/Project approval  
Human cryopreserved AM were supplied by the National Health Service (NHS) Blood 
and Tissue bank, Liverpool, United Kingdom. Donors had undergone medical and 
social history interviews and tissue screening for infective diseases as mentioned above.  
2.7 General Laboratory Practice 
All experiments were performed according to the Control of Substances Hazardous to 
Health (COSHH and BIOCOSHH) regulations. All procedures were in compliance with 
Newcastle University current safety policies. Tissue culture was carried out in 
compliance with regulations for containment of Class II pathogens. 
2.8 Tissue Culture 
2.8.1 3T3 Fibroblast culture 
Immortalised Swiss mouse embryonic fibroblasts from the J2 strain (a gift from Dr. 
Fiona Watt originally from Howard Green’s Laboratory, Harvard) were thawed from 
frozen. The resulting cell suspension was centrifuged with 3T3 medium (Table 2.1) at 
1,000 revolutions per minute (rpm) for 3 minutes at room temperature. 
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2.8.2 3T3 Fibroblast Culture medium 
3T3 fibroblasts were routinely grown in T25cm
2
 flasks [Iwaki/VWR] at 37
°
C, 5% CO2 
in a humidified incubator until 80-100% confluency determined microscopically (Figure 
2.1). Medium was removed and cells washed with Dulbecco’s Phosphate Buffer Saline 
(DPBS) [Sigma].  3ml 0.05% trypsin-EDTA was added into the flask and incubated for 
2 minutes at 37°C. Flask was examined for cell detachment and subsequently agitated. 
Cell suspension was then removed and transferred to a 15ml centrifuge tube and 
centrifuged at 1,000 rpm for 3 minutes.  The supernatant was discarded and the cell 
pellet re-suspended in 5ml 3T3 medium and subcultured into a new T75cm
2 
flask in a 
total medium volume of 10ml. Medium was changed every other day. 
Table 2.1 Composition of the medium for 3T3 fibroblast culture 
Reagent Composition Supplier 
High glucose DMEM (4,500mg/l) 89% Gibco 
FCS 10% Gibco 
Penicillin/Streptomycin 1% Gibco 
 
2.8.3 Cryopreservation of 3T3 fibroblast 
Cells were frozen using Recovery Cell Culture Freezing Medium [Gibco], which 
contains DMSO 10%, high glucose DMEM, and fetal bovine serum. The medium was 
first removed from flask and washed with DPBS. 5ml of 0.05% trypsin-EDTA was 
added to the flask and incubated for 3 minutes at 37°C. Cells were agitated collected in 
a 15ml centrifuge tube which was then centrifuged at 1,000 rpm for 3 minutes. The 
supernatant was removed and 1ml of freezing medium was added to cell pellet 
containing about 1 x 10
6
 cells and transferred to a cryogenic vial and put in a cell 
freezing container [Nalgene], which contains 250ml of 100% isopropyl alcohol [VWR 
BD Prolab]. This provides -1°C/minute cooling rate required for successful cell 
cryopreservation and recovery, and then frozen at -80°C.  
2.8.4 Re-culturing of cryopreserved 3T3 fibroblast  
Frozen cell suspensions were rapidly thawed and cytotoxic cryopreservants were 
inactivated by washing in 3ml of 3T3 media in a 15ml conical centrifuge tube at 1,000 
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rpm for 3 minutes. The supernatant was discarded and the pellet was resuspended with 1 
ml of 3T3 media and transferred to a T25cm
2
 or 75cm
2
 flask containing 10ml 3T3 
medium. The media was changed on the next day and every other day following that.  
2.8.5 Inactivation of mouse 3T3 fibroblast feeder layer with mitomycin C (MMC) 
When cells reached 80% confluence, MMC [Sigma] was added at the concentration of 
10µg/ml of the volume of medium. The tissue culture flask was then incubated for 2 
hours at 37°C. After which, 5ml of 0.05% trypsin-EDTA was added and incubated at 
37°C for 3 minutes. The detached cells were harvested, into 3T3 media and centrifuged 
at 1,000 rpm for 3 minutes at 4°C and the cell pellet was then resuspended in 2ml 3T3 
medium and counted. The cells were plated at 2.4 x 10
4
/cm
2
 in a 6-well plate. The cells 
are amitotic but still living and can be used as a feeder layer. 
2.8.6 Inactivation of 3T3 fibroblast feeder layer with X-irradiation 
Alternatively, confluent 3T3 were exposed to 60 Gy units at 0.01 Gy units per second 
[Astrophysics Research Corporation X-Ray Inspection System]. The medium was 
removed and briefly washed with DPBS, and replaced with 10ml 3T3 medium. The 
cells were then detached from the flaks using 5ml 0.05% trypsin-EDTA and centrifuged 
and the cell pellet then re-suspended in 3T3 media and plated at a density of 2.4 x 
10
4
/cm
2
 in a 6-well plate.  
2.8.7 Cell counting 
Cells were counted prior to experiments/cryopreservation using a haemacytometer 
[Scientific Laboratory Supplies]. 10μl of cell suspension was pipetted onto the 
haemacytometer and allowed to diffuse under the cover slip and examined under a light 
microscope.  Cells in the 25 squares of the grid were counted and the total multiplied by 
1 x 10
4
 to obtain the number of cells/ml. To ascertain cell viability, 20µl sample of the 
cell suspension to be counted was placed in a solution containing 50µl 0.4% trypan blue 
solution [Sigma] and 30µl DPBS [Gibco] and incubated for 10 minutes at room 
temperature. This resulting cell suspension was counted as above. Blue cells were non-
viable cells and excluded from the count. The final count was multiplied by a factor of 5 
to allow for the dilution of volume of cells to volume of trypan blue and PBS (1:5). 
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2.8.8 Plating of 3T3 fibroblast as a feeder layer 
After performing a count of the viable cells, 24,000 cells/cm
2
 in 3T3 medium were 
added to the 9.6cm² tissue culture wells [VWR], containing inactivated 3T3 fibroblasts 
as feeder cells (refer section 2.8.2 and 2.8.5 on culture and preparation of 3T3 feeder 
layer).  
2.9 Primary LEC Culture 
2.9.1 Isolation of LEC 
LEC culture was conducted according to (Graziella Pellegrini et al., 1999)  – Cadaveric 
limbal tissues were obtained in agreement with the UK Eye Bank.  All tissue culture 
work was routinely carried out in a containment level II microbiological safety cabinet. 
Limbal tissues were sourced from discarded corneo-scleral rings as left over from 
penetrating keratoplasty surgeries, or harvested as research grade whole corneas (Figure 
2.2).  
 
The tissue was cut into 4 quadrants and cut further into 1 mm² pieces. These limbal 
pieces were incubated with 0.05% trypsin-EDTA [Gibco] for 20 minutes at 37
°
C, 5% 
CO2 in a humidified tissue culture incubator with gentle agitation of the suspension at 
the 10 minute point of a 20 minute cycle. The resulting cell suspension was removed 
from the limbal pieces, and 1ml limbal epithelial medium (Table 2.2) was added to this 
suspension. The cell suspension was then centrifuged for 3 minutes at 1,000 rpm at 4°C 
and the supernatant discarded. The remaining cell pellet was re-suspended in limbal 
epithelial medium (LEM). This process of trypsinisation of the limbal pieces and 
centrifugation of the resulting cell suspension was repeated for a further three times 
using the same limbal tissue. Finally, the resulting limbal cell suspensions were pooled 
together and centrifuged.  
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Figure 2.1 Confluent 3T3 fibroblast cultures.  
 
 
 
 
Figure 2.2 Harvesting a cornea from an enucleated cadaveric eye. 
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2.9.2 LEC medium 
The composition of reagents and additives for LEC media is listed in Table 2.2.  
Table 2.2 Composition of limbal epithelial medium (LEM). 
Reagent Quantity Supplier 
DMEM (Low Glucose 1g/L) 375 ml (75%) Invitrogen 
Ham’s F12 Medium 125 ml (25%) Invitrogen 
Foetal calf serum 10% Invitrogen 
Penicillin/Streptomycin 1% Invitrogen 
Hydrocortisone 0.4μg/ml Sigma 
Insulin 5μg/ml Sigma 
Triiodothyronine 1.4ng/ml Sigma 
Adenine 24μg/ml Sigma 
Cholera Toxin 8.4ng/ml Sigma 
Epidermal Growth Factor 10ng/ml Sigma 
 
2.9.3 Plating and subculturing of LEC 
The cells in the limbal media suspension were counted for viable cells. 30,000 viable 
LEC in epithelial medium were added to the 9.6cm² tissue culture wells [VWR], 
containing inactivated 3T3 fibroblasts as feeder cells.  
 
Sub-culturing was done according to  (Rheinwald and Green, 1975a) - To expand the 
number of LEC, the primary cultures were sub-cultured prior to confluence of the 
colonies (Figure 2.3). The medium was removed from the culture well and the culture 
was briefly irrigated with PBS. The culture was incubated with 0.05% trypsin-EDTA 
solution for 5 minutes in a tissue culture incubator. Epithelial medium was then added 
to the resulting cultured LEC suspension. The suspension was centrifuged for 3 minutes 
at 1,000 rpm at 4°C and the supernatant was removed. The resulting cell pellet was re-
suspended in epithelial medium. After performing a count of viable cells, the cells were 
plated in a 9.6cm² well containing 3T3 feeder cells. The sub- cultures were then treated 
in the same way as primary cultures above (refer section 2.8.4).  
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Figure 2.3 LEC grown on mitotically inactivated 3T3 fibroblast in different stages of 
cultures. (A) Formation of holoclones on Day 3 (white arrows) (B) enlarging colonies 
on Day 7 (C) spindling of cells at a differentiated stage on day 12 (black arrows).  
 
2.9.4 Culture of LEC on coating matrix using serum-free medium 
Subcultures of LEC were plated in tissue culture well 9.6cm
2
 or 25cm
2
 flask without 
feeder-cells and under serum-free culture conditions (Figure 2.4A, 4B, 4C). Wells and 
flasks were Coated using Coating Matrix Kit [Gibco] which contains 0.5ml sterile 
recombinant human Type-1 collagen as a Coating Matrix (Item # 50-9700) and 50ml 
Dilution Medium (Item # 50-9701) were used. Dilution Medium was added to each 
flask (5ml per each 75cm
2
 flask, or 1.7ml per each T25cm
2 
flask or 0.65ml for a 9.6cm
2
 
well). Coating Matrix was directly added to the Dilution Medium in each flask (50 µl 
per each T75cm
2
 flask, or 17µl per each T25cm
2
 flask or 6.5µl per each 9.6cm
2 
well). 
To ensure uniform distribution of the coating matrix over the surface of the flask, the 
flasks were rocked back and forth gently. The flasks were capped and incubated for 30 
minutes at room temperature.  Excess Coating Matrix/Dilution Medium was removed 
from each flask. The flasks could be used immediately, or stored at 2° to 8° C for short 
periods of time. 
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Prior to plating of LEC the flasks and wells were briefly washed with PBS and cells 
plated in defined keratinocyte serum free medium (DKSFM) [Gibco]. This is a medium 
optimised for expansion of keratinocytes without supplementation of bovine pituitary 
extract or the use of feeder layers. Growth promoting agents were added to enhance 
consistent product performance. Plating of cells was performed as described above. 
2.10 Human telomerase-immortalised cornea epithelial cell line (HTCEC) 
We received a frozen vial of HTCEC from Professor Winston Kao’s laboratory in 
University of Cincinnati, USA. The cell line was originally derived by Professor James 
Jester (University of California, Irvine, USA). We successfully expanded HTCEC and 
maintained this cell line in feeder- and serum-free conditions (Figure 2.4D).  
 
Frozen suspensions of HTCEC were rapidly thawed and mixed and washed with 
DKSFM [Gibco] for 3 minutes at 1,000 rpm at 4°C. The supernatant was discarded and 
the resulting pellet was re-suspended in DKSFM into a T25 cm² tissue culture flask 
[Scientific Laboratory Supplies] and maintained in a tissue culture incubator at 37ºC, 
5% CO2. The medium was changed on the next day and then every three days. 
2.10.1 Maintenance of human telomerase-immortalised cornea epithelial cell line 
For the purpose of maintaining HTCEC, the medium was removed from subconfluent 
cell cultures and the cells washed with DPBS. The cells were detached from the flask 
with a tissue dissociation buffer [Gibco] (the buffer is an enzyme-free aqueous 
formulations of salts, chelating agents, and cell-conditioning agents in either Ca
2+
- and 
Mg
2+
-free Hanks balanced salt solution which is suitable for gentle dissociation of cells 
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Figure 2.4 Human primary limbal cultures (Passage 2) grown on a collagen II coating 
matrix at different stages. (A) Day 2 (B) Day 8 (C) Day 15 (D) HTCEC in serum-free 
and feeder free conditions on Day 3. 
 
from support substrates and each other, or in this case, firmly adherent cells) for 20 
minutes at 37ºC and then incubated with 0.05% trypsin-0.53 mM ethylene 
diaminetetraacetic acid (EDTA) solution [Gibco] for 3 minutes in a tissue culture 
incubator also at 37ºC. The trypsin was then inactivated by the addition of DMEM 
containing 10% fetal bovine serum. The resulting cell suspension was centrifuged for 3 
minutes at 1,000 rpm. The supernatant discarded and the cell pellet re-suspended in 
DKSFM. The cell suspension was then split into two T25 cm² flasks or being put into 
one T75 cm² tissue culture flask [Scientific Laboratory Supplies] containing DKSFM. 
The HTCEC cultures were maintained in a tissue culture incubator and the medium was 
changed every three day. The HTCEC was repeatedly sub-cultured for a maximum of 
20 passages. 
2.10.2 Cryopreservation and reculturing of HTCEC 
For the purposes of maintaining stocks, 1 x 10
6
 cells was suspended in 1ml of Recovery 
Cell Culture Freezing Medium [Gibco], the suspension was then transferred to a 
cryogenic vial and put in a cell freezing container [Nalgene], which contains 250ml of 
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100% isopropyl alcohol [VWR BD Prolabo]. This provides -1°C/minute cooling rate 
required for successful cell cryopreservation and recovery, and then frozen at -80 °C or 
in liquid nitrogen. 
 
The frozen cell suspension was rapidly warmed and washed in DKSFM and centrifuged 
at 1,000 rpm for 3 minutes. The supernatant was discarded and the pellet was 
resuspended in 1ml of DKSFM and transferred to a 25cm
2
 or 75cm
2
 flask containg a 
further 10ml DKSFM. The media was changed on the next day and then every three 
days.  
2.11 Mycoplasma detection and treatment 
Mycoplasma are small and simple prokaryotes which depend on their host for nutrients 
due to their limited biosynthesis. As they compete with the cells for the nutrients in the 
culture media, this will affect cellular growth and proliferation and cause changes in the 
gene expression. Cells were regularly tested for mycoplasma contamination every six 
months. Mycoplasma detection was carried out using the MycoAlert
TM
 assay [Lonza] 
according to the manufacturer’s protocol. In principle, this assay is a selective 
biochemical test that exploits the activity of certain mycoplasma enzymes which upon 
lysis, reacts with the MycoAlert
TM 
substrate and catalyses the conversion of ADP to 
ATP. The level of ATP before and after the addition of the MycoAlert
TM 
substrate 
indicates the presence or absence of mycoplasma and can be measured using a 
luminometer ‘Luminoskan’ [Thermo Scientific]. The bioluminescent reaction involved 
is as follows: 
                                       Luciferase 
ATP + Luciferin + O2                    Oxyluciferin + AMP + PPi + CO2 + LIGHT 
                                           Mg
2+ 
 
Briefly, after dissociation, cells were centrifuged and 100μl of cleared fresh supernatant 
was suspended with 100μl reconstituted MycoAlertTM reagent in assay buffer, and left 
for 5 minutes in a luminometer cuvette. Luminescence was then measured using a 
Luminometer TD-20/20 [Turner Biosystems, Inc.USA] and labelled as Reading A. 
Following that, 100μl MycoAlertTMsubstrate was added to the sample and left for 10 
minutes, after which the second luminescence reading was labelled as Reading B. The 
ratio of Reading B/Reading A is used for the interpretation of mycoplasma 
contamination. The ratio of <0.9 is negative for mycoplasma, 0.9-1.2 is borderline, and 
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> 1.2 signifies mycoplasma contamination. Cells represented with borderline results 
were quarantined and retested within the next 24 hours. Cells with mycoplasma 
infection were discarded and fresh stocks obtained.  
2.12 Other Cell Lines  
Other cell lines were grown in appropriate culture conditions: 
2.12.1 Breast cancer cell MCF-7 
This is a human breast adenocarcinoma cell line. MCF-7 is a cell line that was first 
isolated in 1970 from the breast tissue of a 69-year old Caucasian woman. The cell line 
retains several characteristics of mammary epithelium. It is an oestrogen receptor (ER) 
positive progesterone receptor positive cell line (Yamaguchi et al., 2005). 
MCF-7 cells were grown in complete Dulbecco’s Modified Eagle’s medium (cDMEM) 
that contains 10% fetal bovine serum (v/v) and 1% Penicillin/Streptomycin under 
standard TC conditions, while still subconfluent the medium was removed and the 
adherent cells washed briefly with with PBS, incubated with 0.05% trypsin-0.53 mM 
ethylene diaminetetraacetic acid (EDTA) solution [Gibco] for 5 minutes in a tissue 
culture incubator at 37ºC with 5% CO2. The trypsin was then inactivated by the addition 
of DMEM containing 10% fetal bovine serum. The resulting cell suspension was 
centrifuged for 3 minutes at 1,000 rpm. The supernatant was removed and the resulting 
pellet was resuspended in cDMEM for subculturing. For cryopreservation, 1.0 x 10
6
 
cells were cryopreserved as described previously (refer section 2.8.3). 
2.12.2 Breast cancer cell MDA-MB-231 
This cell line was obtained from pleural effusion of a 51-year old patient at M.D. 
Anderson Cancer Centre, Texas, USA in 1973. It appears spindle-shaped and has 
epithelial morphology, with an invasive phenotype. These cells are oestrogen and 
progesterone receptor negative. The cells were propagated in DMEM. Subculturing, 
cryopreservation and revival of cells follows similar steps as described previously (refer 
section 2.8.4). 
 
2.12.3 Ovarian cancer cell HeyA8MDR 
These malignant ovarian epithelial cancer cells are counterpart to HeyA8. It is taxane-
resistant and was recently demonstrated as secreting endoglin, an angiogenic marker 
49 
 
Chapter 2: General Materials and Methods 
which is associated with chemo-resistance (Ziebarth et al., 2013). The cells were 
propagated in RPMI 1640 Complete Culture medium [Sigma Aldrich] with NaHCO3 
and without L-glutamine. Subculturing, cryopreservation and revival of cells follow 
similar steps as described above in section 2.8.4. 
 
2.12.4 Human Epstein-Barr Virus (EBV)-negative cell line (Ramos) 
These cells were derived from a Caucasian Burkitt's lymphoma patient. It does not 
possess the Epstein Barr Virus (EBV) genome, however these cells may be infected in 
vitro with a prototype strains of EBV (Trivedi et al., 2001). These are non-adherent 
cells and propagated in RPMI 1640 Complete Culture medium [Sigma Aldrich] with 
NaHCO3 and without L-glutamine.  
 
2.13 Primary cells – Other 
2.13.1 Human peripheral blood leukocytes (PBL) 
Peripheral blood leukocytes were used as negative control gating in flow cytometry for 
optimisation of antibodies. PBL isolation was conducted together with Dr Gendie Lash 
(Institute of Cellular Medicine, Newcastle University). Briefly, venous blood was 
acquired from the antecubital vein and collected in a heparinised universal tube. 10ml 
PBS was added to 10ml of blood. In a new universal tube, 5ml lympholyte-H 
[CedarLane Laboratories] was added. Following this, diluted blood was carefully 
layered on top of the lymphoprep. The tube was then centrifuged at 800G for 20 
minutes with no brake (set at 0). This separated the blood into layers, the serum was 
gently removed. The leukocytes were then harvested into a fresh universal tube and 
washed  with PBS 25ml, followed by centrifuged at 400G for 10 minutes, with the 
brake set at 3., this step was repeated a second time and the final cell pellet was 
resuspended in 5ml of media  ready for use. 
2.13.2 Human bone marrow (BM)-derived MSC 
BM-derived MSC [courtesy of Dr Rachel Oldershaw] was used as positive control for 
immunofluorescence. The cells were maintained in MSC-enriched media and incubated 
in hypoxic condition with 5% oxygen, 5% CO2 incubator at 37°C, prior to use. 
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2.14 Flow cytometry 
2.14.1 Definitions and principles 
Flow cytometry is a technological process that involves light scattering, excitation and 
emission of fluorochromes to provide data of cells or particles. Samples were hydro-
dynamically focused in a sheath of PBS before intercepting a light source (usually a 
laser) (Figure 2.5).  
 
Figure 2.5 Principles of flow cytometry-1. The sample is injected into the sheath and 
hydro-dynamically focused at the centre of the stream. When it intercepts a laser source, 
they scatter light and the fluorochrome is excited to a higher energy state.  When the 
molecule goes to a relaxed state, it will release a photon of light that has unique specific 
spectral properties to the fluorochrome (From Current Protocols In Cytometry, Unit 
1.2, p 1.2.2 ). 
 
When a cell intercepts a laser source, light is scattered and the fluorochrome is excited 
to a higher energy state.  When the molecule goes to a relaxed state, it will release a 
photon of light that has unique specific spectral properties to the fluorochrome (Figure 
2.6).  
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Figure 2.6 Fluorescence spectra of commonly used fluorochromes. The bottom part of 
the table summarizes the emission wavelengths of various light sources used in flow 
cytometry. The 488nm line of the argon ion laser is extended over the spectra. (From 
Practical Flow Cytometry, Third Edition, Howard M. Shapiro. P. 245) 
 
Several dichroic mirrors and filters separate the scattered and emitted light into different 
wavelengths which divide the light to a series of photomultiplier tubes (PMT) (Figure 
2.7). PMT processed the potential difference by a series of linear and log amplifiers 
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which give signal pulses proportional to the number of photons reaching the 
photodetector.  
 
Figure 2.7 Light Scattering, 2-parameter histogram. Logarithmic amplification is used 
to measure fluorescence in cells. Different signals or pulses are amplified to allow for 
events to be plotted on histograms. 
 
Logarithmic amplification is most often used to measure fluorescence in cells. After the 
different signals or pulses are amplified they are processed by an Analog to Digital 
Converter (ADC) which in turn allows for events to be plotted on a graphical scale e.g. 
One Parameter or Two parameter Histograms (Figure 2.8).   
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Figure 2.8 Principles of flow cytometry-2. Several dichroic mirrors and filters separate 
the scattered and emitted light into different wavelengths which divide the light to a 
series of photomultiplier tubes (PMT). PMT processed the potential difference by a 
series of linear and log amplifiers which give signal pulses proportional to the number 
of photons reaching the photodetector. 
 
This information can be used to sort subpopulations of cells. Data generated from flow 
cytometry are available in a multiparameter acquisition display software programmes. 
Flow cytometry analysis data of a single suspension yields multi parameter data which 
correspond to Forward Light Scatter and 90 Light Scatter. This information allows 
characterisation of subpopulations and this separation process is called “sorting”. 
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2.14.2 Forward scatter and side scatter 
Forward scatter or low angle scatter is detected in the plane of incident light. The 
amplitude of the signal often corresponds to cell size or cell diameter of cells with the 
same refractive index. 
While SSC or the 90˚ light scatter or “right angle scatter” refers to the internal 
granularity or complexity of a cell. Light tends to scatter at larger angles to the incident 
beam by cells that are more dense or granular. 
2.14.3 Principles of cell sorting 
A cell sorter can rapidly separate the cells in a suspension on the basis of size and the 
properties of the fluorochromes. A cell sorter like FACS DiVa [BD] uses the droplet 
method, where a cell suspension containing cells which are labelled with a fluorescent 
dye is hydronamically focused in the cell sheath to allow single passage of droplets. 
This stream emerges from a nozzle vibrating at some 40,000 cycles per second which 
breaks the stream into 40,000 discrete droplets each second. A laser beam is directed at 
the stream just before it breaks up into droplets. As each labelled cell passes through the 
beam, its resulting fluorescence is detected by a photocell which is electrically charged. 
 
If the signals from the two detectors meet either of the criteria set for fluorescence and 
size, an electrical charge (+ve or -ve) is given to the stream. The droplets retain this 
charge as they pass between a pair of charged metal plates. Positively-charged drops are 
attracted to the negatively-charged plate and vice versa. Uncharged droplets (those that 
contain no cell or a cell that fails to meet the desired criteria of fluorescence and size) 
pass straight into a third container and are later discarded (Figure 2.9).  
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Figure 2.9 Principles of cell sorting. The suspension in the sheath intercepts a laser 
beam, becoming droplets which then pass an electrical field which causes the droplets to 
retain positive or negative charges. Positively-charged drops are attracted to the 
negatively-charged plate and vice versa, the cells are “sorted” according to the desired 
criteria of fluorescence and size.   
 
2.15 Immunocytochemistry (ICC) 
2.15.1 Titration of antibodies  
For antibody optimisation, primary antibodies were diluted in 0.5% Normal goat serum 
(NGS) [Sigma]/PBS to 1:50, 1:100, 1:300, and 1:500 dilutions. For transcription factor 
p63 and ABCB5 antibodies, optimum antibody concentration was determined by 
performing ICC on HTCEC. The optimum expression for p63 was at 1:50 dilution. For 
ATP-binding casette (ABC)-G2 transporter antibody, optimised expression was 
obtained using a rabbit polyclonal anti-human ABCG2 antibody at 1:100 dilutions 
[Novus Biologicals]. In the case of stem cell markers NANOG, Oct 3/4 and Sox2, 
antibody concentrations were optimised using embryonic stem cell (ESC) courtesy of 
56 
 
Chapter 2: General Materials and Methods 
Dr Rachel Oldershaw (Institute of Genetic Medicine). The optimum expression for 
these primary antibodies was observed at 1:100 dilutions. 
 
2.15.2 Staining for markers 
40,000 cells were seeded on an 8-chamber slide [BD Falcon] in appropriate tissue 
culture medium and allowed to proliferate until 80% confluence in 5% CO2 incubator at 
37°C. Upon reaching confluence, culture medium was removed and cells washed with 
PBS three times. Cells were then fixed with cold methanol [BDH Laboratory Supplies] 
at-20°C for 10 minutes. Slides were then washed with PBS and then permeabilised for 
10 minutes in 0.3% (v/v) Triton X-100 [Fisher Scientific] diluted in PBS, and then 
washed again with PBS. Blocking of non-specific binding sites in 5% normal goat 
serum and PBS was performed for 30 minutes in a humid chamber in the dark. Cells 
were incubated with primary antibodies in 0.05% FBS/PBS overnight at 4°C. Cells 
were then washed with PBS 3 x 5 minutes. Cells were incubated with secondary 
antibody for 30 minutes in a humid chamber in the dark. Following that, slides were 
washed with PBS three times/5 minutes and the chamber was removed from the slide.  
 
The slide was then mounted in vectashield anti-fading medium [Vector Laboratories] 
and slides were covered with a cover slip. Slides were stored at 4°C in the dark or taken 
immediately for viewing under a fluorescence microscope. For longer term, storage 
slides were kept at -20°C. Negative controls were cells stained without primary 
antibody, but with secondary antibody. A list of primary and secondary antibodies is 
presented in Table 2.3. 
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Table 2.3 Primary and secondary antibodies used for ICC. 
Antibody 
Cellular 
localisation of 
antigen 
Optimal 
Dilutions Supplier 
PRIMARY 
  
 
Mouse monoclonal anti-human p63 
(clone 4A4)  
 
Nuclear/ 
cytoplasmic 
 
1:50 
Santa Cruz 
Biotechnology 
Mouse monoclonal anti-human ABCB5 
(clone 5H3C6) 
 
 
Transmembrane 
 
1:100 Abcam 
Mouse monoclonal anti-human Oct3/4 
 
Intracellular 
 
1:100 BD Biosciences 
Mouse monoclonal anti-human NANOG 
 
Intracellular 
 
1:100 Abcam 
 
Rabbit polyclonal anti-human ABCG2 
(clone 5D3) 
 
 
Transmembrane 
 
 
1:100 
 
 
Novus Biologicals 
 
Rabbit polyclonal anti-human Sox2 
 
 
Nuclear 
 
1:100 Abcam 
SECONDARY 
  
 
FITC-conjugated secondary goat  
anti-mouse immunoglobulins 
 
Intracellular 
 
1:25 
 
Jackson Immunology 
Research Laboratories 
FITC-conjugated secondary goat  
anti-rabbit immunoglobulins 
 
Intracellular 
 
1:25 
 
Jackson Immunology 
Research Laborotories 
Rhodamine-conjugated secondary goat  
anti-rabbit immunoglobulins 
 
Intracellular 
 
1:25 
 
Jackson Immunology 
Research Laborotories 
 
 
2.16 RNA isolation 
RNA isolation was performed using RNEasy Plus Micro Kit [Qiagen] as per 
manufacturer’s instructions on 500,000 – 1,000,000 cells. Briefly, 350 µl Buffer RLT 
Plus was added to the cells. The lysate was then homogenized by centrifuge at 11,000 
rpm for 30 seconds. The lysate was transferred to gDNA Eliminator spin column in a 2 
ml collection tube. This will remove the genomic DNA. It was then centrifuged for 30 
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seconds at 11,000 rpm. The spin column was discarded and total RNA was collected in 
the 2 ml collection tube. 
 
350µl 70% ethanol was added and mixed by pipetting. It was then transferred to an 
RNEasy MinElute spin column in a 2ml collection tube, and centrifuge at 11,000 rpm 
for 15 seconds. The flow through was discarded. 700µl Buffer RW1 was added to the 
spin column, centrifuged for 15 seconds at 11,000 rpm and the follow through 
discarded. 500μl Buffer RPE was then added to the spin column, and centrifuged at 
11,000 rpm for 15 seconds. The flow through was discarded. 500µl 80% ethanol was 
added to the spin column, and centrifuged at 11,000 rpm for 2 minutes. The flow 
through was then discarded.  
 
In a new 2ml collection tube, then cap of the spin column was opened, and centrifuge at 
11,000 rpm for 5 minutes to dry the spin column membrane. The collection tube was 
then discarded. The spin column was then placed in a 1.5ml collection tube. 14µl 
RNase-free water was added directly to the centre of the spin column membrane, and 
centrifuged for 1 minute at full speed (13,000 rpm) to elute the RNA. 
 
2.16.1 RNA quantification  
RNA was quantified using Nanodrop Spectrophotometer 2000 [Thermo Scientific]. 
Initially the spectrophotometer was calibrated with 1µl blank solution and followed by 
the RNA sample. A260/280 is the absorbance ratio for nucleotides:protein, and  used to 
determine the purity of RNA and DNA. A value of ~1.8 is acceptable for DNA purity 
while a slightly higher level ~2.0 is acceptable for RNA purity.   A260/230 which is the 
absorbance ratio for nucleotide:chemical contamination i.e phenols, alcohol, was also 
documented.  
 
2.16.2 RNA integrity 
As a measure of RNA integrity, RNA were electrophoresed on 1% agarose gel [NBS 
Biologicals] at 90V for 45 minutes in tris-borate-EDTA (TBE) buffer [Sigma]. Agarose 
gel electrophoresis is a technique used to separate DNA or RNA fragments by size. The 
sugar-phosphate backbone results in the nucleic acids being negatively charged. When a 
current is applied, the RNA or DNA migrates towards the positive electrode and the rate 
of migration is dependent on the nucleic acids size, the smaller fragments will migrate 
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faster than the larger fragments. The RNA sample was examined for 28S and 18S 
bands.  
 
To make 50 ml 1% agarose gel, 50 ml 1X Tris/Borate/EDTA buffer was added to 0.5g 
agarose to dissolve it by heating.  The solution was allowed to cool down prior to 
addition of 2µl of 0.5µg/ml ethidium bromide [Bioline]. Ethidium Bromide is a 
fluorescent compound which intercalates into DNA and fluoresces when a UV light is 
exposed. The gel was poured into a cast and allowed to solidify for approximately 30 
minutes. The gel was then placed in an electrophoresis tank and covered with 1X TBE 
buffer. 
 
5µl hyperladder IV [Bioline] was loaded to determine the size of products for each 
sample. 0.5µg – 1.0µg of samples were added to 2µl of 5X Blue DNA loading buffer 
[Bioline] and the mix was made up with RNAse-free water to 20µl final volume. A 
loading dye allows the progress of DNA to be tracked during electrophoresis and the 
presence of glycerol in this solution ensures the DNA remains at the bottom of the well 
prior to electrophoresis. The gel was then visualized under a UV gel documentation 
system [UVP Ltd, Cambridge, UK]. 
 
The ratio of   28S to 18S is approximately 2.1.  This 2:1 ratio is a good indication that 
the RNA is completely intact. Partially degraded RNA will have a smeared appearance, 
will lack the sharp RNA bands, or will not exhibit the 2:1 ratio of high quality RNA 
(Figure 2.10). 
 
 
Figure 2.10 Gel electrophoresis of an RNA sample from LEC to examine RNA 
integrity. [Lane 1 DNA hyperladder, Lane 2 template RNA]. 
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2.17 Reverse transcription  
cDNA was synthesised using a cDNA Synthesis Kit [Bioline]. The following was 
prepared on ice: 
(1 µg) RNA n µl 
Oligo (dT)18  1 µl 
10 mM dNTP 1 µl 
DEPC-treated water  Up to 10 µl 
 
The samples were incubated at 65°C for 10 minutes. Then the samples were cooled on 
ice for 2 minutes. After which, the following reaction mix were prepared: 
5x RT Buffer 4 µl 
RNase inhibitor 1 µl 
Reverse Transcriptase (200u/ µl) 0.25 µl 
DEPC-treated water  Up to 10 µl 
 
10µl of the above reaction mix was added to the tube containing the primed RNA. The 
samples were incubated at 42°C for 50 minutes. The reaction was terminated by 
incubating at 70°C for 15 minutes and then chilled on ice.  
 
2.18 Semi-quantitative Polymerase chain reaction (sq-PCR)  
2.18.1 Primer design 
Gene sequences were obtained from National Centre for Biotechnology Information 
(NCBI) and Basic Local Alignment Search Tool (BLAST®) databases. Invitrogen 
OligoPerfect™, a designer application tool was used to obtain the forward and reverse 
primers. Sequences were designed from two different exon sequences in order to avoid 
genomic contaminants being identified. Designed primers were generally 17-25 
nucleotides in length within the 100-300bp product size, containing 40-60% genomic 
content. The melting temperature (Tm) was determined for both the forward and reverse 
primers using the formula: 
Tm = 4(G+C) + 2(A+T). 
The initial annealing temperature (Ta) used for each PCR reaction was generally 5°C 
below the lowest Tm of the primer pair (forward and reverse primers). However, for 
each primer pair the Ta was optimised by performing serial PCR at temperatures 
varying around the initial Ta.  
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2.18.2 Semi quantitative-PCR (sq-PCR) 
Sq-PCR was performed using a PCR master mix [Promega]. This master mix is a ready-
to-use solution containing Taq DNA polymerase (50 units/ml) in a pH 8.5 reaction 
buffer, dNTPs, and 3mM MgCl2, and reaction buffers at optimal concentrations for 
efficient amplification of DNA templates. A 25µl final solution containing the 
following was prepared in a PCR tube [Scientific Laboratory Supplies] as listed in 
Table 2.4. 
  
Table 2.4 Components of an sq-PCR reaction 
Component Volume (µl) 
PCR Master Mix, 2X 12.5 
Forward primer, 10µM 0.5 
Reverse primer, 10µM 0.5 
cDNA 2.5 
Nuclease-Free Water to 25 
 
Denaturation was set at 94°C for 30 seconds and elongation took place at 72°C for 1 
minute at primer pair specific annealing temperature, and maintained at 4ºC. The final 
PCR product mixture was either stored at +4ºC or electrophoresed on an agarose gel. 
 
For each primer pair the annealing temperatures were optimised by performing serial 
PCR at gradient temperatures from 51°C to 60.0°C using G-storm thermocycler for 30, 
35 or 40 cycles. For the purpose of primer annealing temperature and cycles 
optimisation, template cDNAs were derived from different sources e.g. breast cancer 
cell line (MCF-7), ovarian cancer cell line (HayA8 MDR) and LEC where appropriate. 
Optimum amplification conditions for oligonucleotide primers are provided in separate 
relevant chapters. 
  
2.18.3 Gel Extraction for DNA sequencing  
Gene sequencing was performed to validate detection of target genes. PCR was 
performed and products were electrophoresed and the gel extracted for DNA elution. 
Briefly, 50µl PCR reactions were prepared containing 25µl Master Mix, 1.0µl forward 
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and reverse primers, 5µl cDNA template and 18 µl nuclease-free water. PCR was 
performed at this volume for 35 cycles with annealing temperature of 55.0°C.  
 
Subsequently, 1% agarose gel containing 5µl of Gel Green Nucleic Acid stain [Biotium] 
was prepared in 1x TBE buffer. 2µl of Gel Green loading buffer [Biotium] was mixed 
with PCR product then loaded on the gel and electrophoresed at 85V for 45 minutes. 
5µl of DNA Hyperladder IV [Promega] was also electrophoresed. Gel was viewed on a 
blue illuminator [Claire Chemical Research] and bands removed for gel extraction. 
 
DNA was eluted using QIAquick Gel Extraction Kit [Qiagen] according to the 
manufacturer’s protocol. In brief, DNA fragments were excised from the agarose gel 
and weighed. 3 volume of buffer GQ was added to 1 volume of gel, and incubated at 
50°C for 10 minutes. To ensure complete solubilisation, samples were vortexed every 2-
3 minutes. The reactions were checked for colour changes, to ensure an appropriate pH 
of ≤7.5 (yellow colour) was maintained. 1 gel volume of isopropanol was mixed to the 
reactions.  
 
For DNA binding, the reactions were placed in a spin column in a 2ml collection tube, 
and centrifuged at 13,000 rpm for 1 minute. Flow through was discarded and spin 
column placed back in the collection tube. 0.5ml Buffer GQ was added the reaction 
centrifuged again. To wash, 0.75ml buffer PE was added and centrifuged again for an 
additional 1 minute. Then the spin column was placed in a clean 1.5ml centrifuge tube. 
To elute DNA, 50µl buffer EB was added to the centre of column membrane for 1 
minute and centrifuge at 13,000 rpm for 1 minute. Eluted DNA was sent for sequencing 
to Source BioScience. 
 
2.18.4 Validation of target gene primer(s) by gene sequencing  
Chromatograph of the gene sequences for both forward and reverse primers were 
examined for evenly-spaced peaks, minimal noise, signal intensity (>100) and mis-
spaced nucleotides which are characteristics of unacceptable “noisy” chromatogram. 
 
Gene chromatographs: 
a. ABCG2_Forward  
Signal: G:124 Gene sequences:  
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GGGCTTTGGCCGAAGAAGGGAGAGGCAGTGCCCGCCACTCCCACTGAGATTGAG
AGACGCGGCAAGGAGGCAGCCTGTGG 
AGGAACTGGGTAGGATTTAGGAACGCACCGTGCACATGCTA 
 
  
 
b. ABCG2_Reverse 
Signal: G:143  Gene sequences: 
ATAATAGGTTTCTCCAAGGGCTGCCCTCCTTGCCGCGTCTCTCAATCTCAGTGG
GAGTGGCGGGCACTGCCTCTTCCCTC 
CTGCGCGCCCGGAACCTTTTGAGTGGGCACAGCACGC 
 
 
Gene sequences obtained from the above was entered into the National Centre for 
Biotechnology Information (NCBI) and Basic Local Alignment Search Tool (BLAST®) 
databases and the results showed the sequences were described for  ABCG2 gene as 
follow: 
i. Sequences producing significant alignment with ABCG2 forward primer (121 
bases) shows 94% coverage for ABCG2 gene transcript no. NM_004827.2
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ii. Sequences producing significant alignment with ABCG2 reverse primer (117 
bases) shows 93% coverage for ABCG2 gene transcript no. NM_004827
 
 
Other target genes that were validated by sequencing are listed in Table 2.5:  
 
Table 2.5 List of other primers validated by gene sequencing. 
Genes Primers 
 
 
Cytokeratin 3 (CK3) 
 
Forward: GGATGTGGACAGTGCCTATATG 
Reverse: AGATAGCTCAGCGTCGTAGAG 
 
 
C/EBPD 
 
Forward: ACTCAGCAACGACCCATACC 
Reverse: CGCTCCTATGTCCCAAGAAA 
 
 
Connexin 43 (Cx43) 
 
Forward: ATGAGCAGTCTGCCTTTCGT 
Reverse:  TCTGCTTCAAGTGCATGTCC 
 
 
Bmi-1 
 
Forward: CTGGAGAAGGAATGGTCCAC 
Reverse: GCCTTGTCACTCCCAGAGTC 
 
 
2.18.5 Gel electrophoresis 
PCR products were electrophoresed on 2% agarose gel. To prepare 50ml 2% (w/v) 
agarose gel, 50ml 1X Tris/Borate/EDTA buffer was added to 1.0g agarose and 
dissolved by heating.  The solution was allowed to cool down prior to addition of 5µl of 
Gel Green [Bioline] following the steps as previously described (refer section 2.16.2).  
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2.19 Quantitative Real-timer PCR (QRT-PCR) 
2.19.1 Primer design 
Primer probes were designed and commercially purchased from Life Technologies. The 
probes were customised using the Taqman® Gene Expression Assays. Probes would be 
exon-spanning in order to avoid genomic contaminants, and selected for best coverage.  
 
2.19.2 Primer validation 
Table 2.6 Efficiency values for validation of Taqman primers. 
Assay ID Gene symbol Efficiency (%) 
Hs02758991_g1 GAPDH 88.0 
Hs01053790_m1 ABCG2 60.0 
Hs00184500_m1 ABCB1 74.1 
 
Efficiencies for qRT-PCR primer probes as listed in Table 2.6 were validated using 
cDNA template from MCF-7 cell line diluted in 1:10 fold dilutions in triplicates. 
Average of cycle threshold (CT) values was plotted against log10 [concentration of 
cDNA]. Linear regression analysis was performed with 95% confidence interval for the 
slope of the validation curve, where y is expressed as mx + c, m is the value for the 
slope and c was the value where it intercepts at the y axis.  Slopes between -3.1 and -
3.6, giving reaction efficiencies between 90 and 110% are typically acceptable. The 
value for the slope was then entered into the efficiency formula; 
  E= -1+10
(-1/slope)
. 
Efficiency graphs and values are presented in Figure 2.11. 
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Figure 2.11 Efficiency values (E) for validation of Taqman probes. Linear regression 
analysis gave a standard curve y=mx + c. The slope of a standard curve (m) indicates 
PCR efficiency. Y axis represents CT value, X axis represents log [10] cDNA 
concentration. 
 
2.19.3 Quantitative Real-time polymerase chain reaction (qRT-PCR) and analysis 
For qRT-PCR reactions, each sample was prepared in triplicates. Each reaction contains 
2µl cDNA, 1µl Taqman Gene Expression Assay [Applied Biosystems], 10µl Brilliant II 
QPCR master mix with High ROX [Agilent] and DNase-free water [Promega/Sigma] to 
make up 20µl of reaction mix. No template reaction (NTR) for negative control for each 
gene expression was also included. All reactions were prepared in nuclease-free 0.2 ml 
microcentrifuge tubes. Tubes were capped and inverted several times to mix the 
reactions. Samples were then loaded onto a 96-well plate [Applied Biosystem], and 
sealed with a plastic cover and centrifuged briefly. The plate was then placed in a Light 
Cycler [Applied Biosystems]. qRT-PCR was performed at 95°C for 10 minutes, 
followed by 40 cycles of 95°C for 15 seconds, and 60°C for 1 minute, with a single data 
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acquisition step for comparative cycle threshold (ΔΔCT). Values for CT, ΔCT, ΔΔCT 
and relative expression to genes/fold change were calculated and plotted on a graph. 
 
2.20  Imaging methods and quantification software 
2.20.1 Phase contrast inverted microscopy 
For the purpose of examining cells in cultures, plates, and flasks, we used an Axiovert 
200M microscope [Zeiss] which allows the performance of transmitted light brightfield, 
phase contrast and epifluorescence technique. Images were then processed using the 
AxioVision40 version 4.8.2.0 software [Zeiss]. We also used Nikon Digital Sight–
DSFi1 camera and Nikon NIS-Elements D software [Nikon Metrology] for brightfield, 
phase contrast, and differential interference contrast (DIC). 
 
2.20.2 Fluorescence microscopy 
Fluorescence microscopy was undertaken using an Axiovert 200M [Zeiss] for cells in 
wells and by Axioplan F [Zeiss] for cytological slides.  Images were then processed 
using the AxioVision40 version 4.8.2.0 software [Zeiss]. 
 
2.21 Statistical Analysis 
Descriptive statistics were used to handle data according to the location, dispersion or 
shape. Measurement of location was described as means, median, or mode. Dispersion 
of data where described in range, variance or standard deviations (SD). Standard error 
(SE) of means was measured to show the precision of the sample means. The choice of 
the most appropriate statistical methods often depends on the shape of distribution. A 
normal distribution assumes a “bell-shaped” symmetrical data, which is often used in 
many statistical tests. 
 
Quantitative data which were normally distributed were analysed using parametric 
statistical tests including independent t-test and one way ANOVA.  
For 2 groups of independent data, independent t-test was used to compare the means 
between the groups. For 3 or more groups of univariate data with single factor, one-way 
analysis of variance (ANOVA) was used to obtain p values. Results with p values of 
less than 5% (p < 0.05) were considered statistically significant. 
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For hypothetical testing, the null hypotheses (H0) are tested when the difference in 
means equals to zero (no effect). The alternative hypotheses (H1) is defined and holds 
when the null hypotheses is rejected at a significance level of less than 5% (p < 0.05).  
Data which are not normally distributed were analysed using non-parametric tests which 
make no assumption about the probability distribution. These tests include: sign 
test,Wilcoxon signed-ranks test, Mann-Whitney U test or Kruskal-Wallis test. Sign test 
and Wilcoxon signed-ranks test were used for measurement of mean in one sample. 
Mann-Whitney is the equivalent of independent t-test, where means are measured in 2 
samples. Kruskal-Wallis is equivalent to one-way ANOVA and used when there were 
three or more groups of variables. Results with p values of less than 0.05 (p < 0.05) 
were considered statistically significant. 
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Chapter 3 CHARACTERISATION OF CORNEAL LIMBAL STEM 
CELLS AND HUMAN LIMBAL MESENCHYMAL STEM CELLS 
3.1  Introduction 
Most LSC characterisation techniques have involved in vitro animal studies and/or the 
use of histological specimens (Zhuo Chen et al., 2004; Hyun-Seung Kim et al., 2004; 
Schlotzer-Schrehardt and Kruse, 2005). A limited knowledge of LSC identification has 
been produced using  in vivo techniques such as   live imaging  (Shortt et al., 2007a) or 
observation of label retaining cells (Cotsarelis et al., 1989), which have been  critical in 
studying LSC biology.  
 
In the last twenty years, a lot of studies have focused on trying to identify molecular 
markers for LSC, and the transient amplifying cells of the limbus. However, there are 
species variations in what marker expression clarify and variations in the techniques 
used for these analysis. To this date, there are still no specific markers for LSC and the 
molecular characteristics of LSC remain poorly understood.  
 
To summarise findings to date, basal cells of limbal epithelium strongly express 
cytokeratin 19, vimentin, α-enolase, p63, β1 integrin, ABCG2, TGF-β and EGF-R 
(Zhuo Chen et al., 2004; Hyun-Seung Kim et al., 2004; Schlotzer-Schrehardt and 
Kruse, 2005).  The putative polycomb proto-oncogene, Bmi-1 (Lessard and Sauvageau, 
2003; Molofsky et al., 2003) and C/EBPδ (Barbaro et al., 2007) have also been 
suggested to be potential LSC markers. On the other hand, cytokeratin 3 and 12, gap 
junction protein Connexin 43 and involucrin (Zhuo Chen et al., 2004; Hyun-Seung Kim 
et al., 2004; Schlotzer-Schrehardt and Kruse, 2005) have been put forward as negative 
markers. 
 
The location of the LSC has been identified under the surface of Palisades of Vogt, now 
termed as the “limbal epithelial crypts”. In addition, limbal epithelium also possess 
stromal cells which are adherent to plastic, have fibroblastic morphology and are able to 
differentiate into multiple lineages, characteristics of a human MSC (MSC) (Branch et 
al., 2012; Garfias et al., 2012; Gui-Gang Li et al., 2012). These MSC like cells can be 
isolated using protocols as described previously (Polisetty et al., 2008).  
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As described in Chapter 1, there are three major layers of the cornea which are derived 
from different germ layers. The epithelial layer of the cornea develops from ectoderm, 
while the stroma and endothelium are mesenchymal in origin. Corneal stroma makes up 
90% of corneal volume, is populated by mesenchymal keratocytes which are quiescent 
after birth, but undergo differentiation in response to wound, trauma, inflammation or 
infection (Darby et al., 1990). This suggests plasticity of the cells to adapt to its 
environment.  
 
The corneal limbus has been reported to possess stromal cells which have fibroblastic 
morphology, are adherent to plastic and able to differentiate into multiple lineages, 
suggestive of a MSC population (Branch et al., 2012; Garfias et al., 2012; Gui-Gang Li 
et al., 2012). Human corneal mesenchymal stromal stem cells, unlike bone marrow-
derived MSC, develop from neural crest cells (Hoar, 1982)  and are believed to support 
the growth of limbal epithelial cells (Pinnamaneni and Funderburgh, 2012; Bray et al., 
2014).  
 
MSC are non-haemopoietic stem cells with regenerative ability and can differentiate 
into cell lineages of mesenchymal origin i.e. adipocytes, chondrocytes and osteocytes. 
Due to variable defining characteristics for MSC, the Mesenchymal and Tissue Stem 
Cell Committee of the International Society for Cellular Therapy (ISCT) has defined 
several minimal requirements (Dominici et al., 2006): 1) MSC must be plastic adherent, 
2) they must express CD105, CD73 and CD90, but lack of expression to CD45, CD34, 
CD14, CD11b, CD79α, CD19 and HLA-DR surface molecules. The third minimal 
criteria 3) they have to satisfy the multi potentiality to differentiate into adipocytes, 
osteoblast and chondroblast in vitro.  
 
Paracrine secretions of many bioactive molecules i.e. cytokines, trophic and growth 
factors, by human MSC have been well documented making it an important player in 
regenerative medicine and transplantation (Langer and Vacanti, 1993; Miguel et al., 
2012; Levis et al., 2013; Graziella Pellegrini et al., 2013).   
 
Bone-marrow-derived MSC (BM-MSC) have shown excellent anti-inflammatory and 
wound healing properties when introduced to corneal injury models in animal studies 
(Ma et al., 2006; Augello et al., 2007; Omoto et al., 2009; Jiang et al., 2010; Hsu et al., 
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2012; Jia et al., 2012). In support of that, BM-MSC has been investigated in the repair 
of corneal damage (Ma et al., 2006), and the proposed mechanism is suppression of   
new vessel formation and inflammation post-transplantation.  
 
In this study we look at HTCEC line as a model for primary limbal cultures, by looking 
at molecular markers, stem cell properties, immune-biological response and functional 
assays i.e. side population protocols and migration analysis. The use of primary limbal 
cultures in many optimisation assays is limited due to low availability, especially in 
countries with limited access to donor corneas. There is also the issue of donor-to-donor 
variations which may interfere with optimisation steps or screening protocols.   
 
HTCEC exhibit genetic stability, as evident by normal cell cycle kinetics in the 
presence of high telomerase activity. It could maintain the capacity to differentiate into 
normal human corneal epithelium in vivo (Robertson et al., 2011). Cell immortalisation 
is done to extend cells’ finite life span by eliminating a critical cell cycle point or 
suppress cellular tumorigenesis by incorporating an oncogene (Robertson et al., 2008). 
Telomerase is a specialized cellular reverse transcriptase that can compensate for the 
erosion of telomeres by synthesizing new telomeric DNA. Infection with human 
telomerase reverse transcriptase (hTERT) leads to the activation of telomerase, 
preventing telomere erosion and subsequent telomere-dependent senescence (Morales et 
al., 2003). Side by side comparison of HTCEC with normal primary corneal epithelium 
validated this cell line as a viable model for the study of ΔNp63 isoforms (Robertson et 
al., 2008). 
 
This study aims to improve the current methods of ex vivo expanded corneal epithelial 
transplantation by investigating alternative stem cells sourced from the limbal region. 
LMSC were characterised by immunophenotyping, histology and mRNA expression of 
selected MSC markers for lineage differentiation. LMSC were grown on AM; a 
biological substrate used in limbal transplants which was thawed from frozen.  
3.2 Specific Aims 
1. To isolate LEC andLMSC from whole corneas or corneo-scleral rings by serial 
trypsinisation method. 
2. To establish LEC cultures from cell suspension by co-culture method with 
inactivated mouse 3T3 fibroblasts. 
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3. To establish LMSC cultures from cell suspension by growing in MSC-growth 
promotion media (MGPM) in low oxygen (5%). 
4. To establish HTCEC cultures in serum-free and feeder-free conditions. 
5. To characterise LEC and HTCEC by immunohisto/cytochemistry and mRNA 
expression. 
6. To screen for stem cell antigens expression in LEC and HTCEC cultures by 
immunohisto/cytochemistry and mRNA expression. 
7. To characterise LMSC using LSC markers ABCG2, ABCB5 and p63. 
8. To perform immunophenotyping in LMSC and characterise LMSC by tri-lineage 
differentiation by histological analysis and mRNA expression. 
9. To study growth of LMSC plated on cryo-preserved AM and characterise LMSC 
using limbal markers and stem cell antigen expression. 
3.3 Materials and Methods 
3.3.1 Primary LE) and HTCEC Cultures 
Isolation of LEC and HTCEC were  conducted as previously described  (Shaharuddin et 
al., 2013c) and detailed in Chapter 2.  LEC were isolated and the pooled cell 
suspensions were centrifuged and the resulting cell pellet containing a mixed 
heterogeneous cell population was then resuspended in a selective MSC growth 
promotion media (MGPM) which was made up of; alpha-modified Eagle’s medium (α-
MEM) [Lonza], L-glutamine [Sigma],10% (vol/vol) FBS [Lonza], 5ng/ml human 
recombinant fibroblast growth factor-2 (FGF2) [Pepro Tech] and seeded at a cell 
density of 1×10
6
 cells in a T75cm
2
 flask, incubated at 37°C, 5% CO2, and 5% oxygen 
tension. Non-adherent cells were removed the next day and media was changed every 3 
days. Established cultures of LMSCs were passaged at 90 % confluence by enzymatic 
digestion using TrypLE™ Express [Gibco]. 
 
3.3.2 LMSC tri-lineage differentiation 
Osteogenic differentiation of LMSC 
LMSC were seeded in MGPM into 12-well cell culture at a cell density of 2.5×10
4
 
cells/well until confluence. Media was then removed and replaced with osteogenic 
differentiation medium (α-MEM, 10% (vol/vol) FBS, 10nM dexamethasone, 
10mM β-glycerophosphate and 100μM L-ascorbic acid-2-phosphate; all supplementary 
reagents purchased from [Sigma Aldrich], UK. Cultures were incubated at 37°C, 5% 
CO2, under low oxygen tension (5%) O2  for 4 weeks.  Media was changed every 3 days. 
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Chondrogenic differentiation of LMSC 
LMSC were seeded into three 15 ml centrifuge tubes at a cell density of 500,000 
cells/tube in chondrogenic differentiation medium (α-MEM, 100μM L-ascorbic acid-2-
phosphate [Sigma], 10nM dexamethasone [Sigma], 400μl ITS+1 (10 μg/ml insulin, 
5.5μg/ml transferrin, 5ng/ml selenium, 0.5mg/ml bovine serum albumin, 4.7μg/ml 
linoleic acid) [Sigma] and 10ng/ml transforming growth factor (TGF)-β1 [R&D 
Systems]. Cell suspensions were centrifuged at 1,000 rpm for 3 minutes to form 
spherical pellets and left incubated at 37°C, 5% CO2, under low oxygen tension (5%) O2 
for 2 weeks.  Media was changed every 3 days.  
 
Adipogenic differentiation of LMSC 
LMSC were seeded in MGPM into a 12-well cell culture plate at a cell density of 5×10
4
 
cells/well until confluence. MGPM was then removed and replaced with osteogenic 
differentiation medium, STEMPRO® adipogenesis differentiation kit [Gibco]. From 
this point onwards, cultures were incubated in atmospheric oxygen (22%), 5% CO2 at 
37C. Cells were cultured in this condition for 30 days with media change every 3 days. 
 
3.3.3 Immunocytochemistry 
This was carried in HTCEC, LEC and LMSC to characterize for limbal and stem cell 
markers as detailed in Chapter 2.  
3.3.4 Semi-quantitative Polymerase Chain Reaction (sq-PCR)  
sq-PCR reactions were assembled with 12.5 µl PCR master mix [Promega, UK], 0.5 µl 
forward primer,  0.5 µl reverse primers and 2 – 2.5 µl cDNA template and DEPC-
treated water to a final volume of 25 µl reactions. PCR reactions were amplified for 
each gene and the conditions are summarised in Table 3.1. 
 
PCR was performed on this final reaction mixture for 30-35 cycles. Denaturation was 
set at 94°C for 30 minutes and elongation took place at 72°C for 1 minute at primer pair 
specific annealing temperature, and maintained at 4ºC. The final PCR product mixture 
was either stored at +4ºC or electrophoresed on 2% agarose gel, at 90V for 60 minutes.  
Table 3.1 List of oligonucleotides primers and amplification conditions.   
Gene Primers Sequences Product  
Length 
Annealing 
temperatu
Amplifica
tion 
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(bp) re 
(°C) 
Cycles 
CHONDROGENIC  
 
   
Collagen X   730 55 35 
 Forward CAA GGC ACC ATC TCC AGG AA    
 Reverse AAA GGG TAT TTG TGG CAG CAT ATT    
Aggrecan   129 55 35 
 Forward TGA GTC CTC AAG CCT CCT GT    
 Reverse TGG TCT GCA GCA GTT GAT TC    
Sox9   150 55 35 
 Forward GACTTCCGCGACGTGGAC    
 Reverse GTTGGGCGGCAGGTACTG    
OSTEOGENIC      
Bone 
sialoprotein-1 
  161 55 35 
 Forward AAA GTG AGA ACG GGG AAC CT    
 Reverse GAT GCA AAG CCA GAA TGG AT    
Alkaline 
phosphatase 
  187 55 40 
 Forward GGT GAA CCG CAA CTG GTA CT    
 Reverse CCC ACC TTG GCT GTA GTC AT    
      
ADIPOGENIC      
SREBP-1   230 55 35 
 Forward GGA GCC ATG GAT TGC ACT TTC    
 Reverse ATC TTC AAT GGA GTG GGT GCA G    
Adipocyte 
binding protein-2 
(aP2) 
  130 55 35 
 Forward ATGGGATGGAAAATCAACCA    
 Reverse GTGGAAGTGACGCCTTTCAT    
Adipophilin   200 55 35 
 Forward CGCTGTCACTGGGGCAAAAGA    
 Reverse ATCCGACTCCCCAAGACTGTGTTA    
LIMBAL STEM 
CELL MARKERS 
     
ΔNp63α  
 
143 55 35 
 Forward GTGATGATGGTTCACGTTGG    
 Reverse ACATGACGTCGGGTGTTTTT    
CK3   145 53 35 
 Forward GGATGTGGACAGTGCCTATATG    
 Reverse AGATAGCTCAGCGTCGTAGAG    
ABCG2  
 
143 55 35 
 Forward GCGTGCTGTGCCCACTCAAA    
 Reverse AGCATGTGCACGGTGCGTTC    
ABCB5* 
Hs 02889060_m1 
 N/A 98 55 35 
GAPDH   100 55 35 
 Forward ATG GGG AAG GTG AAG GTC G    
 Reverse TAA AAG CAG CCC TGG TGA CC    
      
*Taqman probe [Applied Biosystems]. 
3.3.5 Immunophenotyping  
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LMSC from passage 1 were characterised for CD19, CD44, CD45, CD90, CD105, 
CD146, CD166, MHC Class I and MHC Class II which were FITC-conjugated [R&D 
System]. Cells were detached from tissue culture flasks with 3ml trypLE express and 
resuspended in flow cytometry buffer solution (PBS/0.1% bovine serum albumin). For 
direct immunofluorescence, 200,000 cells were added into each tube and stained with 5 
μl primary antibodies in 100µl cell suspension. After incubation for one hour in 40C, 
cells were washed with buffer solution and resuspended in 200μl and ran through BD 
FACSCanto™ II [BD Biosciences].  
 
For indirect immunofluorescence, 200,000 cells were added into each tube and stained 
with 5μl primary antibodies in100µl cell suspension. After incubation for one hour in 
4
0
C, cells were washed. Following that, goat anti-mouse IgG FITC-conjugated 
secondary antibody was added at 1:25 dilution in 100µl cell suspension; this was 
incubated again for 30 minutes at 4
0
C. At the end of incubation, cells were washed and 
then resuspended in 200 µl of flow cytometry buffer solution before running through 
FACS Canto II and analysed with FACS Diva software {BD Biosciences].    
 
Flow cytometry was performed using BD FACSCanto™ II and analysed using BD 
FACSDiva™ software [BD, Oxford,UK]. Antibodies used for flow cytometry analysis 
were purchased from R&D Systems. Cell populations were labeled with antibodies 
specific for cell surface antigens expressed by human MSC (CD44, CD90, CD105, 
CD106, CD146 and CD166), haematopoietic cell surface antigens (CD19 and CD45), 
MHC Class I and Class II, and murine Ig G as negative control. 
 
3.3.6 Histological analyses 
LMSC from passages 2-3 were used from three biological replicates for tri-lineage 
differentiation: 
 
Chondrogenic differentiation  
Cell pellets were removed from chondrogenic differentiation media after two weeks, 
and covered with an embedding media to ensure optimal cutting temperature (OCT).  
Blocks were wrapped in aluminium foil and stored at -80C prior to sectioning which 
was done using a cryostat [Leica CM3050]. 5µm sections were placed on histology 
glass slides for staining with Safranin O to determine the presence of collagen 
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deposition. Briefly, 0.1% (vol/vol) Safranin O was prepared with 0.1% acetic acid; 
0.010g  Safranin O powder [Sigma] was added to 1ml 1% acetic acid in 10ml water, 
and filtered through a 0.45µm filter [Sartorius]. At room temperature, OCT was 
dissolved by rinsing the sections with 70% ethanol followed by PBS washes. Slides 
were flooded with Safranin O for 5 minutes and then rinsed with deionised water. 
 
Osteogenic differentiation 
Cell layers cultured in osteogenic differentiation media was stained with Alizarin Red to 
determine areas of mineralisation. Briefly, Alizarin Red stain was prepared by 
dissolving 2g of Alizarin Red in deionised water over night. To adjust the pH of the 
solution between 4.2 and 4.4, 10% ammonium hydroxide in deionised water or HCl 
were used. The required amount of Alizarin Red was filtered through a 0.45µm pore 
size syringe filter [Sartorius] prior to use. The culture media were removed and the 
wells were covered with Alizarin Red and left for 2 hours at room temperature and then 
rinsed with PBS ready for viewing. 
 
Adipogenic differentiation  
 Media was removed from the cultures and cells were rinsed with PBS for staining with 
Oil Red O. A stock solution of Oil Red O was prepared by dissolving 150mg Oil Red O 
powder with 50ml 99% Isopropanol. To prepare a working solution of the stain, 6 ml of 
the stock solution was diluted with 4 ml deionised water and pre-filtered using a 0.45µm 
filter and left at room temperature for 10 minutes before use. Subsequently, the cell 
layers were covered with 2ml of Oil Red O working solution and left for 5 minutes at 
room temperature. The working solution was then removed and rinsed with tap water 
until the water rinses were clear. 2ml Haematoxylin was then added to cover the 
monolayer for 1 minute and rinsed off with tap water before viewing. 
 
3.3.7 Growing LMSC on AM 
LMSC from passages 4-5 were cultured in MGPM in a T75cm
2 
tissue culture flask in 
low oxygen (5%) until 80% confluence. Research grade cryopreserved AM obtained 
from NHS Blood and Transplant was used as a substrate for growth of LMSC. The AM 
was stretched under tension with two 22mm x 22mm cover slips placed in a 6-well plate 
(Figure 3.1). 24,000 cells/cm
2 
were plated directly onto the membrane, initially 
suspended in MGPM. On the following day the media was partially substituted 50:50 
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with DKSFM and on the third and subsequent days, with DKSFM only. 100μl DKSFM 
was supplemented daily directly onto the AM. Cultures were placed in 5% CO2 
incubator with normal oxygen (20%) at 37C for 5 days. At the end of 5 days, the media 
was drained from the well and the AM was rinsed with PBS and embedded in OCT for 
cryostat sectioning. 
 
 
Figure 3.1 Plating of LMSC on cryopreserved AM. The membrane was kept stretched 
and taut using two 22mm x 22mm cover slips. The cells were plated into an area 
confined to an area within a make shift plastic ring, suspended in culture media.  
 
3.3.8 Haematoxylin and eosin (H&E) staining 
Cryostat sections on silane-adhesion pre-coated slides [CellPath] were placed in 95% 
ethanol for 2 minutes to dissolve OCT then fixed with cold methanol for 30 minutes. 
Slides were then placed in 70 % ethanol for 2 minutes and placed in running tap water 
for 5 minutes. Subsequently, the slides were flooded with haematoxylin for 4 minutes 
and washed in running tap water for 5 minutes. Slides were then placed in Schott’s 
water for 2 minutes and washed in running tap water for 5 minutes. Next, the slides 
were flooded with eosin for 2 minutes and washed in running tap water for 5 minutes. 
Following this, slides were briefly placed in 70% ethanol, 95% ethanol and 100% 
ethanol for 30 seconds each. Finally the slides were mounted in vectashield and 
coversliped ready for viewing using brightfield microscopy.  
3.3.8 Harvesting cells for RNA extraction  
Cells grown on AM were detached from the membrane using 0.05% trypsin-EDTA for 
3 minutes, deactivated with 10% fetal bovine serum/PBS and centrifuged to get a cell 
pellet (labeled L-AM). LMSC were detached from T75cm
2
 flask using TrypLE express 
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and centrifuged to get a pellet and subsequent RNA extraction (labeled LMSC). An 
area devoid of any LMSC growth (based on microscopy) but only the epithelia of AM 
(labeled AM) was cut separately. The cells were detached using 0.05% trypsin-EDTA 
for 3 minutes, deactivated with 10% fetal bovine serum/PBS and centrifuged to get a 
cell pellet. Subsequent steps for RNA extraction followed the manufacturer’s 
instructions using RNEasy Plus Micro Kit [Qiagen]. PCR was performed as described 
in Chapter 2. 
 
3.3.9 Immunohistological analysis of LMSC on AM  
The LMSC-AM construct was covered with an embedding media (OCT) and then 
frozen in a -80C freezer before taking to the cryostat.  5 µm sections were placed on 
silane-adhesion pre-coated slides for optimal histology staining [CellPath]. Slides were 
air-dried overnight and stored at -20C. Before staining, slides were flooded with PBS 
for two minutes to wash away the OCT. Subsequent steps followed the ICC protocol (as 
described earlier. Due to the strong background fluorescence from the tissue, Sudan 
Black [Fisher Scientific] was used to reduce autofluorescence, this was done by 
incubating the sections in 0.1% (w/v) Sudan Black for 10 minutes. The slides were then 
washed with PBS and cover slipped for imaging. 
 
3.3.10 Microscopy and Imaging 
All images were taken using a Nikon Digital Sight–DSFi1 camera and Nikon NIS-
Elements D software [Nikon Metrology U.K. Ltd., Derby, UK]. Images were assembled 
using Adobe Photoshop® CS3 [Adobe Systems]. Fluorescence microscopy was 
undertaken using Axioplan F [Zeiss].  Images were then processed using the 
AxioVision40 version 4.8.2.0 software [Zeiss].  
 
3.3.11 Statistical analysis 
Descriptive statistics were used to describe means, median, or mode. Quantitative data 
which were normally distributed were analysed for comparison between 2 groups using 
independent t-test. Results with P values of less than 5% (P < 0.05) were considered 
statistically significant.  
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3.4 Results 
3.4.1 HTCEC as a viable model for LEC 
LEC have been successfully carried out using cell suspension by the trypsinisation 
method as described previously (Shaharuddin et al., 2014). It is well established that 
epithelial cells can be grown successfully on a “feeder” layer of 3T3 fibroblasts. Feeder 
layers are prepared from inactivated 3T3 fibroblast. Inactivation was carried out by the 
using mitomycin C. Mitotic inactivation of the 3T3 fibroblasts is essential to prevent 
them from overgrowing the epithelial cells in culture. 
 
Cultured human LEC expressed ABCG2, Sox2 and p63 (Figure 3.2). Comparably, some 
HTCEC also expressed ABCG2 and p63, in addition to expressing ABCB5 (Figure 3.3).  
Screening for the stem cell antigens NANOG and Oct3/4 antibodies in HTCEC also 
showed some cells expressed these markers (Figure 3.4).  
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Figure 3.2 Results of immunocytochemical analysis of limbal markers in LEC.  Note 
the presence of cells expressing of anti-human ABCG2, Sox2 and p63 antibodies 
(arrows) in panel A, negative control (secondary IgG) on panel B. (DAPI=blue (nuclei), 
FITC-conjugated secondary antibody= green) N=3. 
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Figure 3.3 Results of immunocytochemical analysis of limbal markers in HTCEC.  Note 
the presence of cells expressing of anti-human ABCG2, p63 and ABCB5 antibodies 
(arrows) in panel A, negative control (secondary IgG) on panel B. (DAPI=blue (nuclei), 
FITC-conjugated secondary antibody= green, Rhodamine-conjugated secondary 
antibody= red),, N=3. 
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Figure 3.3 Results of immunocytochemical analysis of stem cell markers in HTCEC.  
Note the presence of cells expressing of anti-human NANOG, Sox2, and  Oct3/4 
antibodies(arrows) in panel A, negative control (secondary IgG) on panel B. 
(DAPI=blue(nuclei), FITC-conjugated secondary antibody= green, Rhodamine-
conjugated secondary antibody= red), N=3.  
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Results of PCR analysis showed mRNA expression of the stem cell genes NANOG, 
Sox2 and Oct 4, both in HTCEC and LEC (Figure 3.5A). ABCB5 was positively 
expressed in HTCEC and in four human LEC samples (L1-L4) as presented in Figure 
3.5B. 
 
Figure 3.4 mRNA expression of stem cell markers and ABCB5. (A) Expression in 
HTCEC and LEC. (B) ABCB5 expression in HTCEC and LEC, N=3. [Abbreviations: 
MDA – MDAMB-231 breast cancer cell line as positive control, H – HTCEC, L – LEC , 
L1-L4 – four LEC samples, NTR – no template reaction]. 
 
Subsequently, we showed comparable expressions at mRNA level of common limbal 
markers in both LEC and HTCEC, which were ABCG2, ABCB1, p63, C/EBPδ, 
putative oncogene BMi-1 and CK3 (Figure 3.6).  CK3 expression in LEC is a marker 
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for corneal epithelial differentiation, which is poorly expressed in HTCEC in our culture 
conditions.  
 
 
Figure 3.5 mRNA expression of common LSC markers and markers for differentiated 
cells CK3 and Connexin43 (A) Cultured LEC (LEC) and (B) HTCEC. Lane 1 DNA 
ladder, lane 2 ABCG2 (143bp), lane 3 ABCB1 (116 bp), lane 4  ΔNp63 (143 bp), lane 5 
C/EBPδ (111 bp), lane 6 bmi-1 (132 bp) lane 7 cytokeratin3 (125 bp), lane 8 
connexin43 (249 bp), lane 9 GAPDH (100 bp), lane 10 –ve control, N=3.  
 
3.4.2 Characterisation of LMSC 
LMSC cultures were expanded from plastic adherent cell populations in MGPM for 5-7 
days or until 90% confluent and subsequently passaged.  ICC analysis for common 
limbal markers revealed expression of ABCG2, ABCB1 and p63 in some cells in 
standard LMSC cultures (Figure 3.7A). Molecular analysis revealed that LMSC also 
expressed ABCB5 as did LEC and HTCEC. MDA-MB-231 cells were used as a 
positive control (Figure 3.7B).  
85 
 
Chapter 3: Characterisation of Corneal LSC and LMSC 
 
 
Figure 3.6 Characterisation of common limbal stem markers and ABCB5 in LMSC. 
(Top) Results of immunocytochemical analysis of stem cell markers in HTCEC.  Note 
the presence of cells expressing of anti-human ABCB5, ABCG2 and p63 antibodies in 
LMSC antibodies in panel A, negative control (secondary IgG) on panel B. 
[DAPI=blue(nuclei), FITC-conjugated secondary antibody= green, Rhodamine-
conjugated secondary antibody=red], N=3. (Bottom) mRNA expression of ABCB5 in 
HTCEC, LMSC and LEC. [Abbreviations: H – HTCEC, M – LMSC, LEC - primary 
limbal cultures, MDA – MDA-MB-231 as +VE control and -VE (no template reactions), 
N=3. 
 
Using FACS analysis in combination with fluorophore labelled antibodies, we observed 
that LMSC expressed the human MSC surface antigens CD44, CD90, CD105, CD146 
and CD166), but were negative for expression of the haematopoietic cell surface 
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antigens CD19 and CD45. LMSC also expressed MHC Class I and had no expression of 
MHC Class II (Figure 3.8A). Graphical representation of percentage of stained-positive 
cells, from three biological replicates (N=3) showing more than 50% of cell population 
stained positively for CD44, CD90, CD105, CD166 and CD146 (Figure 3.8B). 
 
 
Figure 3.7 Results of LMSC immunophenotyping (Top) Cell populations labelled for 
surface antigens expressed in human MSC; CD44, CD90, CD105, CD146, CD166. 
Negative for haematopoietic stem cells; CD19, CD45, CD106. They are also HLAClass 
I-positive and HLAClass II-negative cells. Murine IgG was used as control. Antibody 
profiles (dark grey) were over layered onto the unlabelled population (light grey). 
(Bottom) Percentage of stained-positive cells, results are from three biological replicates 
(N=3). 
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LMSC were capable of tri-lineage differentiation as assessed by staining for 
adiopogenic differentiation using Oil Red O to detect lipid vesicles (Figure 3.9A), 
chondrogenic sections with Safranin O for cartilaginous deposits (Figure 3.9C) and 
osteogenic differentiation was indicated by Alizarin Red staining for matrix 
mineralisation (Figure 3.9 E). These were compared to cultures with respective stains in 
un-differentiated cells as negative control.  
 
Figure 3.8 Histological analysis for LMSC differentiated cells. (A) Oil Red O staining 
of adipogenic differentiated cells showing lipid vesicles stained bright red, nuclei blue, 
after 30 days in culture, photo inset is a magnification of the same image (C) Safranin O 
staining of cartilaginous deposition (orange) on a representative section of a pellet 
generated after 2 weeks culture in chondrogenic differentiation media, photo inset is a 
magnification of the same image. (E) Alizarin Red staining of mineral deposition in 
osteogenic differentiated cells after 3 weeks in culture, photo inset is a magnification of 
the same image. (B), (D) and (F) are cultures with respective stains in un-differentiated 
cells as negative control. (N=3). 
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We demonstrate further here adipogenic differentiation cultures showing vacuolation 
after 7 days, which started to enlarge and developed lipid vesicles from the second week 
onwards (Figure 3.10).  
 
Figure 3.9 Adipogenic differentiation of LMSC. Cultures were grown in adipogenic 
differentiation media over 30 days. Enlarging size of vesicles containing lipid droplets 
evident from day 7 onwards, N=3. 
 
Standard PCR was performed to study mRNA expression of tri-lineage commitment of 
differentiated LMSC (Figure 3.11). Adipogenic differentiated cells from LMSC showed 
expression of adipophylin, adipocyte binding protein-2 and sterol regulatory-element-
binding protein-1. While chondrogenic differentiation was marked by expression of 
aggrecan and Sox9 but cells failed to express collagen X. Osteogenic differentiation was 
marked by expression of alkaline phosphatase and bone sialoprotein-1. 
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Figure 3.10 mRNA expression of tri-lineage committed cells. (A) Adipogenic: Lane 1 
Adipophylin (150 bp), lane 2 Adipocyte binding protein-2 (130 bp), lane 3 Sterol 
regulatory element-binding protein-1 (230 bp) (B)  Chondrogenic: Lane 1 Aggrecan 
(170 bp), lane 2 Sox9 (150 bp), lane 3 – no expression for Collagen X (730 bp)  (C) 
Osteogenic: Lane 1 Alkaline phosphatase (187 bp), lane 2 Bone sialoprotein-1 (161 bp). 
GAPDH was used as housekeeping gene. (N=3). 
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3.4.3 Growth of LMSC on AM 
LMSC were plated onto AM thawed from frozen and grown in MGPM. The media was 
then changed to serum-free keratinocyte medium once the cells had adhered to the 
surface of the membrane on the next day. The growth of LMSC were recorded daily or 
every other day (Figure 3.12). LMSC were adherent on the membrane and observed to 
proliferate and achieved confluence.  
 
There was a change in cellular morphology from the slender shaped, fibroblastic 
morphology of LMSC (day 3) to rounded cell bodies (day 5). Cryostat sections of 
LMSC on AM at day 5 were stained with haematoxylin and eosin (Figure 3.13), note 
the presence of LMSC on the AM (asterisks) compared with AM alone.  
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Figure 3.11 Growth of LMSC (white arrows) on AM. Representative culture images 
from Day 1 until Day 5. On Day 5, there was distinct LMSC colonies growing on AM, 
a magnified image shows changes in cellular morphology (white arrows) from spindle-
shaped cells to rounded bodies with bipolar projections, N=3.  
 
Figure 3.12 Haematoxylin and eosin staining of a cross section of AM. (A) with areas of 
LMSC growth (asterisks) (B) a cross section of AM without LMSC for comparison, 
photo insets show a magnified view. [Blue –cell nuclei, scale bar: 20 μm]. 
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Molecular analyses for common limbal markers were investigated in cells grown on 
AM (L-AM), LMSC and epithelial cells of the AM (Figure 3.14). L-AM and LMSC 
showed high expression of the transcription factor p63 similar to AM, but low/no 
expression of cytokeratin3 (CK3). CK3 was detected in some LMSC culture, but absent   
in other biological replicates (Figure 3.15). Another corneal differentiation marker 
CK12 was also not expressed. GAPDH was used as a loading control. ICC analysis of 
the LMSC grown on AM construct showed some cells expressed ABCG2 (6A), p63 
(6C) and ABCB5 (6C), compared to the sections devoid of MSC (Figure 3.16).   
 
 
Figure 3.13 mRNA expression of CK3 and p63 in LMSC on AM, GAPDH as the house 
keeping gene. [Abbreviations: L-AM: LMSC on AM, LMSC LMSC alone, AM alone, 
+ve control and NTRm-no template reactions].  
 
 
Figure 3.14 mRNA expression of CK3 and CK12 in LMSC and LEC, GAPDH was 
used as the house keeping gene. [Abbreviations: LMSC – LMSC, LEC - Limbal 
epithelial cells, NTR - no template reaction].  
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Figure 3.15 Results of immunohistochemistry of AM sections with LMSC growth. (6A) 
LMSC expressing ABCG2, (6C) ABCB5 and (6E) p63 (6B) and (6D) are negative 
control sections stained with secondary IgG only (6F) the same cross section used for 
p63 staining with DAPI only (6G) and (6H) are cross sections of AM without LMSC 
growth; (6G) p63 staining (6H) negative control with secondary IgG only. [DAPI=blue, 
FITC-conjugated secondary antibody= green, Rhodamine-conjugated secondary 
antibody=red], N=3. 
  
94 
 
Chapter 3: Characterisation of Corneal LSC and LMSC 
3.5     Discussion 
There are still no specific markers for LSC and the molecular characteristics of LSC 
remainpoorly understood. There are molecular markers for cells of the basal layer of the 
limbus and the clusters of cells within this anatomical region that potentially 
characterised the LSC and the limbal progenitor cells, these are categorised into: (1) 
nuclear proteins – transcription factor i.e ΔNp63 (2) drug resistance transporters i.e 
ABCG (3) cytoplasmic proteins – cytokeratins i.e CK3, 12, 19. (4) cell membrane or 
transmembrane proteins – integrin β1, β4,  α6  receptors i.e  epidermal growth factor 
receptor, and (5) Other genes include C/EBPδ and putative oncogenes that modulate 
stem cell pluripotency, BMI-1.  
 
A new marker, ABCB5 which was recently reported to be an important molecular 
limbal marker for corneal development was also looked at. ABCB5 was first identified 
in skin progenitor cells (Frank et al., 2003) and malignant melanoma cells (Frank et al., 
2005). ABCB5 is an ATP binding cassette membrane transporter P-glycoprotein, that 
plays a significant role in cell fusion. Cell fusion is a molecular mechanism implicated 
in cellular differentiation (Frank et al., 2003). ABCB5 has been associated with tumour 
progression and resistance to cancer treatment in melanoma, colorectal and liver 
carcinomas (Frank et al., 2005; Wilson et al., 2011; Linley et al., 2012; Lin et al., 2013; 
Wilson et al., 2014).  
 
In the human cornea, ABCB5 has been identified as an important marker for LSC 
(Ksander et al., 2014). It has been reported that ABCB5 has an important role in LSC 
maintenance and corneal wound healing. In this study we showed mRNA expression of 
ABCB5 in HTCEC and four sample donors of LEC, in addition our ICC analysis 
demonstrated expression of ABCB5 in some cells of the HTCE cell line. 
 
 In addition, ICC analysis of HTCEC showed some cells expressed of ABCG2, ΔNp63 
and the stem cell marker Sox2. This is comparable with ABCG2, p63 and Sox2 
expressions in primary LEC. In addition, HTCEC also expressed the stem cell markers 
NANOG and Oct3/4. Analysis at the mRNA level of both HTCEC and |LEC revealed 
both cell populations expressed stem cell markers NANOG, Sox2 and Oct4.  
 
We compared mRNA expressions of common limbal markers ABCG2, p63, C/EBPδ, 
BMI-1, and cytokeratins 3 (CK3) between HTCEC and LEC. CK3 is a marker for 
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corneal epithelial differentiation was robustly expressed in the LEC cultures, while its 
expression was low in HTCEC; this may be evidence of that HTCEC cells are poorly 
differentiated in the cell culture conditions employed in this study.  
 
Previous studies have demonstrated the isolation of LMSC from corneal tissue although 
protocols varied among the investigators.  Polisetty et al described  harvesting  spindle-
shaped outgrowths from primary limbal cultures after growing them on AM (Polisetty 
et al., 2008). What where termed  “limbal niche cells” by Tseng group, where cells 
isolated from corneo-scleral rings  using collagenase, or with dispase and grown on 
coated matrigels (Gui-Gang Li et al., 2012). The Funderburgh group used dispase and 
collagenase digestion on minced pieces of stromal tissues and successfully grew these 
cells in a selective media containing 2% FBS;  incubated in humidified atmosphere, at 
5% CO2  (Du et al., 2005; Branch et al., 2012). These cells have all been shown to 
express MSC markers (Du et al., 2005; Polisetty et al., 2008; Branch et al., 2012; Gui-
Gang Li et al., 2012) and have been described as having angiogenic potential (Gui-
Gang Li et al., 2012).  
 
Our group used serial trypsinisation which we believe effectively cleaved the epithelial 
layers from the stroma as shown by haematoxylin and eosin staining on cross sections 
of limbal tissues taken from each cycle (unpublished data). Further use of trypsin 
allowed separation of the epithelial layer into single cells.  In this study LMSC were 
cultivated using an MSC-growth promotion media (MGPM) containing α-MEM, FBS 
and FGF2, according to previous literature (Barbero et al., 2003; Knuth et al., 2013). 
Addition of growth factor(s) in a basic media was found to enhance multi potentiality of 
MSC (Barbero et al., 2003; Du et al., 2005).  
 
LMSC cultures were propagated in a hypoxic condition, with the exception of those 
being analysed for adipogenic differentiation which requires normal oxygen levels . 
Hypoxia or low oxygen tension has been shown to be a critical regulator of stem cell 
biology though the activation of hypoxia inducible factor pathways and the maintenance 
of cellular health (Mohyeldin et al., 2010). Hypoxia or low oxygen tension is more 
physiologically relevant to maintenance of stem cell function and differentiation (Bath, 
2013) and in addition has been shown to be physiologically effective for greater cell 
vitality, enhance tri-lineage differentiation and modulates the paracrine activity of MSC 
(Das et al., 2009).  
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Immunophenotyping was used to demonstrate that the cells isolated in this study had the 
characteristics of human MSC; these cells were positive for expressions of cell surface 
antigens CD44, CD90, CD105, CD146 and CD166. They also had low/no expression 
for the haematopoietic commitment markers CD19 and CD45. This is comparable to 
findings of LMSC immunophenotyping reported in previous studies (Polisetty et al., 
2008; Polisetti et al., 2010; Wilson et al., 2011; Branch et al., 2012; Garfias et al., 
2012). It has been noted that there were variations of cell surface antigen presentation in 
LMSC in different culture media or with addition of growth factors (Du et al., 2005). 
For example, CD146+ve was expressed in cultures with serum supplement, but no 
expression in commercially available serum-free media (Bray et al., 2014). A 
CD34+/CD105+ve LMSC population has also been shown to be stem-like and have tri-
lineage differentiation capabilities (Wilson et al., 2011).  
 
Human MSC showed high expression of MHC Class I, but low/no expression of Class 
II, similar to previous findings (Garfias et al., 2012; Bray et al., 2014). Therefore, 
human MSC should be recognised by alloreactive T cells, however transplantation of 
mismatched MSC in non-human primates did not show proliferation of allogeneic 
lymphocytes (Bartholomew et al., 2002). Further, undifferentiated and lineage-
differentiated bone marrow-MSC suppressed proliferation of reactive allogeneic 
lymphocytes (Le Blanc et al., 2003) making these cells attractive for HLA-mismatched 
clinical cellular therapy (Ringden et al., 2007).  
 
Both in rabbit and human studies, LMSC have also been reported to immunosuppress T 
cell proliferation in two-way mixed donor leukocyte assays (Bray et al., 2014). This 
suppression could be mediated by  soluble factor like TGF-β, that are secreted by 
LMSC (Garfias et al., 2012). This support human MSC has a highly suitable cell 
population for cellular therapy and transplantation.  
 
The current study showed that LMSC fulfils the criteria for tri-lineage differentiation. 
LMSC were committed to be osteogenic, adipogenic and chondrogenic by histology. 
Oil Red O staining shows lipid laden cells undergoing adipogenesis, while calcium 
deposition was indicated by Alizarin Red staining, similar to previous findings in 
LMSC (Polisetty et al., 2008; Wilson et al., 2011). We also showed sections from a cell 
pellet grown in chondrogenic media to have cartilage deposition which was indicated by 
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Safranin O staining. Alternatively, characterisation of chondrogenesis has also been 
performed by using Alcian Blue as reported in other studies (Wilson et al., 2011; Gui-
Gang Li et al., 2012).  
 
Further, LMSC showed mRNA expressions to genes known to be expressed by these 
cell types, except for lacking expression of collagen X. Collagen X is normally 
expressed by hypertrophic chondrocytes during endochondral ossification (Gaetani et 
al., 2012), and the expression might need cellular maturity not observed in our cell 
population. Tri-lineage commitment in LMSC shows a similar multipotentiality 
possessed by human BM-MSC (Polisetty et al., 2008; Wilson et al., 2011; Branch et al., 
2012).  
AM has been widely used for ocular surface diseases in the UK since 1998, the outcome 
of AM transplantation has given varying results under different conditions  (Saw et al., 
2007). The beneficial effects of AM include the anti-angiogenic, anti-inflammatory and 
wound healing properties, making it the most common biological substrate for tissue 
constructs. The long term storage of AM in cryopreserved media also did not alter the 
sterility, histology or biological properties (Thomasen et al., 2011). In the case of 
bilateral LSCD, cultivated oral mucosa epithelial transplantation on AM has also been 
clinically applied with promising results (Koizumi et al., 2000; Nakamura et al., 2004).  
 
LMSC grown on AM rapidly became a confluent cell layer and in addition, underwent 
morphological changes from a fibroblast-like morphology (Barbero et al., 2003; Gui-
Gang Li et al., 2012) to cells with a more rounded cell body with bipolar protrusions. A 
series of morphological changes have previously been observed from outgrowths of 
limbal epithelial cells grown on intact versus denuded AM by Tseng group (Wei Li et 
al., 2006) which might be pertinent to the changes observed in our cultures. In their 
publication, they described the morphological changes of small, cuboidal cells (intact 
AM) versus large, spindle-shaped cells (denuded AM), stratification (intact AM) versus 
two-layer cells (denuded AM), etc. These changes were attributed to a process of 
cellular maturation and differentiation by limbal epithelial cells as they dissolved and 
then reassembled AM basement membrane as they grew on the AM.  
 
In this study we show that LMSC share some expression of limbal markers that have 
been widely used to characterise LSC at both the level of gene expression and protein 
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expression. p63 and ABCG2 have been identified as the two most common limbal 
markers (Zhuo Chen et al., 2004; Enzo Di Iorio et al., 2005; Kawasaki et al., 2005; 
Fight-for-Sight, 2014). p63 is responsible for limbal epithelial proliferation (Hsueh et 
al., 2012) and the isomer ΔNp63α of the transcription factor plays a significant role in 
corneal regeneration and wound healing (Enzo Di Iorio et al., 2005). While expression 
of p63 is generally considered to be nuclear we observed that LMSC grown in culture 
and on AM exhibited both punctuate nuclear staining and cytoplasmic staining, this may 
be indicative of cellular differentiation. Galli et al (Galli et al., 2010) reported that 
certain genes like MDM2 can mediate translocation of ΔNp63 from the cell nucleus to 
the cytoplasm under appropriate stimuli that can include cellular differentiation. 
 
CK3 distinguishes undifferentiated LMSC from epithelial cells, and is a good marker 
for corneal epithelium and also as a negative marker for limbal stem cells (Harkin et al., 
2004b). We found mRNA expression of CK3 was not consistent in all our samples 
which may suggests variability between donors. Variability in patient-derived MSC has 
been reported in other MSC derived from other tissues (D'Ippolito et al., 1999).  
 
3.6 Conclusion 
HTCEC is comparable to primary LEC in the expressions of important molecular 
markers for limbal epithelial stem cells, corneal progenitor cells and stem cell antigens. 
Due to existing problems of primary tissues, donor availability and donor-to-donor-
variability, HTCEC is attractive to provide consistent and reproducible results. This 
study demonstrates a simpler way of isolating LMSC from primary corneal tissues by 
serial trypsinisation alone. The cells grew in MSC-growth promotion media in hypoxic 
condition. The advantages of these conditions include shorter duration of reaching cell 
confluence due to the rapid growth of LMSC (5-7 days) compared to 10-14 days for 
proliferation of outgrowths from limbal explants (Polisetty et al., 2008) or using cell 
suspension from primary tissues (Wilson et al., 2011; Branch et al., 2012). LMSC is a 
vital component of the LSC niche. The LMSC-AM tissue engineered construct has great 
potential for ocular surface regeneration and more importantly in the cellular treatment 
of LSCD. 
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Chapter 4 CHARACTERISATION OF LIMBAL SIDE 
POPULATION CELLS 
4.1 Introduction 
Characterisation of LSC remains challenging in part due to the absence of specific LSC 
markers. Successful outcome of ex vivo expanded LSC transplantation is dependent on 
the frequency of stem cells or limbal progenitors in the transplanted tissues (Rama et 
al., 2010). One of the ways to isolate an enriched population of putative stem cells is by 
utilising ATP- binding cassette (ABC)-transporter mediated efflux of a DNA-binding 
dye, such as the most commonly used Hoechst 33342. A seminal work by  (Goodell et 
al., 1996), demonstrated a population of stem cell enriched cells from within the 
haematopoetic cells of the mouse, these were isolated using high-speed dual wavelength 
flow cytometry analysis combine with vital dye efflux (Figure 4.1).  
 
 
Figure 4.1 Flow cytometry profiles of murine bone marrow side population. (A) SP 
cells are indicated with arrows. (B) Loss of SP cells on addition of verapamil (Goodell 
et al., 1996).  
 
Currently, SP assays have been used to identify stem cell and progenitor populations in 
various tissues i.e. umbilical cord blood, skeletal muscle (Annette P. Meeson et al., 
2004), kidney, liver, pancreas (Lechner et al., 2002), cardiomyocytes (Cindy M. Martin 
et al., 2004), mammary glands, lung, brain and cancer cells (Kelly M. Britton et al., 
2011). In most cases it has been shown that the ABC transporter, ABCG2 is over-
expressed in LSP cells, and is the cause of the SP phenotype (Zhou et al., 2001; 
Scharenberg et al., 2002; Savary et al., 2007). ABCG2  has been implicated as the 
determinant  for SP phenotypes  in other systems i.e. musculo skeletal (Annette P. 
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Meeson et al., 2004; Doyle et al., 2011), cardiac cells (Annette Meeson et al., 2013), 
hepatocytes (Shimano et al., 2003), and the airway epithelia (Hackett et al., 2008). 
Another ABC transporter, ABCB1 has been identified as determining the SP phenotype 
in ovarian cancer cell lines and is responsible in part for resistance to chemotherapy 
(Wright et al., 2013b).   
 
Hoechst 33342 is a fluorescent dye which binds to DNA in live cells. When excited by  
ultra violet light, Hoechst 33342 has an emission peak at 450nm which can be detected 
in what is commonly referred to as the Hoechst Blue channel , in this case using a 
450/50 band pass filter.  Hoechst dye also shows a secondary emission defined as 
Hoechst Red detected in this case by a 675nm long pass filter.  This appears to be 
partially dependent on the DNA conformation; as the intensity of the dye signal in the 
blue channel is proportional to the DNA content of the cell.   
 
The SP is detected as a discrete “tail” attached to the G0/G1 subpopulation in a bivariate 
plot of these two signals. In order to determine that this “tail” of cells are indeed SP 
cells confirmation of the SP phenotype is necessary. This can be determined using an 
ABC-transporter inhibitor which needs to be added to the cells (from the same cell 
preparation) to prevent dye efflux. Some of the ABC-transporter inhibitors responsible 
for preventing vital dye efflux are verapamil which blocks ABCB1 efflux activity and 
partially blocks ABCG2 efflux, cyclosporine A which inhibits ABCC1 and FTC that is  
a specific inhibitor for ABCG2 (Dean, 2002). 
 
ABC transporters are proteins which are embedded in lipid membranes and they 
facilitate the import of nutrients into cells or the release of toxic products into the 
surrounding medium. The largest and most important family of membrane transport 
proteins is the ABC transporters. ABC transporters belong to the super family of 
membrane pumps that catalyse ATP-dependent transport of various endogenous 
compounds and xenobiotics out of the cells. This often occurs against a concentration 
gradient, requiring hydrolysis of ATP. 
  
ABC transporters contain a number of membrane-spanning domains that include a 
translocation pathway for a specific substrate. As the ABC cassettes bind and hydrolyze 
ATP, conformational changes occur and are transmitted to the membrane-spanning 
domains, where they induce rearrangements that translocate the substrate from one side 
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of the membrane to the other. The SP phenotype is lost upon inhibition of ABC 
transporter activity. 
 
It should however be noted that ABCG2 expression alone may not be solely responsible 
for conferring on stem cells the ability to efflux vital dyes.  Phylogenetic analysis places 
48 known human ABC transporters into seven superfamilies of proteins (Dean, 2002),  
several of which have been shown to confer on  cells the ability to efflux various 
unrelated compounds. The ABC genes represent the largest trans-membrane proteins 
and these include the ATP-binding cassette sub-family B member 1 (ABCB1), ABCG2 
and ABCC1 genes. 
 
ABCG2, ABCB1 and ABCC genes are the most commonly reported genes that confer 
multi drug resistance phenotypes to cancer stem cells. ABCG2 overexpression has been 
associated with development of many solid tumours; such as laryngeal squamous cell 
carcinoma (Diestra et al., 2003), bladder carcinoma (Sauerbrey et al., 2002), lung 
cancer and leukaemia (Brangi et al., 1999). ABCG2 overexpression is known to cause 
resistance to some currently in use chemotherapeutics which include mitoxantrone and 
camptothecin analogues (Partanen et al., 2012).  In laryngeal squamous cell carcinoma, 
down regulation of ABCG2 through the MAPK pathway  reduced cellular proliferation, 
and led to cancer cell apoptosis (Diestra et al., 2003). Further, amplification and 
overexpression of ABCC3 gene has been implicated in human epidermal growth factor 
receptor (HER)-2 positive breast cancer cell lines (Jin Xie et al., 2014), as well as 
conferring resistance to the chemotherapeutic drug “paclitaxel” in ovarian cancer (Eyre 
et al., 2014).  
 
However, not all cancer SP cells show characteristics of cancer stem cells (CSC), these 
are termed “CSC-like” cells which do not show stem cell activities. SP cells from 
glioblastoma multiforme did not enrich for neurospheres, were not able to self renew 
and had lower tumorigenic potential than the NSP cells (O'Brien et al., 2008). 
Furthermore, SP cells from adrenocortical cancer cell lines did not show a superior 
cellular proliferation,  self renewal capacity or chemoresistance than the NSP cells 
(Broadley et al., 2011).  
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4.1.1 Limbal side population assay 
Studies of ABCG2 expression at mRNA and protein levels have provided convincing 
evidence that ABCG2 is the main transporter implicated in determining the LSP 
phenotype (Zhuo Chen et al., 2004; Budak et al., 2005; Cintia S. de Paiva et al., 2005a; 
Umemoto et al., 2005). 
 
Comparable to other adult tissues, corneal limbal and conjunctival epithelial cells 
derived cells contain SP fraction which is sensitive to the ABCG2-inhibitor FTC 
(Budak et al., 2005). A number of studies have now reported the presence of LSP in 
several species, although the concentration of Hoechst dye used and incubation time of 
cells in the presence of dye are variable between studies, which may reflect on the 
varied percentage of SP populations reported, as summarised in Table 4.1.   
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Table 4.1 Summary of publications on LSP.  
Type of tissues Inhibitors Hoechst  incubation  % SP cell yield References 
 
Human 
-Limbal 
epithelium 
-Corneal epithelium 
(R )+-Verapamil 
Tryprostatin A 
(30min 37°C) 
 
 
Concentration: 3 
µg/ml),Incubation:  
90 min 
at 37 °C. 
Limbal:  0.20% 
gated cells. 
Corneal :0.02% 
gated cells). 
(Watanabe et 
al., 2004)* 
New Zealand White  
rabbits 
-Limbal epithelium 
-Corneal epithelium 
R(+)-verapamil 
(Sigma) or 
tryprostatin-A 
(Alexis 
Biochemicals, 
Carlsbad, 
CA) 
 
Concentration: 3 
µg/ml),Incubation:  
90 min 
at 37 °C. 
Limbal :0.40% 
gated cells 
Corneal:0.01% 
gated cells 
 
(Umemoto et 
al., 2005) 
Wistar rats and New 
Zealand White rabbits 
-Limbal epithelium 
-Corneal epithelium 
R(+)-verapamil 
(Sigma) or 
tryprostatin-A 
(Alexis 
Biochemicals, 
Carlsbad, 
CA) 
 
Concentration: 3 
µg/ml), 
Incubation:  90 min 
at 37 °C. 
Limbal: 
Rabbit: 0.56%  
Rat: 0.40% 
 
Corneal: 
Rabbit: barely  
Rat: 4.6% 
(contaminant) 
 
(Umemoto et 
al., 2006) 
Rabbit 
- limbal epithelial cell 
Tryprostatin-A 
(Alexis 
Biochemicals, 
Carlsbad, 
CA) 
Concentration: 5 
µg/ml),Incubation:  
90 min 
at 37 °C 
0.40% gated cells (Kusanagi et al., 
2009) 
Human  
-corneoscleral tissue 
(primary cultured cells) 
50 µM of verapamil Concentration: 5 
µg/ml), 
Incubation: 
37°C for 120 
minutes  
 
2.1 % gated cells (Cintia S. de 
Paiva et al., 
2005a)* 
Rabbit  and Human 
– cornea and 
Conjunctiva 
 10 µM reserpine 
(Sigma), 10-100 µM 
verapamil 
(Sigma) or 10 µM 
Fumitremorgin C  
 
Conjunctival 
epithelium: 3.0-3.5 
µM for 90 minutes 
Limbal epithelium: 
 2.0-2.5 µM for 60 
minutes at 37° 
SP (% of total) 
Human limbus: 
0.49% 
Human conjunctiva: 
0.58% 
Rabbit limbus: 
0.88% 
Rabbit conjunctiva: 
0.96% 
 
(Budak et al., 
2005)* 
Pig limbal epithelium 
(overnight culture) 
 
Fumitremorgin C Concentration: 5 
µg/ml 1.5 hours 
Limbal: 0.89 % (Akinci et al., 
2009) 
HTCEC 
 
Human primary limbal 
epithelial cultures 
Verapamil (20µM) 
30 minutes 
3 µg/ml 45 minutes 0.2%  
 
 
0.8% 
(Shaharuddin et 
al., 2013c)* 
[* studies involving human tissues. Part of this table was taken from (Shaharuddin et 
al., 2013a)] 
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4.1.2 Are LSP cells stem cells? 
Limbal side population assays have been performed using both animal and human 
cornea tissues. It has been reported that SP cells are present in the conjunctival and 
limbal epithelia of both rabbits and humans but absent from the corneal epithelium 
(Watanabe et al., 2004; Umemoto et al., 2005). A number of studies of LSP cells have 
also determined that the ABC transporter ABCG2 is the main transporter responsible 
for conferring on SP cells their ability to efflux Hoechst 33342 dye (Watanabe et al., 
2004; Budak et al., 2005; Cintia S. de Paiva et al., 2005a; Ki-Sook Park et al., 2006; 
Umemoto et al., 2006; Akinci et al., 2009).  
 
Previous investigations of both human and animals showed LSP cells had features 
consistent with stem cells. In a study of human LSP cells, it was observed that the SP 
cell fraction expressed higher levels of ABCG2 than the NSP using real time PCR and 
immunohistochemical analysis on limbal and corneal tissue sections. ABCG2 was 
expressed in the LEC but not in the corneal epithelial cells (Watanabe et al., 2004). 
Other reported properties of LSP cells include the slow cycling nature, higher in vitro 
proliferation and p63 expression (Wolosin et al., 2000; Cintia S. de Paiva et al., 2005a) 
and data from flow cytometry showed that LSP cells have features which are consistent 
with stem cells; they showed low forward scatter (FSC) and extremely low side scatter 
(SSC) (Budak et al., 2005).  
 
Murine keratinocyte stem cells have also been reported to be slow cycling (Cotsarelis et 
al., 1990; Tani et al., 2000) as have rat conjunctival stem cells (Wensheng Chen et al., 
2003) and LEC (Cotsarelis et al., 1989). These reports support small cell size and slow 
cycling as characteristics of stem cells. 
 
In addition,  LSP cells were shown to express elevated levels of ABCG2, Bmi-1 and 
nestin but lacked expression of CK3 and 12 compared with NSP cells (Umemoto et al., 
2006) (77). CK3 and CK12 are markers of differentiated corneal epithelial cells 
(Chaloin-Dufau et al., 1990; Budak et al., 2005), whereas Bmi-1 has been reported to be 
a marker of a number of stem cell populations (Lessard and Sauvageau, 2003; In-kyung 
Park et al., 2003) including but not exclusive to: neural crest stem cells (Molofsky et al., 
2003), intestinal stem cells (Sangiorgi and Capecchi, 2008.), hematopoietic stem cells 
and neuronal stem cells (Molofsky et al., 2003; In-kyung Park et al., 2003), where it is 
thought to be an important regulator of stem cell renewal. While nestin has been 
105 
 
Chapter 4: Characterisation of  Limbal SP 
reported to be important for self renewal of neural stem cells (Donghyun Park et al., 
2010).  
 
LSP cells have also been reported to have a higher colony forming efficiency than NSP 
cells (Cintia S. de Paiva et al., 2005a). Colony forming efficiency is also considered a 
stem cell characteristic and has been demonstrated in numerous studies of many 
different stem cell populations including but not limited to retinal stem cells (Tropepe et 
al., 2000), bone marrow stem cells (Friedenstein et al., 1987), and dental  pulp stem 
cells (Gronthos et al., 2000). 
 
As LSP cells are small in size, slow cycling, express stem cells markers and are capable 
of colony formation, this would suggest that they are indeed stem cells. However, to be 
useful in the clinical setting LSP cells need to be expanded in vitro while maintaining 
their stem cell characteristics. A relatively low percentage of SP cells within a large 
NSP cell population pose a challenge in determining the best culture system for cell 
expansion.  In a study by Park et al, 2006, post sorted-SP cells were able to show 
stratification and proliferative capacity in a modified 3-D raft culture (Ki-Sook Park et 
al., 2006).   Swiss 3T3 fibroblasts were plated on a type I collagen gel matrix within a 
12-mm culture insert in supplemented Eagle’s medium to mimic an in vitro stromal 
equivalent. Immunohistochemistry performed on the sorted-SP cells successfully 
demonstrated a high proportion of cells expressing p63, which is a marker for cell 
proliferation.  
 
From wound healing models of the cornea,  in vivo ability of LSP cells to increase in 
number in response to injury was observed (Ki-Sook Park et al., 2006). It is also 
possible to expand SP cells ex vivo while maintaining their stem cell characteristics as 
demonstrated in articular synovial tissues (Teramura et al., 2008).  Proliferative capacity 
of cochlear SP cells were also studied in adherent versus non-adherent conditions, in 
which they favour the former (Chao et al., 2013). Based on these published reports, 
expansion of LSP in culture is something that is probable, once the optimal culture 
conditions have been determined. 
 
SP cells have demonstrated regenerative properties in several studies. Jackson et al, 
2001 transplanted highly enriched haematopoietic SP cells into the ischaemic heart in 
lethally irradiated mice and showed these SP cells  were capable of differentiating into 
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cardiomyocytes and endothelial cells (Jackson et al., 2001). This was later emphasized 
in another study where cardiac SP cells were able to differentiate into multiple lineages 
including cardiomyocytes, fibroblasts, endothelial cells and smooth muscle cells 
(Oyama et al., 2007). The role of SP cells in repair and regeneration of skeletal muscle 
has also been widely investigated, these cells proliferate in response to injury and some 
participate in regeneration while others are thought to replenish the SP cell population 
(Annette P. Meeson et al., 2004; Tanaka et al., 2009; Doyle et al., 2011). Similarly, in 
response to an alkali burn central cornea wound, the SP cell population showed a 
transient increase in cell numbers after 24-hours of injury (Ki-Sook Park et al., 2006). 
Further investigations into the role of SP cells in wound healing are warranted. 
4.2 Specific Aims 
In this chapter we aim to;  
1. To describe the methodology for the identification and isolation of corneal 
epithelial SP in both primary LEC and HTCEC. 
2. To describe the optimisation of a protocol for SP isolation from both LEC and 
HTCEC.  
3. To investigate expressions of ABC-transporters in LEC.  
4. To investigate the association between cell confluence and SP percentage 
5. To characterise LSP cells using LSC markers 
6. To study the association of cell diameter and colony formation and LSP. 
 
4.3 Materials and methods 
4.3.1 LEC and HTCEC 
Isolation and cultivation techniques of limbal epithelial sheets followed the protocol 
described in Chapter 2 and published earlier (Shaharuddin et al., 2013c). It was based 
on the keratinocyte culture system by Rheinwald and Green (Rheinwald and Green, 
1975a; Rheinwald and Green, 1975b; Green et al., 1977) and described in many reports 
(Notara et al., 2007; Shortt et al., 2007b; Osei-Bempong et al., 2009; Meyer-
Blazejewska et al., 2010). The cells were propagated in a co-culture system with murine 
3T3-J2 fibroblast feeder layer (a kind gift from Professor Fiona Watt, King’s College, 
London, United Kingdom). 
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Our stock of HTCEC line (Robertson et al., 2005; Robertson et al., 2008; Robertson et 
al., 2011) was generously contributed by Dr James Jester and Winston Kao, of the 
University of Cincinnati, Cincinnati, Ohio, USA. We successfully expanded HTCEC 
and maintained this cell line in feeder- and serum-free conditions using defined 
keratinocyte serum free medium (DKSFM) [Gibco].  
 
4.3.2 Reagents 
Hanks balanced salt solution (HBSS) medium  
This was prepared as follows; 500ml HBSS [Sigma] containing 2% fetal bovine serum 
(FBS) [Lonza], and 5ml of 5,000 units of penicillin/streptomycin [Gibco]. 
 
Verapamil [Sigma Aldrich ] 
Verapamil is a general calcium channel inhibitor, which inhibits efflux of drugs at the 
ATP-dependent pumps e.g. Hoechst 33342 dye in SP discrimination assay. Verapamil is 
made into a 5mM stock solution in H2O and stored frozen at -20
0
C, once thawed it can 
be stored at 4
0
C for 1 month and is used at 20 – 40µM concentration.  
 
Fumitremorgin-C [Axxora]  
FTC is a specific inhibitor of ABCG2. FTC is diluted in DMSO to make a 10mM stock 
and stored at -20
0
C and is used at a final concentration of 5µM.  
 
Hoechst 33342 [Sigma]  
25mg Hoechst 33342 in powder form was dissolved in 25ml H2O to a final 
concentration of 1mg/ml, filter sterilized and aliquots frozen at-20°C. Once thawed 
Hoechst was kept at 4°C for 1-2 months. 
 
Propidium iodide (PI)  
25mg PI powder was dissolved in 2.5ml H2O to a final concentration of 10mg/ml, filter 
sterilised and aliquots were stored at -20°C, once thawed vials were kept at 4°C. 
 
4.3.3 LEC and HTCEC sample preparation 
On Day 10, cells from LEC were detached from  tissue culture wells by first adding 1ml 
of Ethylenediaminetetraacetic acid (EDTA) for 3 minutes to remove any residual feeder 
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cells, and subsequently adding 1 ml of 0.05% trypsin-EDTA and placed in a CO2 
incubator at 37°C for 3 minutes. To inactivate trypsin, 1ml of medium containing 10% 
Fetal Bovine Serum (FBS) [Lonza] was added to the well subsequently. The cell 
suspension was then centrifuged and the cell pellet resuspended in Hank’s medium.  
 
For HTCEC sample preparation, DKSFM was first removed and cultures irrigated with 
Dulbecco’s Phosphate Buffer Saline (DPBS) [Sigma]. Cells in a 75cm2 tissue culture 
flask were then treated with a cell dissociation buffer – enzyme free, Hank’s based 
[Gibco] in a CO2 incubator at 37°C for 20 minutes and then rinsed with PBS. 5ml 
0.05% Trypsin-EDTA was then added and incubated for another 3 minutes. The steps as 
described above were repeated. 
 
Cells were counted manually using an improved Neubauer haemocytometer [Reichert], 
1.0 x 10
6
 cells/ml were resuspended in Hank’s media and placed into micro centrifuge 
tubes [Fisher] to be stained with either Hoechst 33342 dye alone or with Hoechst dye in 
the presence of ABC-transporter inhibitors. As a control to the confirm the SP 
phenotype, cells from the same cell preparation as those being analysed (prior to 
addition of Hoechst)were incubated in the presence of inhibitor for 30 minutes in a 5% 
CO2 incubator at 37°C in a MACsMix rotator [Miltenyi Biotec]. After this, Hoechst dye 
was then added to all tubes as described above.  
 
All reactions were terminated by placing the contents of the tubes in a 15ml centrifuge 
tube [Fisher] containing 10ml ice cold Hank’s/FBS medium. The tubes were then 
centrifuged at 2,500 rpm for 5 minutes and cells resuspended with 500µl Hank’s 
medium and passed through a 70µm pore size cell strainer [BD Falcon] and stored on 
ice prior to FACS analysis. 
 
4.3.4 Flow Cytometry Analysis and Fluorescence Activated Cell Sorting 
FACSanalysis and cell sorting was done using either an LSR2 SORP analyser or a 
FACSAria IIu sorter [Becton Dickinson]. Both machines used identical filter sets and 
laser configurations. Propidium iodide (PI) was added immediately prior to analysis at a 
final concentration of 2µg/ml.  Initial gating was designed to exclude non viable cells, 
these were defined as PI positive and were detected using 488nm excitation and a 
610/20 emission filter (data not shown). SP cells were identified on a bivariate plot 
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showing Hoechst Blue (355nm excitation, 450/50 emission) versus Hoechst Red 
(355nm Excitation, 675LP emission). For analysis, at least 50,000 events were 
collected. For sorting SP and NSP, cells were collected into either culture media for 
molecular characterisation and cell culture or directly onto microscope slides for 
immunofluorescence studies. 
 
4.3.5 ICC of LSP and NSP cells 
100 HTCEC SP and NSP cells were sorted directly onto glass slides. Slides were fixed 
with cold methanol [BDH Laboratory Supplies] at -20 °C for 20 minutes and then 
washed with PBS. Cells were permeabilised in 0.3% (v/v) Triton X-100 [Fisher 
Scientific] in PBS for 10 minutes and then washed again with PBS. Non-specific 
binding sites were blocked with 5% normal goat serum [Invitrogen] in PBS for 30 
minutes in a humid chamber in the dark. Cells were then incubated with primary goat 
anti-mouse monoclonal antibody to ABCB5 (1:100 dilution) [Abcam], CXCR4 (1:100 
dilution) [R&D Systems], p63 (1:50 dilution) [Santa Cruz biotechnology] and goat anti-
rabbit polyclonal antibodies to ABCG2 (1:100 dilution) [Novus Biologicals] in 0.05% 
FBS/PBS overnight at 4°C. Cells were then washed 3x5 minutes PBS and incubated 
with appropriate secondary antibody either goat anti-mouse FITC or anti-rabbit 
Rhodamine [Jackson Immunology Research Laboratory] 1:25 dilution for 30 minutes in 
a humid chamber in the dark, then washed with PBSX3 5 minutes and mounted in 
vectashield anti-fading media containing DAPI [Vector Laboratories], cover slipped and 
examined using an Axioplan F microscope [Carl Zeiss]. In the case of ΔNp63 slides, 
vectashield without DAPI was used. Negative controls were cells incubated without 
addition of primary antibody, but with secondary antibody.  
 
4.3.6 Image quantification 
Under 20X magnification, the collection site for cells on the slides were arbitrarily 
divided into 5 quadrants (Figure 4.2). For each quadrant, all cells were selected for 
image quantification using image quantification software [Image J version 1.44]. The 
means (± standard deviation) of fluorescence signal intensities were averaged and 
analysed to compare the means between SP and NSP cell fractions, using independent  
t-test [IBM SPSS Statistics Version 19].  P value of < 0.05 was taken as a significant 
difference in means between two groups.    
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Figure 4.2 Schematic diagram for arbitrary division of areas for microscopic 
quantification of markers-positive cells in NSP and SP cells.  
[Abbreviations: UL – Upper left quadrant, UR – Upper right quadrant, MD – Middle 
quadrant, LL – Lower left quadrant, LR – Lower right quadrant].  
 
4.3.7 Measurement of cell diameter 
Cell diameter was measured using the Axiovision software version 4.8.2.0 [Zeiss], by 
drawing a straight line at the longest diameter across a cell.  The fluorescent filter was 
switched off during this measurement. The mean values for SP and NSP cells were then 
entered into IBM SPSS statistical software Version 19 and analysed with independent t-
test for difference in means between two groups. P value of < 0.05 was taken as 
significant. 
 
4.3.8 Semi quantitative-Polymerase chain reaction (sq-PCR) 
sq-PCR reactions were assembled with 12.5µl PCR master mix [Promega, UK], 0.5µl 
forward primer,  0.5µl reverse primers and 2 – 2.5µl cDNA template and DEPC-treated 
water to a final volume of 25µl reactions. Denaturation was set at 94°C for 30 minutes 
and elongation took place at 72°C for 1 minute at primer pair specific annealing 
temperature, and maintained at 4ºC or electrophoresed on a 2% agarose gel [NBS 
Biologicals]. PCR reactions were amplified for each gene and conditions are 
summarised in Table 4.2.   
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Table 4.2 Oligonucleotide sequences and amplification conditions. 
Gene Primers Oligonucleotide Sequences Product  
Length 
(bp) 
Cycles Annealing 
temperature 
°C 
ABCG2  
 
143 35 55.5 
 Forward GCG TGC TGT GCC CAC TCA AA    
 Reverse AGC ATG TGC ACG GTG CGT TC    
      
ABCB1   116 35 55 
 Forward GAC GTC ATC GCT GGT TTC GAT    
 Reverse TCA TTT CCT GCT GTC TGC ATT GT    
      
GAPDH   150 30 55 
 Forward GCA CCG TCA AGG CTG AGA AC    
 Reverse GCC TTC TCC ATG GTG GTG AA    
      
 
4.4 Results 
4.4.1 Optimisation of LSP protocol 
Due to the limitations associated with primary limbal tissues and its culture conditions 
which involve co-culture expansion with animal-sourced feeders or AM, and often 
limited cell numbers, optimisation for LSP was performed using the HTCEC line based 
on bone marrow SP as established by Goodell (Goodell et al., 1996). The steps involved 
optimising for Hoechst dye concentration and duration of incubation, and verapamil 
concentration. FTC was used at a concentration of 5µM based on  pre-optimisation by 
other investigators (Rabindran et al., 2000)  (Figure 4.3). We achieved a final LSP 
protocol using Hoechst dye concentration 3.0µg/ml for 1.0 x 10
6
 cells/ml, 45 minutes 
incubation at 37
O
C, using Verapamil 20µM as an SP-inhibitor for 30 minutes.  
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Figure 4.3 Optimisation steps to limbal side population protocol.  
[*pre-optimised in previous literature (Rabindran et al, 2000). This figure was 
previously  published (Shaharuddin et al., 2013c)] 
 
To determine the optimal Hoechst concentration, a Hoechst concentration curve was 
first determined. Cells were incubated in the presence of a range of concentrations from 
0.5µg/ml to 5.0µg/ml. In the presence of 3µg/ml of Hoechst dye, an SP population of 
0.2% could be detected with cell death of 37% (Figure 4.4A), furthermore the efflux 
ability of these cells could be blocked in the presence of verapamil (Figure 4.4B).   A 
higher concentration e.g. 5μg/ml of Hoechst dye led to reduced SP resolution or loss of 
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the SP phenotype.  Cell viability was severely reduced at 47% (Figure 4.4C), and in the 
presence of verapamil further cell death occurred - 54% (Figure 4.4D). Using a lower 
concentration of Hoechst than the optimum concentration, will lead to under saturated 
SP profile where NSP cells will be introduced into the SP gate giving a high, but 
unlikely SP phenotype (Golebiewska et al., 2011).    
 
Figure 4.4 Representative FACS data plots showing SP protocol optimisation. Gating 
indicates SP cells. (A) Cells stained using Hoechst concentration of 3µg/ml, note the 
presence of SP cells in the gated region (B) Absence of cells in the SP gate in the 
presence of VP. (C) Cells incubated with 5μg/ml of Hoechst and (D) Cells from the 
same preparation but with the addition of VP. In both C and D no SP phenotype was 
observed. [Abbreviations:  SP – side population, VP – Verapamil. Part of this figure 
was previously published (Shaharuddin et al., 2013c)] 
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The gating strategy for isolating a final population of cells by SP discrimination is 
presented in Figure 4.5. The steps involved initial debris exclusion, followed by a 
strategy to gate out cell doublets and cellular aggregates using the properties displayed 
by FSC and SSC. Next, dead cells were distinguished by its affinity to a cell death 
discrimination marker e.g. propiodium iodide (PI). Due to the function as a DNA-
binding dye, Hoechst dye fluorescent signals give indication for DNA content in the 
cells, thus specific cellular phase i.e G0/G1, S and G2/M can be identified. SP cells 
appear as the “tail” at the left hand side of the G0/G1 cell population. A gating tree 
gives information to the final SP population as a percentage to the parent gated events 
or as a percentage of the total recorded events.  
 
Figure 4.5 Step by step gating strategy for SP. (A) Cells are distinguished from debris 
by FSC (based on cell size) and SSC (based on granularity) (B) To ensure signals are 
directed from single cells, cell doublets and aggregates are singled out based on FSC-
Area (FSC-A) or SSC-A against FSC-Height (FSC-H) or SSC-H.(C) Dead cells are 
gated out by its positivity to a  dead cell discrimination marker e.g. Propiodium iodide 
(PI) (D) DNA-binding property of Hoechst gives off fluorescent signal which gives 
information on the specific cell cycle indicated by the DNA content of the cells (E) SP  
cells are recognised as a dim “tail” which appears first  at the left hand side of the 
G0/G1  population (F) The gating tree is a sequential events leading to isolation of an 
SP population. %Parent refers to percentage of gated events relative to the preceding 
gate. %Total refers to percentage of gated events relative to total events recorded.  
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4.4.2  LSP in primary LEC cultures 
Using our optimized SP protocol, harvested limbal colonies from co-cultures with 3T3 
feeder layer were analysed for the presence of SP. SP cells were present as shown in 
Figure 4.6A. Cells from the same culture but incubated in the presence of verapamil 
were used to confirm the SP cell phenotype (Figure 4.6B). Samples from 11 donor 
corneas were processed and the epithelia cultured and prepared for SP assays with the 
final SP phenotype being confirmed by addition of either verapamil or FTC. SP yields 
from these are presented in Figure 4.7. Range of SP yields was between 0.1 to 0.8% 
with a median value of 0.2 (SE 0.07).  
 
Figure 4.6. Representative FACS dot plots showing SP cells in LEC. (A) SP in primary 
LEC (SP gate indicated by arrows). (B) The same preparation but with the addition of 
Verapamil . Note the absence of SP cells in the gated region on addition of verapamil. 
(Shaharuddin et al., 2013a; Shaharuddin et al., 2013c). 
 
 
Figure 4.7 SP yields in primary LEC, N=11. SP yield ranges from 0.1 – 0.8%  
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4.4.3 ABC-transporters in LSP cells 
The ability of both primary limbal epithelial SP and HTCEC to efflux Hoechst dye 
could be inhibited by the addition of verapamil or FTC alone. This inhibition was either 
complete or partial, which was the same for both cell line and primary epithelial 
cultures, but partial inhibition is a phenomenon more frequently associated with primary 
epithelial cultures, an example is given in Figure 4.8A, 4.8B and 4.8C. In the presence 
of 3 µg/ml of Hoechst dye, an SP population of 0.4% could be detected (4.8A), which 
was partially inhibited by verapamil, note the reduced number of SP cells in the SP gate 
(4.8B), with the addition of FTC note no SP cells can now be seen in the SP gate (4.8C).  
 
 
Figure 4.8. Representative FACS dot plots showing SP cells in HTCEC (A) SP gates 
are indicated with arrows (SP=0.4%). (B) Note reduction of SP on addition of 
Verapamil 0.3%), and (C) Loss of SP cells on addition of FTC (Shaharuddin et al., 
2013c). 
 
When a partial inhibition was observed we hypothesised this was due to there being 
more than one ABC transporter being responsible for the SP phenotype. Both ABCG2 
and ABCB1 transporter genes were expressed by both primary LEC and HTCEC, as 
evident by sq-PCR results (Figure 4.9A and 4.9B). Results from immunocytochemistry 
showed ABCG2 was expressed in HTCEC and LEC (Figure 4.9C and 4.9D). The co-
culture system for culture of primary epithelial  cells called for further investigations on 
the possible role of 3T3 fibroblast to contribute to the SP cell populations. However sq-
PCR and ICC results suggest this is not the case as no gene (ABCG2 and ABCB1) or 
protein expression (ABCG2 ICC only) could be detected (Figure 4.9E and 4.9F). 
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Figure 4.9. Representative image of gene expression  of ABCG2 and ABCB1 and 
protein for ABCG2  in unsorted HTCEC and LEC (A) sq-PCR results for mRNA 
expression in HTCEC and (B) primary LEC, (N=3).  Note both expressed ABC G2 and 
ABCB1 (C) Results of immunocytochemical analysis showing representative images of 
ABCG2 expression in HTCEC (N=3), and (D) primary LEC (N=2).  (E) sq-PCR results 
for mRNA expression  showed  no expression of ABCG2  and ABCB1 in 3T3 murine 
fibroblast (feeder layer), (N=2)  (F) No ABCG2 expression could be detected in 3T3 
fibroblast using ICC  (N=2). [DAPI=blue, ABCG2  green. Part of this figure was 
previously published ]..  
 
Quantitative RT-PCR was performed using  primary LEC (N=5) to study the expression 
of ABCG2 and ABCB1.A differential expression of ABC transporter genes in the LEC 
samples  was observed (Figure 4.10). Results were normalised to GAPDH and HTCEC 
was used as a reference sample. Statistics for relative expression, standard error and P 
values for up- and down-regulated genes are presented in Table 4.3.  
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Figure 4.10. RT-QPCR showed variability in relative expression of ABCG2 and 
ABCB1 in 5 samples of LEC, data normalised to GAPDH, using HTCEC as reference 
(control).  
 
Table 4.3 Statistics for ABCG2 and ABCB1 expression in LEC by RT-PCR. 
Donor ID Genes Relative 
expression 
SE P value  Results 
 
B29804A 
 
ABCG2 
ABCB1 
 
3.268 
1.147 
 
3.0-3.6 
1.0-1.2 
 
*0.000 
0.186 
 
UP 
M17760A ABCG2 
ABCB1 
0.910 
0.181 
0.6-1.2 
0.1-0.2 
0.851 
0.104 
 
M17761A ABCG2 
ABCB1 
1.48 
0.27 
1.2-1.6 
0.1-0.2 
*0.032 
*0.000 
UP 
DOWN 
M17859B ABCG2 
ABCB1 
5.356 
0.733 
4.5-6.1 
0.6-0.7 
*0.032 
*0.000 
UP 
DOWN 
M17963A ABCG2 
ABCB1 
2.952 
0.785 
2.5-3.4 
07-0.8 
*0.022 
*0.031 
UP 
DOWN 
*Significant difference in relative gene expression compared to control. 
 
In four samples of LEC (B29804A, M17761A, M17859B and M17963A) significant 
upregulation of ABCG2 gene was demonstrated compared to control group. In three 
LEC samples (M17761A , M17859B and M17963A) there was significant 
downregulation of ABCB1 gene compared to control group.   
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4.4.4 Effects of cell confluence on SP yields 
Analysis of the impact of low  cell confluence on SP cell yields has been reported to 
increase SP yields in cancer  cell cultures (Tavaluc et al., 2007). We further investigated 
this in LSP. HTCEC were plated at different cell densities; 250,000, 500,000, and 
1,000,000 cells in T75cm
2
 flasks and incubated in 5% CO2, 37C.  
 
After four days, different cell confluence was observed using brightfield microscopy 
(Figure 4.11). The cells were then harvested and the SP assay performed. Cell density 
was counted as total cell count divided by 75cm
2
 tissue culture flask area to obtain the 
number of cells/cm
2
.  
 
 
 
Figure 4.11 SP and cell confluence. Representative photo micrographs of cultures at day 
4. Each figure represents different cell densities plating (A) 250,000 cells, (B) 500,000 
cells, (C) 1,000,000 and (D) 2,000,000 cells. 
 
 
Experiments were performed twice (Figures 4.12. and 4.13). Harvesting densities 
(number of cells/cm
2
) were calculated and plotted against SP yields. We found the cell 
populations with lower cell confluence gave higher SP percentages (Figure 4.14). 
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Figure 4.12. Representative FACS dot plots showing cell confluence and SP yield on 
day 4 of culture. SP gates are indicated with arrows. [A(i)] initial plating density of 
250,000 cells/cm2: note SP 0.5% was detected, [A(ii)] Cells from the same preparation 
lost the SP phenotype on addition of verapamil (B) Cultures with initial cell density of 
500,000 cells (C) 1,000, 000 cells/cm2 and (D) 2,000,000 cells; note no SP cells are 
detected in B, C and D.  
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Figure 4.13 Representative FACS dot plots showing cell confluence and SP yield on 
day 4 of culture. SP gates are indicated with arrows. (A) Initial plating density of 
250,000 cells/cm
2
 [B(i)] Cultures with initial cell density of 500,000 cells: note SP 0.9% 
was detected, [B(ii)] Cells from the same preparation lost the SP phenotype on addition 
of verapamil (C) Cultures with initial cell density of 1,000, 000 cells/cm2. Note no SP 
cells are detected in A and C.  
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Figure 4.14. Cell confluence and SP in HTCEC. SP percentage (Y axis) plotted against 
harvesting densities (X axis).  
 
4.4.5 Side population and hypoxia 
We prepared HTCEC from cultures growing under normal atmospheric oxygen level 
(20%), 5% oxygen and 1% oxygen for side population assays (N=2). There was no 
significant difference between SP in the two oxygen levels (Table 4.4). 
 
Table 4.4 SP yields in cultures grown at 5% and 1% oxygen levels. 
Oxygen (%) SP (%) Cell death (%) 
5 0.4 15.3 
0.3 6.3 
1 0.4 9.9 
0.4 10.8 
 
4.4.6    Characterisation of SP cells from HTCEC 
Using our optimised LSP protocol, we sorted SP and NSP cells of the HTCEC directly 
onto slides and stained them with antibodies to p63, Sox2, ABCG2 and ABCB5. Under 
20x magnifications, areas were arbitrarily divided into five fields for image 
quantification.  
 
Using Image J software, the fluorescence intensity for each marker in SP and NSP 
fractions were quantified, values were analysed using independent t-test for parametric 
data by IBM SPSS software.  
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For ABCG2, ABCB5 and Sox2, the expression of all three markers was significantly 
higher in the SP versus NSP cells, while NSP signal intensities for p63 were 
significantly higher than in SP fraction. Statistics for signal intensity (ICC) 
quantification for SP and NSP cells with limbal markers are tabulated in Table 4.5.  
Table 4.5 Statistics for fluorescence intensities (arbitrary units) for positively 
stained cells with LSC markers. 
 
Markers  N Means (±) SD P value* 
ABCG2 
-SP 
-NSP 
 
131 
131 
 
18.43 
16.33 
 
7.40 
5.91 
 
0.012 
 
Sox2 
-SP 
 
 
33 
 
 
29.17 
 
 
4.19 
 
 
0.000 
-NSP 34 18.36 7.16  
 
ABCB5 
-SP 
-NSP 
 
 
160 
160 
 
 
26.35 
24.17 
 
 
8.70 
8.07 
 
 
0.020 
 
p63 
-SP 
 
 
170 
 
 
40.17 
 
 
7.10 
 
 
0.000 
-NSP 165 44.25 7.31  
     
[Abbreviations: ABCG2= ATP-binding cassette sub-family G member 2, ABCB1= ATP-
binding cassette sub-family B member 1, ABCB5 = ATP-binding cassette sub-family B 
member 5, SP= side population, NSP= non side population].  
*Independent t-test. 
 
Representative ICC images for SP and NSP cells stained positive for limbal markers 
ABCG2, ABCB5, p63 and stem cell marker Sox2 are shown in Figure 4.15.  
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Figure 4.15. Representative images of ICC analysis of SP and NSP cells. Note 
Expression of ABCG2, ABCB5, p63 and Sox2 antibodies in both SP and NSP cel 
populations, N=3. [FITC-conjugated secondary anti-mouse antibody= green, 
Rhodamine-conjugated anti-rabbit secondary antibody = red. DAPI = blue. Part of this 
figure was previously published (Shaharuddin et al., 2013c)]. 
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FACS-sorted LSP cells were stained using ICC to examine the expression of ABC 
transporters ABCG2 and ABCB5 in HTCEC. In addition to ABCG2 expression, SP-
sorted HTCEC also expressed ABCB5 (Figure 4.16A). An overlay of these images 
showed a number of cells had dual expression of these transporters in the SP fraction 
(Figure 4.16B).  
 
 
Figure 4.16 Representative images of dual labelling ICC analysis for ABCB5 and 
ABCG2 expression in SP-sorted HTCEC, N=3. (A) Expression of ABCG2 and ABCB5 
in SP cells. Arrow heads indicate cells that express both. (B) Image overlay showing co-
expression by some cells in the SP fraction of both transporters. ([FITC-conjugated 
secondary anti-mouse antibody= green, Rhodamine-conjugated anti-rabbit secondary 
antibody = red, DAPI –nuclear, stain blue].  
 
 
4.4.7 Cell diameter and SP 
Analysis of ABCB2 stained HTCEC derived SP and NSP showed SP cells were smaller 
in size compared to the NSP cells (Figure 4.17)  Image J was the used to to measure 
diameter of stained cells in both population fractions and values were analysed using 
independent t-test for parametric data by IBM SPSS software. The cell diameter was 
significantly smaller for SP fraction 11.49 (±1.59) µm, than the NSP fraction 11.94 
(±1.91) µm, as presented in Table 4.6.  
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Figure 4.17 Representative   images of HTCEC stained with ABCG2 antibody 
demonstrating  SP cells to  have smaller cell diameter  compared to NSP cells., (N=3). 
[ABCG2 FITC = green, DAPI = blue (cell nuclei)]  
 
Table 4.6 Cell diameter from SP- and NSP-sorted cells. 
                   N Means (µm) (±) SD P value 
SP 179 11.49 1.59 0.019* 
NSP 163 11.94 1.91  
     
[Abbreviations: SP = side population, NSP = Non-side population.This table was 
previously published (Shaharuddin et al., 2013c)] 
*Independent t-test 
 
4.4.8 Colony formation of SP cells 
Next we examined the colony forming potential of SP and NSP cells of the HTCEC line 
in a plastic adherent mono layer culture conditions which demonstrated SP-sorted 
HTCEC formed colonies in tissue culture wells (Figure 4.18A). The NSP cells also had 
colony formation (Figure 4.18B) but the colonies were smaller and contained fewer 
cells/colony than the SP counterpart.  The difference in the cell number per colony 
between the SP and NSP cell fractions was calculated by using the cell counter in Image 
J and statistically analysed by IBM SPSS. There was a significantly higher number of 
cells/colony in SP than NSP, P=0.01 (Mann-Whitney) (Figure 4.18C).  
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Figure 4.18 Colony formation of SP and NSP-sorted cells on Day 5 of culture. (A) SP 
fraction (B) NSP fraction (C) Number of cells per colony plotted against cell count in 
SP and NSP cells in HTCEC.  
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4.5 Discussion 
One of the advantages of SP assay is the feasibility for further analysis on the viable 
cells such as in vitro and in vivo functional characterisation, some of the examples are 
molecular characterisation using stem cell markers (Pfister et al., 2010). After an initial 
wash out with PBS, the two cell fractions may further be characterised by PCR 
(Watanabe et al., 2004; Cintia S. de Paiva et al., 2005a), immunophenotyping by FACS 
(Pfister et al., 2010), propagated for proliferative studies such as colony forming 
efficiency (Cintia S. de Paiva et al., 2005a) or spheroid formation (Ostrowska et al., 
2011). 
 
Optimisation of the SP protocol 
There are critical parameters that can challenge the design of experiments and 
interpretation of the results which necessitates the process of optimising an SP protocol. 
When an established or stable cell line is used, factors that needed to be looked into are 
the cell density, nutrient used, serum or oxygen levels (Tavaluc et al., 2007), therefore it 
is advisable to keep to the same culture conditions. It is also important to maintain 
similar cell concentration/number of cells to gather the equilibration of the dye with the 
intracellular components.  
 
It is crucial to obtain a single cell suspension with limited cellular damage because the 
assay is based on active physiological process which depends on viability and protein 
integrity at the cellular membrane. This poses a challenge when processing tissues using 
enzymatic digestion which is potentially damaging to the cells.  
In a critical appraisal for SP methods, Golebiewska et al listed a number of  parameters 
that need to be optimised to ensure reproducibility and standardisation of SP data 
(Golebiewska et al., 2011). The optimisation included several steps such as appropriate 
dye concentration, stable incubation conditions such as incubation time, temperature, 
darkness and inhibition controls all essential to obtain a high resolution SP FACS plot 
and to allow for discrimination between the SP and NSP fraction.  
 
Cumulative data from previous SP protocols showed differences exist between various 
tissues of the same species, or the same tissues from different species. Furthermore, 
human tissue sourced SP cells often required different Hoechst concentration and 
contact times from those of their animal counterparts. For example, in  murine bone 
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marrow and skeletal muscle assay, 5 µg/ml Hoechst dye was  used, while in liver, 
spleen and kidney, 10 µg/ml of dye was used (Asakura and Rudnicki, 2002).  The SP 
assays for murine cardiac progenitor cells, has been reported to use between 1 – 5 µg/ml 
of Hoechst dye and a 90 minute incubation period (Pfister et al., 2010; Annette Meeson 
et al., 2013). However, a study in a human developing heart used 1.25 µg/ml of Hoechst 
dye and a 60 minutes incubation time (Alfakir et al., 2012).  
Although the cell count of 1.0 x 10
6
 cells/ ml is standard for SP cell analysis, it is 
particularly important especially when doing a profile on primary tissues/cultures to 
include only viable cells or nucleated cells. Therefore, adequate gating during analysis, 
paying attention to single, viable and nucleated cells is crucial when determining an SP 
phenotype. Hoechst dye stains all DNA regardless if cells are alive or dead, therefore 
dead cell discrimination is an important step in FACS analysis. Appropriate gating for 
cell debris and dead cells should be integrated during analysis.  
 
For a consistent temperature control, Hoechst incubation should be carried out under 
stable temperature control. We advise the use of a 37C incubator using a gentle shaker 
or rotator. It is also important to note that to maintain Hoechst  within cells after 
staining is complete, all activities post staining which include washing, centrifugation 
and data analysis should be  performed cold (4°C).    
 
LSP in LEC and HTCEC 
In the rat, SP cells have been shown to be present in both limbal and central cornea 
(Umemoto et al., 2005) suggesting species variations as this contradicts findings from 
rabbit and human LSP studies. A number of studies have demonstrated the presence of 
LSP cells in both animal and human limbus. They have provided evidence that these SP 
cells have some stem cell characteristics; however few have looked at optimisation of 
the SP assay.  
 
In the field of limbal corneal SP, a noticeable variation among species was also 
observed. As examples, in the pig – Hoechst concentration of 5 µg/ml for 90 minutes 
was used (Akinci et al., 2009) and rabbit –3 µg/ml for 90 minutes (Umemoto et al., 
2006).  Budak and colleagues (Budak et al., 2005) commented that optimisation of their 
protocol for LSP cells (rabbit and human) was initially done on rabbit cells and from the 
results of these they concluded what the optimal Hoechst dye concentration and 
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incubation time would be for the human cells. Whereas de Paiva and colleagues (Cintia 
S. de Paiva et al., 2005a) used both freshly isolated primary human cell cultures  as a 
source of LSP cells but did not optimise the SP cell assay, instead they based  their SP 
protocol on a method previously used to isolate SP cells from hematopoietic stem cells. 
Watanabe and colleagues (Watanabe et al., 2004) also reported on the identification of 
human LSP cells from human limbus but again did not report on optimisation of the SP 
assay used.  However they did use a Hoechst concentration of 3µg/ml and an incubation 
time of 90 minutes.   
 
In this study we optimised our SP protocol using HTCEC and achieved an optimal 
Hoechst concentration of 3µg/ml which gave a consistent and reproducible SP 
percentage of 0.2%. The optimal incubation time for Hoechst dye was 45 minutes, as 
more HTCEC death occurred at a longer incubation times (90 minutes) (data not 
shown). The shorter exposure of cultures to Hoechst dye was preferred to prevent 
cellular toxicity as Hoechst 33342 has proven to cause cytotoxicity by causing single 
and double strand breaks in DNA and markedly increase sensitivity of DNA and cells to 
ultra violet damage (R. F. Martin and Denison, 1992; Singh et al., 2004).  
 
A number of studies have determined that the ABC transporter ABCG2 is the main 
transporter responsible for conferring on SP cells their ability to efflux Hoechst 33342 
dye (Watanabe et al., 2004; Budak et al., 2005; Cintia S. de Paiva et al., 2005a; Ki-
Sook Park et al., 2006; Umemoto et al., 2006; Akinci et al., 2009). Confirmation that 
the cells identified are SP cells is important due to issues that can be caused by under or 
over saturation therefore the inhibitor and its concentration need to be validated. We 
opted for the use of verapamil, a calcium channel which blocks both ABCG2 and 
ABCB1 instead of FTC which is a specific inhibitor for ABCG2. 
 
In our laboratory, a median value of 0.2% of SP yield was obtained from 11 primary 
LEC samples (range: 0.1 – 0.8%), which is comparable to previous investigations on 
human LSP (summarised in Table 4.1). Data in previous literatures showed a broad 
range of SP yields in human LSP from 0.2% to 2.1%. Differential expression of 
ABCG2 and ABCB1 has also been demonstrated in the SP cells derived from fine 
needle aspiration biopsy of the breast (K. M. Britton et al., 2012).   
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We demonstrated here SP yields in HTCEC were consistent at the value of 0.2% for 
cells cultured under normal atmospheric oxygen levels. The use of established cell lines 
as sources of SP cells have been reported previously (Hirschmann-Jax et al., 2005; 
Yamazaki et al., 2008; Kelly M. Britton et al., 2011; Rizzo et al., 2011).  
 
While the percentage of SP cells is relatively small in the HTCEC, stem cells are in 
many systems rare cells, moreover it was also demonstrated that as few as 500 rabbit 
LSP cells were able to regenerate cornea like epithelium which was p63+ve in a 3-D 
culture system (Ki-Sook Park et al., 2006). The convenient use of an established cell 
line surpasses the difficulty in the isolation and identification of LSC from primary 
cultures and enables studies to be performed when valuable primary tissue is 
unavailable. 
 
ABC-transporters and inhibition of SP phenotype  
We observed that both LEC and HTCEC could be inhibited by verapamil and FTC, and 
that both the ABCG2 and ABCB1 transporters were expressed in primary LEC and 
HTCEC by ICC and PCR. Data on ABCG2 and ABCB1 expression in primary cultures 
of LEC showed co-expressions of both genes at variable levels of expressions. 
However, the ABCG2 gene was more upregulated and ABCB1 gene more down 
regulated in LEC compared to HTCEC. This explains the partial inhibition of SP profile 
by verapamil which blocks ABCB1 but partially blocks ABCG2 efflux activity. This 
effect was more evident in LEC compared to HTCEC line. Incomplete inhibition by 
verapamil is not exclusive to LSP cells, it has also been observed in the SP assays of 
murine skin and muscle (Montanaro et al., 2004).  
 
Cell confluence and hypoxia in SP 
We also show that cell confluence affects SP yields in our results, which is an important 
parameter when a cell line is being used in SP protocols. Lower cell confluence has 
shown a higher SP yields in colonic and breast cancer cell lines (Tavaluc et al., 2007). 
Cell confluence was demonstrated to be more important than the duration of cultures for 
cellular differentiation (Tavaluc et al., 2007).  Reduced cell density would be perceived 
as a stressor which stimulate proliferative and renewal capacity of stem cells which 
directly results in increased expression of ABC transporters and Hoechst dye efflux. In 
the current study we demonstrated harvesting densities between 4,000 to 6,000 
cells/cm
2 
gave increased SP percentages above that of higher densities.  
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Hypoxia was also a factor that gave an increased SP yield in malignant colonic and 
breast cancer stem cells (Tavaluc et al., 2007). Hypoxia is a significant factor towards 
stabilisation of the hypoxia inducible factors (HIF). HIF targets the ABC transporter 
genes, among others; which leads to more efflux of Hoechst dye and increased SP 
percentages. In a malignant condition, this confers the cancer SP cells to be more 
malignant. 
 
We studied HTCEC cultures incubated at O2 level of 1% and 5%, as this closely mimics 
the physiological relevant state of cells, as demonstrated by (Bath, 2013), in a series of 
oxygen levels from 2% to 20%, they found cultures grown at 2% oxygen had higher 
proliferative capacity, higher expression of ABCG2 and p63, higher colony formation 
potential  and lower number of cells in  the S/G2 cell cycle. 
 
In our project, at the two oxygen levels tested, we did not find any significant difference 
in SP percentage. However, there was an increased of SP to 0.4% compared to 0.2% at 
normal atmospheric oxygen of 21%, although this result was inconclusive due to limited 
number of biological repeats. Further investigations on different hypoxia levels i.e. 
0.2%, 0.5%, 1%, 2% and/or 5% needs to be conducted to see the true effects of hypoxia. 
Due to logistic and cost limitations, this has not been performed in the current study. 
 
LSP characterisation 
Studies of ABCG2 expression at mRNA and protein levels have provided convincing 
evidence  that ABCG2 is the main transporter implicated in determining the LSP 
phenotype (Zhuo Chen et al., 2004; Budak et al., 2005; Cintia S. de Paiva et al., 2005a; 
Umemoto et al., 2005). However, in previous studies of human LSP cells, while 
ABCG2 expression has been reported to be upregulated in SP cells versus NSP cells, 
this has been focused on gene expression (Watanabe et al., 2004; Cintia S. de Paiva et 
al., 2005a).  
 
Several studies have used immunohistochemical staining to examine tissue sections to 
show the location of ABCG2 expressing cells in the human eye and have reported that 
ABCG2 positive cells can be found in the limbal epithelial basal layer (Zhuo Chen et 
al., 2004; Watanabe et al., 2004; Cintia S. de Paiva et al., 2005a), however this does not 
prove that they are stem cells.  
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de Paiva and colleagues also selected out ABCG2-positive and ABCG2-negative cells 
using an anti-ABCG2 antibody combined with flow cytometry from their primary 
limbal cell cultures (Cintia S. de Paiva et al., 2005a). They showed that these cells 
expressed ABCG2 and ΔNp63 mRNA whereas the ABCG2-negative cells did not, 
moreover the positive expressing cells had a great colony forming efficiency than the 
negative cells, suggesting that within the ABCG2-positive population there were stem 
cells. Moreover they also selected SP and NSP cells from the primary human limbal cell 
cultures and showed that these SP cells showed upregulated expression of ABCG2 and 
ΔNp63 mRNA and that these SP cells had a greater colony forming efficiency than 
NSP; however they did not look at protein expression for either of these markers.  
 
In our study we not only looked at protein expression for ABCG2, ABCB5, ΔNp63 and 
Sox2 in SP cells and NSP cells from the HTCEC, we also quantitated the level of 
expression, this is important as NSP cells can also express some level of all these 
markers.   
 
We showed that SP cell fraction when stained with ABCG2 antibody also presented 
with significantly higher expression compared to NSP , supporting previous results by 
mRNA expression in both human and animals (Watanabe et al., 2004).  The functional 
role of ABCG2 as a putative marker for  limbal progenitor cells has been explored in a 
study of oxidative stress in ABCG2-knock out mice and immortalized corneal epithelial 
cells (Kubota et al., 2010). Although ABCG2-knock out mice had morphologically 
normal corneal epithelium, the cornea cells were susceptible to oxidative stress and 
prone to cellular damage induced by mitoxantrone in a dose and time dependent 
manner. Further, we also provide evidence of expression of mRNA for another ABC 
transporter ABCB5, in HTCEC which co-localised with ABCG2. The expression of 
ABCB5 in SP fraction was also significantly higher than in NSP. This is the first data 
which relates co-localisation of ABCG2 and ABCB5 in LSP phenotype, which supports 
further the evidence of LSP as an enrich population of LSC. 
 
However, LSP in the HTCEC line showed that the mean fluorescent intensity in the SP 
cell fraction was significantly lower than NSP for the transcription factor p63. p63 is a 
common molecular marker present at the nucleus of basal cells in stratified epithelial 
cells in the skin, oral mucosa, cervix, vaginal epithelium, urothelium, prostate and 
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others (Di Como et al., 2002). p63 marks for cellular proliferation and its expression is 
lost with reduced DNA-content (cell cycle arrest) and decreased cellular proliferation. It 
is also downregulated during terminal differentiation (Westfall et al., 2003).  A study in 
the rat LSP showed that the percentage of p63-+ve expression was low at the start of 
cultures in a day-to-day analysis of LSP cells (Epstein et al., 2005).  We conclude that 
LSP cells from HTCEC are more quiescent, slow cycling in nature and lack cellular 
proliferation, which are defining characteristics of stem cells. 
 
Cell diameter 
We observed the SP cell fraction of HTCEC contained cells with a smaller cell diameter 
compared to NSP cells. This supports previous finding in rabbit LSP which contained a 
high proportion of cells with a smaller  diameter then the NSP cells  (Umemoto et al., 
2006). The same findings were also observed in skeletal muscle SP, where the SP cells 
had a relative small diameter and a high nuclear to cytoplasmic ratio than NSP  (Annette 
P. Meeson et al., 2004). Cell size was a  parameter used to describe stem cell 
populations, including epidermal stem cells (Juxue Li et al., 2008) and epithelial stem 
cells (Tani et al., 2000).  
 
Colony formation 
LSP cells have also been shown to be enriched for stem cell activities such as increased 
colony-forming and high proliferative capacity (Budak et al., 2005; Cintia S. de Paiva et 
al., 2005a; Akinci et al., 2009) than NSP cells. Colony forming efficiency is considered 
a stem cell characteristic in other adult stem cells such as retinal stem cells (Tropepe et 
al., 2000), bone marrow stem cells (Friedenstein et al., 1987), and dental  pulp stem 
cells (Gronthos et al., 2000).  Our SP cells had a higher colony forming potential that 
the NSP cells. 
4.6 Conclusion 
The sensitivity of SP assay to different species and cell types makes standardisation of 
SP protocols mandatory to ensure reliability and reproducibility of SP data. This will 
ultimately result in better interpretation of SP results and enable more accurate 
comparison between data generated in multiple studies. In the past 17 years since 
Goodel, et al demonstrated SP in murine haematopoietic stem cells, accumulating 
evidence has shown this assay to be useful for functional characterization of putative 
stem cells and cancer stem cells, especially in the absence of specific molecular 
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markers. Characterisation of LSP using ABCG2, ABCB5, p63 and stem cell antigen 
Sox2 in HTCEC show that SP cells mark for LSC and HTCEC is a useful and robust 
model for LSC. An enrichment method by SP has a lot of potential for increasing the 
quality of LSC in a cellular-based therapy to treat LSCD or to be used in ocular surface 
regenerative surgery.   
136 
 
Chapter 5: Immunobiology of LEC 
Chapter 5 IMMUNOBIOLOGICAL CHARACTERISATION OF 
CORNEAL LIMBAL EPITHELIAL CELLS; IMPLICATIONS ON 
LIMBAL STEM CELL TRANSPLANTATION 
5.1 Introduction 
The cornea has a potentially proliferative and self-renewal capacity due to the presence 
of corneal stem cells which are believed to be located at the limbal region (reviews 
(Daniels et al., 2001; Limb and Daniels, 2008)). Replacement of donor cells by the 
host-derived cells is a feature of tissue transplantations, which takes place in the cornea 
1 – 2 years after surgery (Wollensak and Green, 1999). In most cases, all types of donor 
cells; epithelial, stromal keratocytes and endothelial layers, were observed to be taken 
over by the host cells (Hatanaka et al., 2013) .  
 
However, corneal transplantation is contraindicated in the treatment of LSCD an 
important cause of corneal blindness. Failure of grafts in this condition is due to loss of 
host stem cells and inadequate self renewing cells to replenish the surface of the graft 
from the donor. In the case of LSCD, cellular therapy such as ex vivo limbal epithelial  
transplantation has shown impressive advances as a treatment in the past decade or so 
(Graziella Pellegrini et al., 1997; S. C. G. Tseng, 2001; Shortt et al., 2007b; Shortt et 
al., 2008; Rama et al., 2010). In addition, endothelial cell transplantations have also 
shown promising results in animal studies (Okumura et al., 2009; Okumura et al., 2011; 
Koizumi et al., 2012; Okumura et al., 2012). 
 
Tolerance towards allogeneic organ grafts represents one of the major aims of 
transplantation medicine. Stem cells are promising candidates for promoting donor-
specific tolerance  (Imberti et al., 2011). Adult stem cells have immune-suppressive 
mechanisms to protect them from immunological reactions and apoptosis which are 
damaging to the survival of the transplanted tissues (review (Baraniak and McDevitt, 
2009). 
 
5.1.1 MHC Gene Complex 
The human MHC is located on chromosome 6. MHC genes control several antigens 
most of which influence allograft rejection. These genes or antigens are divided into 
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three classes; Class I, II and III. Class I and II are expressed on cells and tissues while 
Class III are associated with serum proteins and body fluids.  
 
The Class I gene complex has three significant major loci antigens; A, B and C, and 
some other less significant undefined loci. Each loci codes for antigenic polypeptide α 
chains which have many alleles (polymorphic) and each are associated with β chains e.g 
β-2-microglobulins. A non-functional α-β-chain causes non-expression of Class I 
antigens on the cell surface and deficiency in cytotoxic CD8 T cells.  
 
The MHC Class II gene complex also contains three major loci; DR, DP and DQ. Each 
of these loci is associated with one α and variable β polypeptide chains, making up the 
Class II antigens. MHC Class II genes feature polymorphism. HLADRB has more than 
700 alleles at population level, HLADRA has three variants. Both chains of HLADP 
and HLADQ are also polymorphic. For HLADP, a few alleles are present in the 
heterodimer DPA1/DPB1.  
 
MHC Class II molecules play an important role in the immune system. They are 
essential in the immune system for defence against infection and are the main player in 
transplantation immunology. MHC Class II present antigens from extracellular sources 
to CD4+ T cells and also mediate thymic selection of helper T cells.  
 
The Human Leucocyte Antigen system (HLA) represents MHC which encodes for 
genes related to immune system and cell surface antigen presenting proteins. MHC class 
II antigen presentation pathways are expressed by professional antigen presenting cells 
(APC) e.g. dendritic cells, macrophages, B-cells, or epithelial LC.  
 
5.1.2  Stem cells as a potential therapeutic strategy to overcome rejection 
Evidence for immunological privilege of corneal stromal stem cells was supported by 
the absence of T cell mediated immune rejection, when  these stem cells were injected 
in mouse corneal stroma (Du et al., 2009). Proliferative capacity of corneal stroma stem 
cells and its immune privilege clearly play an important role in corneal stromal tissue 
engineering (Alaminos et al., 2006; Jian Wu et al., 2012)
,
 (Zajicova et al., 2010).  
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In a study conducted in adult mice, a small population of LSC effectively inhibited 
lymphocyte proliferation and modulated cytokine production.  LSC were also noted to 
display an enhanced expression of genes for the anti-apoptotic proteins like induced 
myeloid leukaemia cell differentiation protein (Mcl-1), B cell lymphoma-2 (Bcl-2), X-
linked inhibitor of apoptosis protein (XIAP), and survivin. The LSC were  more 
resistant to CTL-mediated or apoptotic cell death compared to other limbal cells which 
are necessary for tissue survival (Holan et al., 2010). These regulatory properties are 
important to safeguard LSC from the damaging effects of inflammatory processes and 
cell toxicity in the anterior chamber of the eye. 
5.1.3  Pro-inflammatory cytokines 
Interferon-gamma (IFN-γ) 
IFN-γ is a Type II interferon secreted by thymus-derived T cells. It is secreted under 
certain activated conditions, by CD4+ T helper cells (Th1 lymphocytes), CD8+ 
cytotoxic lymphocytes, natural killer (NK) cells, B cells, NKT cells and professional 
APCs.  
 
IFN-γ potentially upregulates antigen presentation through Class I and II MHC 
pathways. IFN-γ may induce the pro-apoptotic effect of TNF-α by increasing surface 
expression of TNF-α receptors in human endometrial stromal cells (Fluhr et al., 2007) 
and human foetal astrocytes (Wosik et al., 2001). 
 
Tumour necrosis factor-alpha (TNF-α) 
TNF-α is a cytokine involved in general inflammation and induces acute phase 
reactions. It is chiefly produced by activated macrophages, although other cells like 
CD4+ lymphocytes, endothelial cells, mast cells, fibroblast and NK cells also produce 
it. The main function of TNF-α is to regulate the immune response. It also produces a 
synergistic anti-proliferative effect when combined with IFN-γ on the growth of human 
salivary gland (HSG) cell line (AJ Wu et al., 1994) due to  apoptotic cell death 
(Kamachi et al., 2002) .  This synergistic effect was also observed in the IFN-γ 
mediated epithelial dysfunction in the intestinal epithelial mucosa of patients with 
inflammatory bowel disease (Fish et al., 1999). 
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5.1.4 Chemotaxis  
Chemokines are important molecules for leukocyte migration and immune cell 
trafficking in pathological and physiological conditions. Chemokines mediate their 
effect through G-protein coupled 7-transmembrane chemokine receptors (Trosko et al., 
2000) on the cell surface of specific and well-defined leucocyte subsets (Groves and 
Jiang, 1995).  However, some chemokine receptors are found on non-haematopietic 
cells, including neuron and microglia (Cheung et al., 2011), epithelial (Lin et al., 2013) 
and endothelial cells (Linley et al., 2012).   
 
Chemokines are especially important in endothelial cell functions for proliferation, 
migration and differentiation and wound healing process, whereby CXCR4 has been 
shown to play an important role in vascularisation during angiogenesis (Linley et al., 
2012), migration of neural crest cells to the dorsal root ganglia (A. Pajoohesh-Ganji et 
al., 2005), homing mechanism of renal transplanted cells  (C. S. de Paiva et al., 2005b) 
and adhesion of MSC to target sites (Budak et al., 2005). CXCR4 signalling was also an 
important indication of growth and metastases of germ cell tumours (Gilbert 2009). In 
the cornea, CXCR4 proved to be important in maintaining the physical contact between 
corneal stem cells with the subjacent stromal mesenchymal cells or the “niche cells” for 
the maintenance of LSC (Hua-Tao Xie et al., 2011). 
 
5.2 Specific Aims 
 
The aims in this chapter are: 
1. To present data on HLA typing in HTCEC. 
2. To optimize HLA antibodies concentration by flow cytometry. 
3. To optimize concentration and duration of pro-inflammatory cytokines 
treatment in HTCEC for HLA expression. 
4.  To study HLA expression in unstimulated and stimulated HTCEC with pro-
inflammatory cytokines. 
5. To examine CXCR4 expression in HTCEC and LMSC 
6. To examine cellular migration in HTCEC and LMSC in CXCL12-mediated 
migration. 
 
140 
 
Chapter 5: Immunobiology of LEC 
5.3 Materials and methods 
5.3.1 Human Leucocyte Antigen (HLA) typing for HTCEC  
The HTCEC line was HLA typed, the procedure was outsourced to NHS Blood and 
Tissue Bank (Newcastle), courtesy of Dr Vaughan Carter.  
 
5.3.2 Optimisation of HLA antibodies and treatment with pro-inflammatory 
cytokines  
Anti-human HLA antibodies to Class I (A,B,C) and Class II HLA-DR were optimized 
for concentrations using HTCEC stimulated with IFN-γ. Anti-human HLA-DP and 
HLA-DQ antibodies were optimized using peripheral blood leukocytes (PBL) because 
of very low expression of these antibodies in HTCEC at initial optimisation methods. 
The concentrations used for the antibodies were 0.05, 0.25, 0.5 and 1.0μg/ml.    
 
Briefly, 100,000 HTCEC were plated in T25 cm
2 
tissue culture flasks and incubated in 
5% CO2. On day 2 of culture, at approximately 20-30% confluence, the cells were 
treated with either interferon-γ (IFN-γ) or tumour necrosis factor-α (TNF-α) or with a 
combination of both. For optimization of dose and time of stimulation with the 
cytokines, each treatment lasted for 1 day, 3 days or 5 days. The concentrations used 
were 0.25ng/ml, 0.5ng/ml and 10ng/ml for IFN-γ, and 5ng/ml, 10ng/ml and 20ng/ml for 
TNF-α. At cut-off points, cells were detached from tissue culture flasks and 
resuspended in flow cytometry buffer solution (0.1% (w/v)/FBS/PBS, ready to run 
through flow cytometry (Figure 5.1).  
 
141 
 
Chapter 5: Immunobiology of LEC 
 
Figure 5.1 Results of HLA antibody titrations. (A) Percentage of stained positive-cells 
for Class I (HLA-A,B,C) and Class II HLA-DR antibodies using IFN-γ stimulated 
HTCEC cells. (B) Anti-HLA-DQ and (C) HLA-DQ antibody titration using 
unstimulated peripheral blood leucocytes.  
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In the case of peripheral blood leukocytes, titrations for anti- HLA-DQ antibodies were 
performed at 0.05, 0.25, 0.5 and 1.0μg/ml and for HLA-DP, the concentrations used 
were 0.25 and 0.5μg/ml. CD45+ve and secondary IgG only populations were used as 
negative controls to isolate only the signals from HLA-DP antibody (Figure 5.2).  
 
Figure 5.2 Histograms showing detection of anti human HLA-DP antibody in 
(unstimulated) peripheral blood leucocytes. (A) CD45+ve antibody expression (red) is 
distinguished from  unstained (control) population (green) (B) Anti-HLA-DP antibody 
expression (red) as a distinct population from CD45+ve cells (green) (C) CD-45+ve 
population only.  
 
Finally, the individual concentration of IFN-γ and TNF-α which gave the highest 
expression of HLA antibodies, was used in the combined stimulation experiment and 
subsequent repeats. This concentration was 10ng/ml, for the duration of 3 days. Direct 
and indirect immunofluorescence was performed using FACS Canto [BD Sciences] and 
analysed with FACS Diva software [BD Sciences] to obtain median fluorescence index 
(MFI). Experiments were performed using two biological replicates to get average MFI 
values. 
 
5.3.3 Flow cytometry  
For screening of purified antibody on HTCEC, cells were detached using cell 
dissociation buffer and trypsin/EDTA, centrifuged and resuspended in 100µl 
2%FBS/PBS. 200,000 cells were added into each tube and stained with primary 
monoclonal antibody conjugated to Allophycocyanin [R&D system] at 10µl, 20µl and 
30µl for antibody optimisation.  
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For HLA expression, HTCEC were incubated with anti-HLA Class I-A,B,C 
[BioLegend], HLADR [BioLegend] or HLADQ [Biolegend] monoclonal antibodies in 
100 µl 2%FBS/PBS. After 1 hour incubation at 4ºC, cells were washed twice with 2% 
FBS/PBS and resuspended into 200µl of FBS/PBS before running through FACS Canto 
II [BD Biosciences] and analysed using a FACS Diva software [BD Biosciences]. 
 
For indirect immunofluorescence, cells were stained with primary antibody and 
incubated for 30 minutes at 4C. After incubation, cells were washed twice with 2% 
FBS/PBS and stained with secondary antibody for 20 minutes at 4
0
C. After incubation, 
cells were washed twice with 2% FBS/PBS and resuspended into 200µl of FBS/PBS 
before run through FACS Canto II [BD Biosciences] and analysed using FACS Diva 
software [BD Biosciences]. A list of antibodies used in flow cytometry is listed in Table 
5.1. 
Table 5.1 HLA antibodies used in flow cytometry. 
Antibodies 
 
Optimum dilution Manufacturer 
PRIMARY  
Mouse monoclonal FITC anti-
human HLA-DR (Clone L243) 
 
1:20 Biolegend 
Mouse monoclonal FITC anti-
human HLA-A,B,C (Clone W 6/32) 
1:20 
Biolegend 
Mouse FITC anti-human HLA-DQ 
(Clone HLADQ1) 
1:20 
Biolegend 
Mouse monoclonal Anti-human 
HLA-DP (Clone HI43) 
1:20 
Abd Serotec 
Mouse monoclonal 
Allophycocyanin anti-Human 
CXCR4- (Clone 12G5) 
 
1:20 R & D Systems 
 
SECONDARY 
Goat anti-mouse FITC-conjugated 
IgG 
 
 
1:25 
 
 
Jackson Immuno 
Research Lab 
144 
 
Chapter 5: Immunobiology of LEC 
 
5.3.4 Chemotaxis assay: Transwell Migration Analysis 
For the purpose of optimization for CXCL12 concentration and duration of treatment, 
100,000 cells were suspended in 300µl of media and added to the upper chamber of a 5 
um pore diameter 24-well plate transwell filter. The lower chamber was filled with 200 
µl media without cells but supplemented with CXCL12 at 0ng/ml (internal control), 
200ng/ml and 300ng/ml. Treatment was repeated for 3, 5 and 7 hours in 5% CO2 at 
37C (Figure 5.3).  
 
At the end of incubation, the lower chamber was removed. The inner part of the insert 
was swabbed with a cotton bud to remove non-migrant cells. Following that, the filters 
were washed in tap water and stained in haematoxylin for 1 minute, then washed by 
submerging in Scott’s water to help develop the colour. The migrant cells were captured 
in 5 randomly selected fields under 20X magnification and cells were counted using a 
light microscope [Nikon Digital Sight–DSFi1]. The optimum concentration of CXCL12 
used was 300ng/ ml for 5 hours incubation.  
 
5.3.5 Side Population assay 
Following our optimised side population protocol, cells were counted manually using an 
improved Neubauer haemocytometer [Reichert], 1.0 x 10
6
 cells/ ml were resuspended in 
Hank’s media and placed into micro centrifuge tubes [Fisher] to be stained with either 
Hoechst 33342 dye alone or with Hoechst dye in the presence of ABC-transporter 
inhibitors. Prior to addition of Hoechst the cells were incubated in the presence of 
inhibitor for 30 minutes in a 5% CO2 incubator at 37°C in a MACs Mix rotator 
[Miltenyi Biotec]. After this, Hoechst dye was then added to both tubes. All reactions 
were terminated by placing the contents of the tubes in a 15 ml centrifuge tube [Fisher] 
containing 10 ml ice cold Hank’s medium/2% FBS. The centrifuge tubes were then 
centrifuged at 2,500 rpm for 5 minutes and the cells resuspended with 500µl Hank’s 
medium and passed through a 70µm pore size cell strainer [BD Falcon] and stored on 
ice prior to FACS analysis. 
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Figure 5.3 Representative images of transwell migration test for chemotaxis assay. Cells 
were treated with 200 and 300ng/ml for 3, 5 and 7 hours or in DKSFM as negative 
control (0ng/ml CXCL12). Migrant cells (arrows) were examined under at least 5 high 
power fields, photographed and analysed.  
 
5.3.6 ICC of LSP and NSP cells 
Post sorting, 100 HTCEC from each SP and NSP fractions were directly concentrated 
onto glass slides. Slides were fixed with cold methanol [BDH Laboratory Supplies] by 
incubation at -20°C for 20 minutes and then washed with PBS. Cells were 
permeabilised in 0.3% (v/v) Triton X-100 [Fisher Scientific] in PBS for 10 minutes and 
then washed again with PBS. Non-specific binding sites were blocked with 5% normal 
goat serum in PBS for 30 minutes in a humid chamber in the dark. Cells were then 
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incubated with primary goat anti-mouse monoclonal antibody to ABCB5 (1:100 
dilution) [Abcam], CXCR4 (1:100 dilution) [R&D Systems], p63 (1:50 dilution) [Santa 
Cruz biotechnology] and goat anti-rabbit polyclonal antibodies to ABCG2 (1:100 
dilution) [Novus Biologicals] in 0.05% FBS/PBS overnight at 4°C. Cells were then 
washed 3x5 minutes PBS and incubated with appropriate secondary antibody, either 
goat anti-mouse antibodies conjugated with FITC or anti-rabbit secondary antibodies 
conjugated to rhodamine [Jackson Immunology Research Laboratory] at a dilution of  
1:25 for 30 minutes in a humid chamber in the dark, then washed with PBS three times, 
5 minutes and mounted in vectashield anti-fading media containing  DAPI [Vector 
Laboratories], cover slipped and examined using an Axioplan F microscope [Carl 
Zeiss]. Negative controls were cells incubated without addition of primary antibody, but 
with secondary antibody only. Antibodies used in ICC are listed in Table 5.2. 
Table 5.2 List of antibodies used in immunocytochemistry. 
Antibody 
Cellular localisation 
of antigen 
 
Dilution Manufacturer 
PRIMARY 
  
 
Mouse monoclonal anti-human ABCB5 
(clone 5H3C6) 
 
 
Transmembrane 
 
1:100 Abcam 
Mouse monoclonal anti-human CXCR4 
(clone 44716.111) 
 
Cell surface  
 
1:100 R & D Systems 
SECONDARY 
  
 
FITC-conjugated secondary goat 
anti-mouse immunoglobulins 
 
 
Intracellular 
 
 
1:25 
 
Jackson 
Immunology 
Research 
Laboratories 
 
 
5.3.7 Imaging methods and quantification software 
For the purpose of examining cells in cultures, plates, and flasks, Axiovert 200M 
[Zeiss] microscope which allows the performance of transmitted light bright field, phase 
contrast and epi-fluorescence technique were utilised. Images were then processed using 
the AxioVision40 version 4.8.2.0 software [Zeiss]. Nikon Digital Sight–DSFi1 camera 
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and Nikon NIS-Elements D software [Nikon Metrology] for bright field and phase 
contrast were also used. Fluorescence microscopy was undertaken using Axiovert 200M 
[Zeiss] for cells in wells and by Axioplan F [Zeiss] for immunocytological slides. 
 
5.3.8 Image quantification 
All images were taken using a Nikon Digital Sight–DSFi1 camera and processed with 
Nikon NIS-Elements D software [Nikon Metrology U.K. Ltd., Derby, UK]. Images 
were assembled using Adobe Photoshop® CS3 [Adobe Systems. Cell count or cell 
signal intensities were performed using Image J [Image J version 1.44].   
 
5.3.9 Statistical Analysis 
IBM SPSS statistics processor (Version 19) was used for descriptive and statistical 
analysis. A normal distribution assumes a “bell-shaped” symmetrical data. Quantitative 
data which were normally distributed were analysed using parametric statistical tests 
and the equivalent non-parametric tests were used for data which were skewed or 
outside the normality curve. For 2 groups of independent data, independent t-test or 
Mann-Whitney U test was used to compare the means between the groups. Results with 
p values of less than 5% (P < 0.05) were considered statistically significant.  Data 
requiring comparison between more than two groups were analysed by one way 
ANOVA. 
 
5.4 Results 
5.4.1 Human Leucocyte Antigen (HLA)-typing and HLA expression in HTCEC  
HLA-typing for HTCEC demonstrated expression of both Class I-A,B,C and Class II 
(HLA-DR and HLA-DQ) antigens:   
MHC Class I: A*02, A*26, B*38, B*56, BC*01, C*12.  
MHC Class II: DR B1*01, DR B1*13, DQ B1*05, DQ B*06  
 
We further examined HLA expressions in HTCEC when stimulated with IFN-γ and 
TNF-α using flow cytometry. HTCEC expressed HLA Class I and II and are 
upregulated, especially in response to IFN-γ stimulation. We examined HTCEC for 
HLA expression in unstimulated  and stimulated by interferon (IFN)-γ, tumour necrosis 
factor (TNF)-α and combination of both at 10 ng/ml for 3 days (pre-optimised).  
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In unstimulated condition, there was constitutive expression of HLA Class I-A,B,C but 
very low/no expression of Class II antigens compared to unstained (control) population, 
N=3 (Figure 5.4). Statistics for Median Fluorescence Index (MFI) for expression of 
HLA in unstimulated HTCEC is presented in Table 5.3.  
 
Figure  5.4 FACS analysis of HLA expression in HTCEC of unstimulated cell 
populations (A) Histograms showing unstained population (control) and cell 
populations stained with HLA Class I-A,B,C and Class II antibodies. (B) Median 
Fluorescence Index of HLA expression for control and stained populations without 
cytokines stimulation (N=3). Mean MFI for Class I was significantly different to control 
but not for other Class II molecules (One-way ANOVA- Fisher’s LSD test).  
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Table 5.3 Statistics for HLA expressions in unstimulated HTCEC. 
 N Mean MFI SD *P value 
Control 3 890.67 211.86  
Class I-A,B,C 3 2171.33 938.68 0.003 
HLA-DR 3 1039.0 57.19 0.668 
HLA-DP 3 1164.67 238.70 0.433 
HLA-DQ 3 997.33 145.55 0.758 
IgG 3 922.0 138.17 0.928 
*One way ANOVA (Fisher’s Least Significant Difference test) 
HLA expression in HTCEC after cytokine stimulation is presented in Figure 5.5 and 
Figure 5.6. After stimulation with IFN-γ 10 ng/ml for 3 days, HTCEC expressed high 
levels of Class I and Class II antibodies compared to unstimulated control samples. The 
highest expression was observed for HLA-Class I and HLA-DR, followed by lower 
expression of HLA-DP and very low expression of HLA-DQ. MFI values were 34,560 
(Class I-A,B,C), 162,000 (HLA-DR), 46,187 (HLA-DP), 17,250 (HLA-DQ) and 1,135 
(Ig G – internal control).  
 
The treatment with TNF-α at the same concentration and duration showed low 
expressions for all HLA antibodies, except for a slight rise in Class I expression 
compared to control, followed by HLA-DR. MFI values were 5,906 (Class I-A,B,C), 
1,129 (HLA-DR), 1,292 (HLA-DP), 1,217 (HLA-DQ) and 1,175 (Ig G). When treated 
with combination of IFN-γ  and TNF-α at the same concentration and duration, HLA 
expression for all antibodies were higher than that observed when treated with TNF-α 
alone, especially in HLA-DR (MFI 9,329) although this did not surpass the levels 
observed in INF-γ treatment (Figure 5.5).  MFI values for HLA Class I (1,450), HLA-
DR (9,329), HLA-DP (3,464), HLA-DQ (3,043) and IgG (1,378).  
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Figure 5.5 Representative FACS histograms out of 3 replicates showing HLA 
expression of Class I and Class II antigens in HTCEC under stimulation of Interferon-γ, 
tumour necrosis-α and combined stimulation of both. Cells were stained with FITC-
conjugated Class I, HLA-DR, HLA-DQ antibodies and HLA-DP. Negative control for 
HLA-DP was secondary IgG only [Light grey – unstimulated cells, red – stimulated 
cells, yellow – IgG only stimulated cells].  
 
 
Figure 5.6 Median Fluorescence Index of HLA Class I-A,B,C and Class II expression in 
HTCEC for control (unstimulated) and stimulated populations in response to cytokines 
treatment at 10ng/ml for 3 days (N=3). Treatment by (A) Interferon-γ alone (B) Tumour 
necrosis-α alone (C) Combined treatment. Results are from two biological replicates.  
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5.4.2   Expression of CXCR4 in HTCEC and LMSC 
CXCR4 expression in HTCEC and LMSC using ICC were examined. HTCEC and 
LMSC expressed anti human CXCR-4 antibody which was localised at the cell surface 
(Figure 5.7). Bone-marrow derived-MSC and breast cancer cell line MDA-MB-231 
were used as positive controls.  Staining with secondary IgG only was used as negative 
control and did not show any staining.  
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Figure 5.7 Results of immunocytochemical analysis for expression of CXCR4 in 
unsorted HTCEC and LMSC. Bone marrow-MSC and MDAMB 231 were used as 
positive control, N=3. Note presence of cells expressing CXCR4 (arrows) in panel A, 
negative control (secondary IgG) on panel B. IgG-only negative control shows no 
staining (DAPI=blue, CXCR4 FITC-conjugated anti-mouse secondary antibody= 
green).  
 
 
153 
 
Chapter 5: Immunobiology of LEC 
Flow cytometry to look for CXCR4 expression in HTCEC and LMSC using unstained 
cells as negative controls were performed. FACS histogram showed right shift from the 
unstained (control) population (Figure 5.8).  Median fluorescence index (MFI) which is 
the median or the mid-point of the generalised population of events; for anti-human 
CXCR4 antibody titration in HTCEC was also performed for objective quantification 
and showed increased MFI from 258 (no antibody) to 651, for three CXCR4 antibody 
concentrations used for HTCEC staining LMSC gave higher expression with MFI 
values increased from 600 (no antibody) to 1652 (Figure 5.9).   
 
 
Figure 5.8 FACS histograms for anti-human CXCR4 antibody expression at  10, 20 and 
30μl of antibody in  unsorted HTCEC and LMSC. [Light grey -unstained cells (negative 
control), dark grey – stained cells].  
 
 
Figure 5.9 Median fluorescence index for expression of anti-hCXCR4 at three antibody 
concentrations in HTCEC and LMSC.  
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5.4.3   mRNA expression of CXCL12 in HTCEC and LEC 
Real time quantitative PCR was performed to examine CXCL12 expression in HTCEC 
and LEC. Breast cancer cell lines MDAMB-231 and MCF-7 were used as positive 
controls. Delta CT values were calculated normalised to GAPDH. Delta Delta CT 
values were calculated using MCF-7 as a calibrator (reference) sample (Table 5.4).  
 
Table 5.4 mRNA expression of CXCL12 in HTCEC and LEC 
 Mean Δ CT Δ CT SE ΔΔ CT Fold change 
HTCEC Undetermined Undetermined   
LEC 16.5 0.27 11.9 0.00026 
MDAMB-231 18.7 0.11 14.1 0.000056 
MCF-7 4.6 0.07   
 
mRNA expression of CXCL12 was not detected in the triplicate samples of HTCEC. A 
low level of CXCL12 RNA expression was detected in LEC and MDAMB-231 
compared to MCF-7.   
 
5.4.4 Chemotaxis in HTCEC and LMSC  
In order to examine CXCL12-mediated cellular migration in HTCEC and LMSC, 
chemotaxis experiments were performed. As a control (background migration) the 
equivalent number of cells as used for the experimental samples but without addition of 
CXCL12 in the media was used. There was a minimal/negligible number of migrant 
cells in the control samples. Following stimulation with 300ng/ml CXCL12 for 5 hours 
(pre-optimised), HTCEC and LMSC were found to be migratory in response to 
CXCL12 (Figure 5.10).  
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Figure 5.10 Transwell chemotaxis assay. Brightfield images showing cells incubated for 
5 hours with 0 ng/ml (negative control or background migration) and presence of 
migrant cells in transwells with 300 ng/ml CXCL12, 5 hours stimulation in LMSC, 
HTCEC and  breast cancer cell line MDA-MB-231, N=3.  
 
The difference in the means of migrant cells/high power fields in comparison to 
background migration (negative control) were statistically significant for HTCEC 
(P=0.009), LMSC (P=0.01) and MDAMB231 (P=0.01) (Figure 5.11).    
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Figure 5.11 Mean number of migrant cells/high power fields from three biological 
replicates for CXCL12-mediated migration of LMSC, HTCEC and MDAMB231 in 
comparison to background migration (control). Treatment with CXCL12 ligand was at 
300ng/ml for 5 hours. [* Difference in mean values between control and CXCL12 
treated groups (Mann Whitney test)]  
 
 
5.4.5 Expression of CXCR4 in SP-sorted HTCEC  
To examine the expression of CXCR4 in SP and NSP, HTCEC was sorted into SP and 
NSP fractions and stained with anti- human CXCR4 antibody (Figure 5.12).  
 
 
 
Figure 5.12 Results for CXCR4 expression (arrow heads) in SP cells and  NSP of 
HTCEC [DAPI=blue, CXCR4 FITC-= green].  
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Following that, fluorescence signal intensities (arbitrary units) were measured in both 
populations using Image J software. There was a statistically significant difference in 
means for fluorescence signal intensity in SP= 18.0, NSP=9.0, P=0.001 (Table 5.5).   
 
Table 5.5 Statistics for CXCR4 expression in SP and NSP-sorted cells 
Group N Mean 
Std. 
Deviation P values 
SP 46 18.1650 7.21965 0.001* 
NSP 39 8.9036 3.48029  
*Independent t-test 
 
 
 
5.5 Discussion 
Firstly, HLA typing of HTCEC was performed to study the potential of HTCEC line for 
LSC transplantation and to investigate further the immunological response in HTCEC. 
As detailed in the Results section, this cell line expressed HLA class I – A,B,C and 
HLA Class II molecules –DR and DQ. HLA-DP was not expressed in this cell line.  
 
HLA Class I-A,B,C could be detected in the unstimulated HTCEC population, however, 
Class II antigens HLA-DR, HLA-DP and HLA-DQ expression was low/minimal 
compared to control. This finding was similar to previous reports describing Class I 
expression in unstimulated human corneal epithelial cultures where only Class I 
antigens were detected (Whitsett and Stulting, 1984; el-Asrar et al., 1989; Iwata et al., 
1994).   
 
HLA Class II expression in HTCEC was inducible using pro-inflammatory cytokines 
stimulation in a dose and time-dependent manner. Interferon (IFN)-γ in particular, 
upregulated HLA Class I-A,B,C and Class II-HLA-DR, HLA-DP and HLA-DQ 
expression with the highest expression being HLA-DR and HLA-Class I, followed by 
HLA-DP and a lesser expression of HLA-DQ.  
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In human cornea, HLA Class I antigens were readily detected in the epithelium and 
keratocytes but not HLA Class II antigens.  On the other hand, HLA-DR antigen has 
been detected in dendritic cells at the limbus (Whitsett and Stulting, 1984). Induction of 
HLA-DR expression by IFN-γ stimulation in human corneal epithelial and endothelial 
cultures has been demonstrated previously (el-Asrar et al., 1989) (Iwata et al., 
1992)
,
(Iwata et al., 1994). Induction of HLA-DR antigen expression by IFN-γ 
stimulation is not exclusive to the cornea and has been observed in other unstimulated 
cell populations such as thyroid epithelium and melanoma cells (Tsujisaki et al., 1987; 
Yang et al., 1999; Fernández et al., 2008; Yu et al., 2013), liver cells, endothelial cells 
and human fibroblasts (Maurer et al., 1987; Espana et al., 2004; Harkin et al., 2004a). 
 
Importantly, IFN-γ also induced HLA-DP antibody expression in this HLA-DP- 
negative cell line. There is limited literature on induction of HLA-DP in non-marrow 
derived cells or HLA-DP-negative population. However, experimental induction of 
Class II antigens by IFN-γ stimulation in human endothelial cells and dermal fibroblasts 
showed  comparable expression of HLA-DR in all endothelial cells and dermal 
fibroblasts followed by a smaller increase in HLA-DP and a negligible level of HLA-
DQ expression (Maurer et al., 1987; Espana et al., 2004).  In contrast, our study showed 
HTCEC expressed HLA-DQ after IFN-γ stimulation.  
 
When both IFN-γ and TNF-α were combined, expression of all HLA were very much 
lower than of IFN-γ alone. The inhibitory effect on IFN-γ induced uregulation of HLA-
DR expression has been demonstrated in cultured human gingival fibroblasts (Keiso 
Takahashi et al., 1994). Here the investigators had proposed the endogenous secretion 
of prostaglandin E2 to have immunosuppressive effect on HLA-DR expression. 
Alternatively, the suppressive effect when both cytokines were combined  together has 
previously been attributed to the pro-apoptotic effect of TNF-α  through the Fas 
signalling pathway in human endometrial stromal cells (Fluhr et al., 2007), human 
salivary gland cell line (AJ Wu et al., 1994) and human foetal astrocytes (Wosik et al., 
2001).  
 
Our results show that HTCEC closely mimics the immunogenicity of human corneal 
epithelium as demonstrated by Iwata et al, 1992 where HLA Class II (-DR and –DP) 
expression was inducible by IFN-γ treatment, and a very low but concomitant HLA-DQ 
expression was related to cellular differentiation. HLA-DP antigen is not naturally 
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occurring in this cell line but was shown to be inducible under IFN-γ stimulation. IFN-γ 
stimulated HTCEC expressed HLA-DP and HLA-DQ in monolayer cell cultures 
making it a unique and excellent model for inflammatory eye conditions, auto-immune 
diseases or transplantation.   
 
IFN-γ induces expression of HLA class II antigens through the activation of Janus 
kinase (JAK)/signal transducers and activator of transcription (STAT) of the 
JAK/STAT pathway (Watling et al., 2008). Janus kinase is a non-receptor intracellular 
tyrosine kinase that transduces the cytokine-mediated pathway (Figure 5.13). After the 
cytokine binds to the receptor, JAK phosphorylates and activates downstream proteins 
involved in the signal transduction pathway.  
 
The JAK autophosphorylation induces an internal conformational change which attracts 
the phosphorylated STAT proteins to bind to each other forming dimer pairs. The dimer 
moves into the nucleus, binds to the DNA, and causes transcription of genes.  Kamper 
et al 2012 have also shown involvement of B-associated transcript-3 (BAT3) in the 
expression of  HLA Class II whereby they observed strongly elevated levels of BAT3 
transcription in various tumour cell lines and macrophages following IFN-γ treatment 
(Kämper et al., 2012). Expression of Class II antigens was also linked with the 
expression of a Class II transactivator detected within hours of IFN-γ treatment of 
endothelial cells (Fritchley et al., 2000).  
 
 
 
Figure 5.13 The key elements in the JAK/STAT pathway. The JAK-STAT system 
consists of three main components: (1) a receptor (green), which penetrates the cell 
membrane (2) Janus kinase (JAK) (yellow), which is bound to the receptor and (3) 
Signal Transducer and Activator of Transcription (STAT) (blue), which carries the 
signal into the nucleus and DNA. Red dots -phosphates. (Image from Peter Znamenkiy - 
All right released, donated to public domain. Downloaded on 08.01.2015).  
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In the cornea, LC, which are  professional antigen presenting cells (APC) reside in the 
limbal region, but migrate to the cornea in inflamed conditions (Jerry Y Niederkorn, 
1995). LC trigger HLA class II antigen presentation pathways by sensitising the host’s 
alloreactive T cells to recognise foreign antigens on the grafts. Indeed this is an 
important mechanism to explain activation of T lymphocytes in inflammatory eye 
disease such as herpetic keratitis (Yang et al., 1998) and corneal allograft rejection 
(Khaireddin et al., 2003; Joseph et al., 2004). 
 
However, there are evidences that LC are also present in the central cornea (Hamrah et 
al., 2002; Hamrah et al., 2003) and these dendritic cells are capable to express Class II 
antigens after surgery and drain into the regional lymph nodes of the allografted hosts. 
 
The role of corneal epithelial cells to function as APC and produce T-cell response 
needs further investigation. It would also be useful to study whether Class II-bearing 
corneal epithelial cells associate with other signalling factors like intercellular adhesion 
molecules (ICAM) to interact with APC. The role of ICAM-1 and its ligand leukocyte 
function –associated antigen-1 (LFA-1) has been implicated in inflammation, 
immunologic response and wound repair. For example, upregulation of  ICAM in 
activated cornea fibroblasts caused adhesion of eosinophils and subsequent fibroblast 
damage in severe allergic corneal ulcers  (Okada et al., 2005). 
 
Chemokine CXCL12 ligand secretion in LMSC has been published previously (Polisetti 
et al., 2010) and in corneal fibroblast (Wilson et al., 2014). However, our results 
showed that mRNA expression of CXCL12 in the HTCEC cell line was not detected by 
q-RT-PCR, and the fold change expression in LEC was low compared to the breast 
cancer cell line MCF-7. CXCL12-mediated cellular migration in HTCEC could 
probably not be directed due to the unsupported expression of CXCL12 in this cell line, 
as opposed to LMSC. This finding alludes to the role of other potential factors being in 
play to direct cellular migration for corneal repair.  
 
MSC are non-haemopoietic stem cells which have regenerative ability and can 
differentiate into cell lineages of mesenchymal origin i.e. adipocytes, chondrocytes and 
osteocytes. In our project we have successfully isolated and expanded LMSC which 
fulfil the minimum criteria defining them as human MSC. Bone-marrow-derived MSC 
has shown excellent anti-inflammatory and wound healing properties when introduced 
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to corneal injury models in animal studies (Ma et al., 2006; Augello et al., 2007; Omoto 
et al., 2009; Jiang et al., 2010; Hsu et al., 2012; Jia et al., 2012). Bone-marrow-derived 
MSC has been investigated in the repair of corneal damage (Ma et al., 2006), and the 
proposed mechanism is suppression of   new vessel formation and inflammation post-
transplantation. The role of human LMSC for transplantation and ocular regeneration is 
an avenue to be further explored. 
 
Previously we described HTCEC cell line contains side population (SP) cells which 
proved to be enriched for expression of LSC markers ABCG2, p63 and the stem cell 
antigen Sox2 using an optimised human LSP protocol (Shaharuddin et al., 2013c).  SP 
phenotyping can lead to further functional characterization of putative stem cells as 
demonstrated in both humans and animals. Studies have shown that LSP cells had 
features consistent with stem cells (Budak et al., 2005; Cintia S. de Paiva et al., 2005a; 
Umemoto et al., 2005; Umemoto et al., 2006; Selver et al., 2011). In addition, here we 
demonstrated evidence that SP-sorted HTCEC showed higher expression of CXCR4 
compared to the NSP fraction.  
 
Corneal wound healing can be alluded to involve new vascular formation and cellular 
migration. This is possibly regulated by pro-inflammatory cytokines via the CXCR4 - 
CXCL12 axis; similar to that observed to occur in bone marrow-MSC migration for 
bone regeneration (Feng et al., 2014)  and MSC migration to sites of injury in cord 
blood (Deshpande et al., 2013). Additionally, Polisetti et al has demonstrated vascular 
endothelial growth factor (VEGF) was also found in abundance in LMSC (Polisetti et 
al., 2010).  
5.6 Conclusion 
To our knowledge, this is the first study to provide data on HTCEC HLA-typing which 
is an important step to study immunogenicity in this cell line. HTCEC expressed HLA 
expression when stimulated with pro-inflammatory cytokines which suggests that 
HTCEC is a suitable candidate to be an in vitro and in vivo model to study corneal 
inflammation, auto immune diseases and allograft corneal transplantation. Both HTCEC 
and the limbal sourced-LMSC exhibited cellular migration in response to CXCL12 
ligand stimulation which is an important property for angiogenesis and cellular 
regeneration. SP-sorted HTCEC also contained a significant number of CXCR4-
positive cells which may also be useful for studying stem cell migration. 
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Chapter 6 GENERAL DISCUSSION
6.1 Summary of aims  
 
At the beginning of this study, these specific aims were outlined; 
 To characterise LEC and HTCEC by LSC markers and stem cell antigens 
 To isolate human LMSC  
 To study growth and proliferation of LMSC on AM and characterise LMSC 
using limbal markers and stem cell antigens. 
 To isolate and identify LSP phenotypes in both primary LEC and HTCEC 
 To characterise LSP cells using LSC markers and stem cell antigens 
 To study the constitutive HLA expression in HTCEC both unstimulated and 
stimulated by pro-inflammatory cytokines 
 To examine CXCR4 expression in primary HTCEC and LMSC in both SP and 
NSP cells of HTCEC  
 To study chemotactic potential of HTCEC and LMSC in CXCL12-mediated 
cellular migration 
 
6.2 Summary of outcomes 
 
1). HTCEC was comparable to primary LEC in the expressions of common molecular 
markers for LSC and stem cell antigens.  
The challenges in LSC biology and its applications revolve around the identification, 
isolation and expansion of the stem cell phenotype. Characterisation of LSC is made 
more difficult with absence of specific LSC markers.  
2). MSC isolated from the limbus “LMSC” fulfils the minimum requirement defining 
them as human MSC, and they characterised for LSC markers.  
This study demonstrates a simple way of isolating LMSC from primary corneal tissues 
by serial trypsinisation alone. The cells grew in MSC-growth promotion media in 5% 
O2, 5% CO2 incubator at 37°C. LMSC have the characteristics of human MSC being 
plastic adherent and were positive for expressions of cell surface antigens CD44, CD90, 
CD105, CD146 and CD166. They also had low/no expression for the haematopoetic 
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commitment markers CD19 and CD45.  LMSC have the tri-lineage commitment to be 
osteogenic, adipogenic and chondrogenic.  
 
3). LMSC on AM tissue construct showed expression of important limbal markers, in 
addition to rapid growth without the use of feeder layers.  
The advantages of these culture conditions include shorter duration of cell cultures (5-7 
days) compared to 10-14 days for using outgrowths of limbal explants or using cell 
suspension from primary tissues. LMSC characterised for p63, ABCG2 and ABCB5. 
 
4). HTCEC has shown a side population which proved to be enriched for LSC.  
 The fact that ABC transporters are located transmembranously allows a prospective 
strategy for LSC enrichment using SP protocols. The sensitivity of SP assay to different 
species and cell types makes standardisation of SP protocols mandatory to ensure 
reliability and reproducibility of SP data. This will ultimately result in better 
interpretation of SP results and enable more accurate comparison between data 
generated in multiple studies.  
 
5). LSP cells were characterised by common limbal markers, stem cell antigen Sox2 and 
also ABCB5. 
 Here we provide the first data on ABCB5 characterisation in LSP cells which support 
the importance of this marker as an LSC marker.  
 
6). HTCEC was HLA-typed, and they constitutively expressed HLA Class I antigens. 
 
7). HLA Class II expressions were inducible and upregulated in HTCEC after 
stimulation with pro-inflammatory cytokines. 
Expression of HLA Class II molecules in HTCEC had similar trends as observed 
previously in primary human corneal cultures.   
 
8). HLA-DP expression was inducible and upregulated in HTCEC 
From the results of HLA typing, it was noted that this cell line does not possess allelles 
for HLA-DP, but the expression was inducible after stimulation with IFN-γ. Due to the 
limited published data on induced HLA-DP expression, this provides new insight to 
Class II antigen-specific immunological response in the cornea and also other systems. 
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9). CXCR4 was expressed in HTCEC and LMSC and both these cell types were 
migratory in response to CXCL12 ligand stimulation.  
 
10). The high expression of CXCR4 in SP cells is useful to study CXCL12-mediated 
cellular migration of LSC for re-epithelisation during cornea injury. 
As an example, CXCR4 and its specific ligand CXCL12 has been implicated in the 
“homing mechanism” to sites of injury in the renal system. This is an important 
mechanism for LSC to migrate to the site of corneal injury for repair and reconstruction. 
 
The main outcomes of this thesis are graphically represented in Figure 6.1. 
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Figure 6.1 Graphical presentation of important outcomes. Limbus is hypothesised to be 
the location of LSC (i) LEC and HTCEC contain SP cells that characterised for LSC 
markers and stem cell antigens  (ii) LMSC are multipotent stem cells sourced at the 
corneal limbus which characterised for LSC markers(iii) HLA molecules are also 
abundant at the limbus and the Class II expression is inducible following IFN-γ 
stimulation (iv) LMSC express LSC markers (v) LMSC and HTCEC express CXCR4  
and migrate in response to CXCL12.  
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6.3 Implications of the project and recommendations for future work 
 
A major requirement for successful LSC transplantation is viable isolation of these cells 
by identification of its molecular markers. It has been shown that there are no specific 
markers which mark LSC. Thus a panel of positive and negative molecular markers 
would be necessary for isolation of LSC.  
An alternative approach to the reliance on absent/presence of surface markers would be 
the utilization of a stem cell enrichment strategy for LSC such as SP discrimination 
assay. This would also allow for the isolation of more stem cells for transplantation. The 
use of SP assay with an immortalized corneal cell line that contains LSC would be 
useful in addressing questions about LSC biology.  
The LSP discrimination assay could be used as an enrichment or purification method to 
further characterise and/or enrich for LSC. Studies have shown that LSP cells were 
enriched for stem cell activity had an increased colony forming and proliferative 
capacity (Budak et al., 2005; Cintia S. de Paiva et al., 2005a; Akinci et al., 2009). In 
addition, SP cells represent a source of stem cells that does not rely for identification on 
the use of a panel of defined stem cell markers and lineage negative markers and can be 
sourced from the host if healthy corneal tissue remains.  
The LMSC-AM tissue engineered construct has great potential for ocular surface 
regeneration. Currently there are no clinical trials using LMSC for LSC transplantation 
despite many clinical trials using MSC in other organs such as in the lungs, intestine 
and liver. LMSC also have immunomodulatory effects e.g. trophic and growth factors, 
and these cells can be expanded readily in culture, stored frozen and brought back up in 
culture and are therefore a potential cellular tool. 
The challenge would be to achieve an effective SP cells expansion system. The 
problems exist in the low yield of fresh SP-sorted cells, and absence of molecular LSC 
markers. SP cells need to be grown successfully to be transferred on an appropriate 
scaffold system for clinical use. It is reasonable to believe that a stem cell-enriched 
population of cells might proliferate rapidly in appropriate and supportive culture 
conditions. More evidence to address the variations in percentage of SP populations 
across mammalian species needs to be collected, which might be directly or indirectly 
related to SP protocols. However, culture confluence can be a tool for isolation of 
higher numbers of SP. SP cells could readily expand in numbers and colony size 
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compared to NSP. Further, reduced cellular confluence and hypoxic culture condition 
were two factors which might be strategies for SP cellular expansion.  
 
Roles of ABCB1, ABCG2 and ABCB5 transporters with LSP and possible mechanisms 
of signalling factors have been investigated in other systems and shown to confer the SP 
phenotypes. The importance of ABC transporters responsible for the SP phenotype in 
LSC has been previously investigated. Here we have shown the inhibition of efflux 
activity of SP cells by verapamil (which mainly blocks ABCB1 and ABCG2). We have 
also demonstrated mRNA and protein expression of ABCG2, ABCB1 (mRNA) and also 
ABCB5 expression by PCR and ICC in HTCEC and LMSC. Further investigations with 
knock out animal models would reaffirm the role of these genes in LSP phenotypes, and 
their links to LSC maintenance and regeneration.  
 
To our knowledge, this is the first study to provide data on HTCEC HLA-typing which 
is an important step to study immunogenicity in this cell line. HTCEC also expressed 
similar trend of inducible HLA expression as demonstrated in previous human corneal 
cultures when stimulated with inflammatory cytokines, especially by IFN-γ.  On top of 
that, there is a limited knowledge in previous literature on inducible HLA-DP 
expression, such as provided in our results. This alludes to the suitability of HTCEC for 
LEC replacement and as a robust model for corneal inflammations, auto immune 
diseases and allograft corneal transplantation.  
 
Both HTCEC and the limbal sourced-LMSC exhibited cellular migration in response to 
CXCL12 ligand stimulation in the presence of CXCR4 receptors. However, it was 
demonstrated that LMSC was more responsive than HTCEC, which could attribute to 
the presence of CXCR4 and secretion of CXCL12 in LMSC as previously reported. 
Conversely, although CXCR4 was expressed by HTCEC, our results showed this cell 
line did not exhibit CXCL12 gene expression. This finding suggests the role of other 
potential factors such as inflammatory mediators being in play to direct cellular 
migration for corneal repair. 
 
The recruitment of adult stem cells to the site of injury for cellular repair, loosely 
termed as the “homing” mechanism has been observed in the haematopoietic 
(Deshpande et al., 2013) and renal systems and is regarded as essential for tissue 
engraftment (C. S. de Paiva et al., 2005b). Using knock out gene models or neutralizing 
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antibodies to CXCR4, or CXCR7 receptor, a novel endothelial receptor for ligand 
CXCL12, we could further explore into their role in corneal epithelial regeneration in 
response to injury as demonstrated in the renal system (C. S. de Paiva et al., 2005b). 
The role played by adhesion molecules in this signalling mechanism is also an attractive 
area to investigate. 
 
Due to existing problems in donor availability and donor-to-donor-variability, HTCEC 
is an attractive consistent and a reproducible source of corneal stem cells and can be 
used for refinement of methods or optimisation protocols and useful for experiments 
requiring large number of cells. Although cell lines could not be more superior to donor 
samples, the use of cell lines have proven to be economical in term of reducing animal 
experiments and ultimately the results could be translated for therapeutic potentials.  
The outcomes of this project have shown HTCEC has remarkable biological properties 
as a robust model for further understanding of LSC biology.  
 
Future studies will focus on the proliferation and maturation of HTCEC and the limbal 
derived-MSC on biological and non-biological substrates for ocular surface 
reconstruction such as in vivo transplantation for LSCD. Alternatively, to study the 
usefulness of these cells to address a basic problem such as cell signalling and the 
factors involved in LSC biology.  Bone-marrow-derived MSC, these cells have shown 
excellent anti-inflammatory and wound healing properties when introduced to corneal 
injury models in animal studies (Ma et al., 2006; Augello et al., 2007; Omoto et al., 
2009; Jiang et al., 2010; Hsu et al., 2012; Jia et al., 2012) and in the repair of corneal 
damage (Ma et al., 2006). The proposed mechanism is suppression of   new vessel 
formation and inflammation post-transplantation.  
 
Further investigation into the immunological factors in the cornea that allow tolerogenic 
potential of the organ to respond to ocular antigens is necessary to exploit corneal 
immune privilege to its full advantage. Identification of inflammatory molecules and 
apoptotic markers, their signalling pathways, and role of HLA matching, are some of 
the strategies to promote the survival of whole corneal and LSC transplantation. 
Tolerance towards allogeneic organ grafts represents one of the major aims of 
transplantation medicine.  
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Ex vivo expanded LSC transplantation has been proven to be able to reconstruct the 
ocular surface in LSCD eyes using a biological scaffold system which provides transfer 
of proliferative cells to the target site. Alternately, producing a scaffold which 
incorporates stem cell-enriched population from a corneal cell line could be the answer 
to ensure uniformity in the quality of the grafts. However, these methods need to be 
further refined to include protocols to assess tissue viability, the quality of   tissue 
constructs and safety assessment. Needless to say, the quality of cells in the tissue 
construct is vital to ensure permanent tissue repair and successful engraftment. In order 
for LSC to be successfully translated into favourable clinical outcomes, a good 
manufacturing practice (GMP)-compliant protocol would be a positive step towards 
achieving high quality tissues to fulfil the requirements for clinical transplantation.   
 
Currently, it is still unclear how restoration of the damaged ocular surface takes place 
after LSC transplantation. It is very unlikely that it is due to replacement of stem cell 
numbers alone. Studying the LSC fate in different aetiologies of stem cell deficiency 
and the types of tissue transplantation would be a future direction to explain the process 
of cellular restoration. At present, there is no consensus on LSC fate in different types 
of transplantation (Shimazaki et al., 1999; Daya et al., 2005; Djalilian et al., 2005) such 
as in penetrating keratoplasty, alone or in combination with limbal allograft 
transplantation, or in the case of ex vivo LSC transplantation. The problem for case to 
case comparison exists in multiple diagnosis of LSCD, tissue transplantation types, 
methods for cell tracking to determine the cellular fate, and non-standard cut off points 
for cellular analysis to take place.  
Molecular mechanisms regulating the immune plasticity of corneal stem cells could be 
relevant in clinical setting and may explain the differences in the outcomes between 
murine and human systems. Thus understanding these mechanisms will contribute to 
the development of better therapeutic approaches for transplantation of not only the 
cornea, but other organs as well. 
The role of CXCR4/CXCR7 and their unique ligand CXCL12 in the endothelial cells 
has been previously investigated (So and Epstein, 2004). It would be interesting to study 
the roles of these receptors to address the process of angiogenesis and corneal 
vascularisation which occur in LSCD. Corneal conjunctivalisation is due to the 
encroachment of vascularised tissue   into the cornea which leads to blindness and 
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ocular pain. The role of vascular endothelial growth factor receptors and its inhibitors to 
prevent vascularisation is also an interesting area to investigate in the quest for 
improved outcomes of cellular therapy for LSCD.  
 
During the course of this project, the field of LSC has dramatically advanced with a lot 
of research on basic and fundamental sciences and clinical application. LSC has 
acquired a niche in cornea biology and drawn tremendous interest from research 
scientists. Publications in this field have soared remarkably which draws the necessity 
for more translational approach to address the gap in the management of LSCD and 
ocular surface regeneration. This project offers strategies to improve the outcome of 
LSC transplantation by offering a cellular selection strategy, alternative cellular tools 
and also a robust cellular model for further understanding of LSC biology.  
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